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Abbreviations and symbols
List of used abbreviations LASER localised adiabatic selective
AFP adiabatic full passage refocusing
AHP adiabatic half passage M E N G meningioma
Ala alanine MET metastasis
Asp aspartate ml myo-inositol
ATP adenosine triphosphate M M macromolecules
BIR-4 Bj-insensitive rotation with 4 MRI magnetic resonance imaging
segments MRS magnetic resonance spectroscopy
Cho choline MRSI magnetic resonance spectroscopic
Cr creatine imaging
CSDE chemical shift displacement error MS mean squares
CSF cerebral spinal fluid N A A N-acetylaspartate
CT computerized tomography NABT normal appearing brain tissue
CoV coefficient of variance NM R nuclear magnetic resonance
CRLB Cram er Rao lower bound N O E nuclear Overhauser effect
DEPT distortion less enhancement of O VS outer volume saturation
polarisation transfer PC phosphocholine
FDG 2-deoxy-2-,8F-fluoro-D-glucose PCr phosphocreatine
FE fractional enrichment PDE phosphodiesters
FID free induction decay PE phosphoethanolamine
FOV field of view PET positron emission tomography
FT Fourier transform Pi inorganic phosphate
F W H M full width at half of the maximum PME phosphomonoesters
G ABA y-aminobutyrate PNET primitive neuroectodermal tumours
Glc glucose PO peritumoural oedematous
Gin glutamine ppm parts per million
Glu glutamate PRESS point resolved spectroscopy
G ly glycine PSF point spread function
G B M glioblastoma multiforme Pyr pyruvate
G M gray matter RF radio frequency
GPC glycerophosphocholine RINEPT refocused insensitive nuclei
GPE glycerophosphoethanolamine enhanced by polarisation transfer
GSH glutathione ROI region of interest
G ua guanidoacetate SADLOVE single-shot adiabatic localised
ICC intraclass correlation coefficient volume excitation
INEPT insensitive nuclei enhanced by SAN surrounding apparent normal
polarisation transfer SAR specific absorption rate
ISIS image selected in vivo Scyllo sc///o-lnositol
spectroscopy SD standard deviation
Lac lactate SE spin echo
SNR signal-to-noise ratio List of used symbols
sRINEPT selective refocused insensitive 'H proton-1
nuclei enhanced by polarisation ,3C carbon-1 3
transfer 31 p phosphorous-31
STEAM stimulated echo acquisition mode ,9F fluor-1 9
Sue succinate B0 main magnetic field [T]
SVS single voxel spectroscopy B, RF magnetic field [T]
Tau taurine 8 chemical shift [ppm]
TCA tricarboxylic acid E (magnetic) energy [J]
TE echo time 9 phase offset [Hz]
TMS tetramethyl silane phase shift [-]
TR repetition time Y gyromagnetic ratio [H z/T ]
VO I volume of interest G gradient strength [mT/m]
W M white matter h Planck's constant (6 .63  • 1 0"34Js)
nuclear spin, first quantum number [-]
J nuclear coupling frequency [Hz]
k Fourier transformed distance [rrr1]
M- magnetic moment [A /m ]
M magnetisation [A /m ]
m second quantum number [-]
V frequency of nucleus [Hz]
i RF pulse length [s]
T, longitudinal relaxation time [s]
t2 transverse relaxation time [s]
V transverse relaxation time
[s] including influence from 
macroscopic inhomogeneities
9 flip angle of RF pulse [°]
co frequency [Hz]
Introduction
Nuclear Magnetic Resonance
Since the discovery of the nuclear magnetic resonance (NM R ) phenomenon in 1 9 4 5 ,  
the number of its applications has increased impressively. Initially, this technique was  
only used in solid-state physics and chemistry, but later evolved into biom edicine. Its 
m edical diagnostic applications becam e apparent by the discovery that N M R  could 
be used to generate anatom ical images of living tissue, an application that w as called  
M agnetic Resonance Im aging or M RI. During the last 3 0  years the clinical use of 
MRI has developed enormously. N o w ad ays , MRI has become part of d aily  clinical 
routine in every modern hospital. Besides M RI, the N M R  technique is app lied  in several 
other ways in life sciences such as M agnetic  Resonance Spectroscopy, which is w id e ly  
used as a tool for research in (bio-)chemistry, m edicine, and the food industry. This 
thesis deals with a particular application of this N M R  branch: M agnetic  Resonance 
Spectroscopy of human brain tumours.
Clinical diagnosis of human brain tumours
W hen  patients have symptoms that are suspicious for having a brain tumour the diagnosis 
of a tumour is typically achieved by an MRI exam ination, fo llowed by a histopathologic 
review  of a tissue sample from the brain taken during surgery. The histopathology  
of brain tumour tissue samples is currently the only method that unambiguously can 
determine the tumour type and aggressiveness, and is therefore considered the 'ground  
truth'. However, this form of diagnosis is far from ideal. To obtain a tissue sample from 
a suspicious lesion in the brain , surgery is needed which can be very dem anding for 
patients. M oreover, brain surgery has a mortality risk for the patient of 3% . W h a t might 
be even more severe is that the obtained tissue sample does not necessarily reflect all 
features and characteristics of the brain tumour and m ay therefore lead to a wrong  
diagnosis or underestimated diagnosis. This can have enormous consequences for the 
treatment of the patient. Therefore, there is a need for a non-invasive tool to diagnose  
brain tumours and to study their behaviour in vivo in the patient.
M agnetic  Resonance Spectroscopy (MRS) is a non-invasive technique by which some 
aspects of the metabolic composition of tissues, and of its physiology and morphology  
can be studied directly inside the patient. This technique has large potential to improve 
the diagnosis of brain tumours and might even circumvent the need for surgery, 
greatly improving patient care. Furthermore, MRS may be used for monitoring brain  
tumour therapy in a non-invasive w ay. Since MRS provides information about tumour 
metabolism it m ay reflect tumour presence and tumour activity in an earlier stage than 
its ap p earan ce as anatom ical changes on MRI.
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Introduction
Aim of this thesis:
To develop new methods for M agnetic  Resonance Spectroscopy of the human brain  
that can be used for the diagnosis and characterisation of brain tumours.
Outline of this thesis
The scientific publications that have em erged from my w ork as a PhD student are  
em bedded as chapters in this thesis. I included two introductory chapters that should 
fam iliarise the reader with the two main topics of this thesis: M agnetic  Resonance 
Spectroscopy and brain tumours. Therefore, Chapter 2 presents a brief introduction 
into M agnetic Resonance Im aging (MRI) and M agnetic Resonance Spectroscopy (MRS), 
focussing on the last technique. Finally this chapter briefly describes a new technique  
that was developed for 3D  'H  M agnetic  Resonance Spectroscopic Imaging (MRSI) of a 
w ell-defined region in the brain.
Subsequently Chapter 3 describes w hat the pathology of brain tumours is and how  
these tumours are diagnosed in clinical practice, fo llowed by a brief overview  of 
current research on brain tumours using MRS.
Chapter 4 discusses the reproducibility of the newly developed sequence for 3D  
'H  MRSI of the human brain in a multi centre study. A  study on human brain tumours 
using this technique is presented in Chapter 5. In that study an infiltrating and 2  
circumscribed human brain tumours w ere  investigated and discrim ination between the 
tumour types was based on results from MRSI. M etabo lic  changes in the infiltrating part 
of the glioblastom a w ere  the key elements exam ined in this study.
Chapter 6 presents a new technique for optimal detection of the phosphorylated  
mem brane compounds in the human brain. In this 3,P MRS technique polarisation  
transfer is used to increase the sensitivity of the measurement. The method was extended  
to an MRSI mode and w as tested on volunteers of different age. The results of these 
measurements together with the findings of a pilot study in which patients with brain  
tumours w ere exam ined using the same technique are described in Chapter 7.
The first results of a dynamic ,3C MRS measurement during ,3C enriched glucose 
infusion of a patient with a brain tumour are presented in Chapter 8. W e w ere  
the first to use this technique in a patient with a brain tumour to study the glucose 
metabolism of the tumour.
Finally, the w ork described in this thesis and some general conclusions and remarks 
about multi-nuclear MRS of brain tumours are summarised in the last chapter.
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A brief introduction to 
Magnetic Resonance
Abstract
This chapter briefly describes the main principles underlying (nuclear) M agnetic Resonance 
Imaging (MRI) and (nuclear) M agnetic Resonance Spectroscopy MRS. Nuclear M agnetic  
Resonance (NMR) is the study of the magnetic properties of nuclei. In 1 9 4 5 , Purcell1 and 
Bloch2 independently discovered the interaction of electromagnetic radiation with nuclear 
spins positioned in a strong magnetic field. In the first decade thereafter N M R  was mainly 
used as an experimental tool to investigate the chemical properties of molecules. The first 
in vivo N M R  experiment with diagnostic value was performed by Dam adian3 in 1971  
w ho showed that the N M R  properties of malignant tumour tissues significantly differed 
from normal tissues. Since then the field of N M R  has been rapidly evolving and many 
applications and methods for N M R  on living tissues and on humans have been developed. 
Some of them have become indispensable in medical research and diagnosis.
16
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2.1 Physics of Nuclear Magnetic Resonance
N uclear M agnetic  Resonance (NM R ) is based on the physical property of atomic nu­
clei, called 'sp in '. Spin causes the nuclei to interact with an externally app lied  m ag­
netic field. In a given energy state a non-zero spin system has a total magnetic d ipole  
moment  ^and spin angular momentum L. Consider the magnetic moment of a loop 
current, ƒ, which is given by ^=j A, w here A is the surface vector of the area enclosed 
by the current. Analogue to this system, the angular momentum of a rotating electrically  
charged object is related to the magnetic moment by ^=y L, w here y is the gyrom ag- 
netic ratio and equals q/2m  for a spherical object with uniform distribution of charge  
q and mass m.
To understand more about the interaction of nuclei possessing spin with a magnetic 
field it is necessary to use quantum mechanics. In the quantum mechanical theory, 
one important rule is that angular momentum of elem entary particles (e.g. protons, 
neutrons, electrons) is limited to discrete values. In quantum mechanics the direction of 
the angular momentum is specified by a second quantum number, m, which can have  
certain discrete orientation with respect to a given direction. The component in z- direc­
tion of the angular momentum of a spin is given by 45:
(Eq. 2 .1 )
W h e re  h is the Planck's constant (6 .6 3  1 0 34 Js). The second quantum number can have 
2/+1 values, w here I is the first quantum number of the nucleus i.e. m= -I, -1 + 1, -1+2, ..., 
1-1, I. For protons, neutrons and electrons, the first quantum number I is V2 (Table 2 .1 5) .
Table 2.1: Magnetic properties of commonly encountered nuclei in in vivo NMR
Isotope Spin Gyromagnetic
ratio
M HzT1
Resonance Frequency 
at 3 .0  Tesla
M Hz
Natural
abundance
%
Relative
sensitivity
*
'H 1 /2 42 .578 127.734 99 .985 1
,3C 1 /2 10.708 32 .124 1.108 1 .7 6 *1 0 4
3,P 1 /2 17.252 51 .756 100.000 6 .6 5 *  10-2
,5N 1 /2 4 .317 12.951 0 .370 3 .8 5 * 10-6
,9F 1 /2 39 .427 118.281 100.000 0.833
23Na 3 /2 11.262 33 .786 100.000 9 .2 7 *  10-2
* Relative sensitivity is calculated as product o f NMR sensitivity and natural abundance.
17
Since the angular momentum of particles is quantised its magnetic moment is also quan­
tised. The magnetic moment along the z-direction of a nucleus is given by:
2 n
(Eq- 2 .2 )
A  nucleus with magnetic moment exposed to an external magnetic field B0 (Fig. 2.1 A) will 
have magnetic energy E:
E = -n A = -r
2 k
mB„ (Eq- 2 .3 )
The energy is also quantised since m is a discrete quantum number and its number of varia­
tions is dictated by I. In case of I = V2 , the most common value of /, the difference between 
the two possible (2 /+ 1 ) energy levels is:
AE = y(— )B0 (E q -2.4)
2 K
The two possible energy levels in case of 1= Vi, are often also called the 'spin up' and the 
'spin down' level. W hen an oscillating magnetic field is applied perpendicular to ^ w i t h  
a frequency v:  such that its energy equals the energy difference AE  between the two spin 
energy levels, the resonance phenomenon, a transition between the two energy levels, can 
be observed. The energy of the oscillating magnetic w ave equals A E = hv0. W hen combin­
ing this with equation 2.4, the Larmor equation is obtained (Fig. 2.1 B):
B
Figure 2 .1 : A) a nuclei in an external magnetic field starts to precess around the magnetic field. B) The 
energy difference between the two possible energy levels o f the spin. C) Macroscopic magnetisation. The 
net magnetisation is aligned along B0
X
2 n
(Eq. 2 .5 )
The above description was applied to a single particle system. However, in magnetic 
resonance w e are mostly dealing with a large ensemble of spins and w e should consider 
the behaviour of a large group of spins with / = V2 in a magnetic field BQ. Each spin with 
magnetic moment fi is rotating around B0 (precession) and for each spin two energy
18
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levels are possible. These two energy levels have a different population, described with the 
Boltzmann equation for the population ratio, also called 'polarisation'.
n -  -A E /kT  —h v /k T  ^ - 6 )—  = e = e
»+
W here n and n+ are the population in the high and the low energy state respectively, k 
is the Boltzmann constant (1 .3 8 0 7 -1  O'23 J /K  ) and T is the temperature in Kelvin. Thus in 
thermal equilibrium at non-zero temperature, there is an occupancy difference between the 
two energy levels and the high energy states are less populated than the low energy states. 
For exam ple, in w ater protons of biological tissue at room temperature the difference in 
energy level occupancy is about 1 O'5 at 3 Tesla, resulting in a small net magnetisation of the 
system along the direction of the externally applied magnetic field BQ. This is the so-called 
longitudinal magnetisation M Q, along the z-direction (Fig. 2 .1 C ). Since the magnetic mo­
ments of individual spins are randomly distributed in a cone around B0 (see Fig. 2.1 .C), 
there will be no net magnetisation in the x-y plane, resulting in no transverse magnetisation 
M  . The thermal equilibrium magnetisation M 0 is the maximum magnetisation that is avail­
able for the N M R  experiment and is given by the expression:
Mr, =
,  \ 4 k T y
(Eq. 2 .7 )
where n is the spin density.
If w e want to observe a signal, M 0 needs to be perturbed such that the magnetisation causes 
a detectable oscillating magnetic field. This can be done by applying a magnetic field per­
pendicular to B0, This B, field should also have the Larmor frequency to be able to observe 
the resonance phenomenon. The B, field is in the radio frequency (RF) range, and is there­
fore often called an RF pulse. During this RF pulse, the magnetisation will feel a torque due 
to the B, field and starts to rotate. W hen stopping the RF pulse, w e can follow the behaviour 
of M  during the so-called free induction decay (FID). The alternating magnetic field will gen­
erate a current in a nearby conducting wire according to Faraday's law of induction. The 
current can be detected. Later on, w e will explain about how information about the chemical 
properties of the particles and spatial information can be encoded in this current signal. First 
we will consider in more detail what happens to the net magnetisation after a perturbation.
Rotating frame of reference
Since the magnetisation precesses around B0 it is quite difficult to follow the behaviour of the 
magnetisation in the static environment, also called the laboratory frame of reference. There­
fore, a rotating frame of reference is introduced. This frame rotates at the Larmor frequency 
in the transverse plane, while the z-direction stays along the direction of the main magnetic 
field B0 (Fig. 2 .2 ). The rotating frame helps to describe what happens with the magnetisation 
when it relaxes back to equilibrium.
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Figure 2 .2 : A) Movement o f the net magnetisation during a 90° RF pulse along the x-axis in the laboratory  
frame o f reference. B) The same movement o f the net magnetisation during a 90° RF pulse along the x-axis, 
now in the rotating frame o f reference.
2.2 Relaxation mechanisms
The process of an arbitrary magnetisation M <M 0 returning back to the equilibrium situa­
tion is called relaxation. Two types of relaxation processes can be distinguished: the 
longitudinal re laxation, 'spin-lattice' or T, relaxation and the transverse relaxation, 
2  'spin-spin' or T2 relaxation 6.
® T, relaxation describes the interaction between the spin and its environment (lattice), e.g.
o' how energy from the spins is dissipated in its environment. The z-component of magnetisa-
u  tion during T, relaxation can be described as follows:
M z(t) =  M 0( l - a e  "T' ) (Eq. 2 .8 )
W here , M Q is the steady state magnetisation and a  is the coefficient of inversion. If a  is
1, the magnetisation is initially in the transverse plane, if a is 2 the initial magnetisation is 
fully inverted along the - z  direction (Fig. 2 .3 A ).
The time constant T, is the longitudinal or spin-lattice relaxation time and it is determined 
by the environment. The relaxation process can be very slow, for exam ple in solids the 
relaxation time is in the order of minutes. In conductors, however, the T, relaxation time 
is much faster and can be as short as a few  milliseconds. The w ater protons in biological 
tissues have T, values in the order of one second, depending on tissue type and the main 
magnetic field strength BQ. An exam ple of T, relaxation of one metabolite observed in cells 
(choline) is given in Figure 2 .3 A .
T2 relaxation describes the loss of the transverse magnetisation Mxy, which is in the 
plane perpendicular to /Mz (Fig. 2 .3B ). Transverse magnetisation, or phase coherence, 
decreases due to a process called dephasing. The individual magnetic moments that
2 0
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Figure 2 .3 : T, relaxation (A) o f Choline in the human brain at 3 Tesla (T^-relaxation time o f 1200ms) starting 
from inversion (dashed linej and from the transverse plane (solid line). T2 relaxation o f Choline (B) in the 
human brain a t 3 Tesla (solid line, T^relaxation time o f 200ms) and a t 1.5 Tesla (dashed line, T^relaxation 
o f 400ms). Signal intensities are normalised to M 0.
build up Mxy , start to spread out because the interactions between spins cause rapidly  
changing local magnetic fields. Individual spins, having their own magnetic field, influ­
ence their neighbours by d ipolar coupling, chemical exchange or diffusion and they 
cause their local magnetic fields to slightly differ in amplitude and frequency. Due to 
this spread of resonance frequencies, the 'phase coherence' is lost over time, causing a
dec rease of M
(Eq. 2 .9 )
In addition to this process of T2 relaxation on the microscopic scale, M  will also decay  
due to changes on the macroscopic scale, for exam ple, when small spatial inhomogene­
ities in the magnetic field are present. The combination of the pure T2 relaxation and this
macroscopic re laxation is called T *  relaxation:
1 _ J_ + 1 (Eq- 2.10)
^  2 ^ 2 ^ 2 macroscopic
It is important to understand the spin properties and relaxation mechanisms because these 
properties are used to form contrast in an image and they determine the intensity of signals 
from metabolites in an MR spectrum. The relationships between the properties of spins and 
MR observations are explained in the following sections.
2.3 Interaction with an external field and the Bloch equations
Consider the equilibrium situation, where a sample of spins has a net magnetisation that is 
aligned with the B0 field. The z-component of the magnetisation is constant according to:
2 1
J £ M  =  0 (Eq. 2 .1 1 )
dt
The x and y component of M  have random orientations and precess with the Larmor fre- 
jnd B0 th us the mean amplitude is zero.
^ M  = 7M B 0 (Eq. 2.12)
d t ' 0
d M r{t)
dt
=  -yM xB0 (Eq- 2 .1 3 )
As explained before, when a sample of spins with a net magnetisation M  is exposed to an 
external B, field, the spin sample will experience a torque and starts to rotate. Assuming 
that the RF is formed according to the quadrature principle (meaning that the vector B, 
has 2 perpendicular components), the net magnetisation is multiplied by the vector B(t);
/ S I cos (at)
B(t) = -B i sin(atf)
Bn
(Eq- 2 .1 4 )
W here w is the Larmor frequency.
This leads to the following magnetisation in the absence of relaxation:
dM' ^  = y[M (t)B0 - M z(t)B, sin(a»)] (Eq. 2 .1 5 )
dt
d M ' ' _ y[MM)Bt cos(M )- M x(t)B0] (Eq- 2 .1 6 )
dt
J I M  = y[Mx(t)BlSm (a t )-M v(t)BlCos(cot)] (Eq. 2 .1 7 )
dt
These are the Bloch equations 7 in the laboratory frame (not the rotating frame of reference 
(Fig. 2 .2A )) that describe the rotation of the magnetisation in the presence of external fields 
B0 and B ,. Including relaxation processes as described in the previous section equations 
2 .1 5 -2 .1 7  will become:
dA4j ^  = y[My(t)B0- M 2(t)Bl s i n i w t ) ] - * ^  (Eq. 2 .1 8 )
at T2
d M  (t) M  ft)  / r  9  iQ i
— j —  =  y[Mz(t)Bl cos(cot)-Mx(t)B0] ----^  W  2.19)
dt T2
dMM  -  y\Mx{t)B, sin(a x )-M r(t)Bl c o s ( ® 0 ] - ^ ^ — 1 E^q- 2 '2 0 '1
2 2
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These Bloch equations form the basis of the design of N M R  pulse sequences. So far, the 
physical properties of spin have been described following the example of protons. How ­
ever, these principles also hold for other nuclei possessing spin 1 /2  (Table 2 .1 ).
2.4 The MR spectrum and chemical shift
Recall that an alternating magnetic field will induce a current in a nearby conducting wire. 
This current is obtained in the receiver coil and represents the time domain signal f(tj. It can 
be transformed to a frequency-domain signal by Fourier transformation:
+oo
F(a>) =  ƒ ƒ (t)e~'mdt (Eq. 2 .2 1 )
Fourier transform of a time domain signal results in a spectrum where each point has a real 
and im aginary component given by:
R(co) = A(a>) cos cp -  D(a>) sin cp (Eq. 2 .2 2 )
/(to) = A(co)sin(p + D(co)costp (Eq. 2.23)
W here A(u>) and D(u>) are the absorption and dispersion components of a Lorentzian line 
shape (Fig. 2 .4 ). The width of this line is determined by T2* ,  the longer the T2*  the nar­
rower the line. To obtain a line shape in R(a>) that is positive only, the phase of the signal 
can be adjusted by adding a phase offset cpc until the dispersion component cancels itself. 
Usually cpc has a linear and a first order component:
(pc = %  + ( f t ) -© 0)<p, (Eq. 2 .2 4 )
The main reason to transform the time domain signal into a spectrum is that a spectrum 
provides a clear overview of the specific resonance frequencies that are present. This 
is extremely useful in unravelling the chemical structure of the sample that is measured. 
M ore exactly, the electrons that surround the nucleus determine its precise frequency. Each 
nucleus has an orbiting cloud of electrons around it and each chemically different nucleus 
has a specific configuration of this electron cloud. These electrons can also be pictured as
Figure 2 .4 : The spectrum o f a signal with one frequency, shown in absorption and dispersion.
a moving current around the nucleus, which will generate a magnetic field at the nucleus. 
This magnetic field will reduce the effective magnetic field and causes a slightly different 
resonance frequency of the nucleus. This phenomenon is called chemical shift, and since 
the differences in resonance frequencies are small compared to the Larmor frequency, they 
are expressed in parts per million:
g = V ~ V* .10‘ (Eq. 2 .2 5 )
v,,f
W here  S is the chemical shift, v, the frequency of the nucleus of interest and vmf the frequen­
cy of a reference compound. For 1H and ,3C MR spectra the signal of the chemically inert 
tetramethylsilane (TMS) is usually placed at 8 = 0 ppm as a reference, f o r 31P spectra, the 
energy compound phosphocreatine (present in living tissue) is often used as a reference.
2.5 Nuclear coupling
In molecules multiple nuclei can be bound together by chemical bonds (electron clouds). 
Therefore, the magnetic field of a nucleus is not only influenced by its own electron cloud 
but also by its neighbours' clouds 8. The process of spins influencing their neighbouring 
spins is called coupling. This can happen through space and through chemical bonds (Fig. 
2 .5 ). During dipolar coupling the magnetic moment of one proton in an external magnetic 
field B0 (parallel gray lines in figure 2 .5 A ) is perturbed by the magnetic field at the other 
proton within the same w ater molecule, or between different molecules (Fig. 2 .5 A ). As 
the w ater molecule rotates and translates randomly, the direction and magnitude of the 
dipole-dipole interaction changes according their orientation in BQ. Coupling through 
space, or dipolar coupling, is mostly cancelled out in liquids due to the rapid motion of 
the molecules. Coupling through chemical bonds, also called scalar coupling, spin-spin 
coupling and J-coupling 9, is not cancelled out.
B
(Glycerol)
\ I 
0 — P— 0
0  Jph .....  H*‘ Jhh ’’ H
t t
3.98-4.31
ppm
3.22-3 66 
ppm
6 .0 -7 .3  2 .2 - 7 3
Figure 2 .5 : A) D ipolar coupling o r through space coupling o f protons in two water molecules in an exter­
nal magnetic field. B) Chemical structure o f phosphocholine in which homonuclear (between two proton 
spins JHHj  and heteronuclear (between proton and phosphorous spin JpH) J-coupling are present.
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Consider a nucleus A which is coupled to nucleus 8. Nucleus A has two energy levels, 
(recall spin up and spin down), and a corresponding energy transition that results in one 
peak in the spectrum (Fig. 2 .6 A ). Due to the near presence of nucleus 8, nucleus A senses 
the two possible energy levels of nucleus 8, which causes the energy levels to split into four 
(Fig. 2 .6B ). The two different energy transitions give rise to two spectral lines per nucleus: it 
forms a doublet instead of one peak. These doublets are positioned around the resonance 
frequency of the nucleus and the distance between the peaks is the characteristic J-coupling 
constant of nucleus A and 8.
The J-coupling between nuclei provides information about molecule configuration and is 
for example used in characterisation of proteins in chemistry. However, these split peaks 
can also be unwanted, for example in spectra with a low signal to noise ratio. To avoid 
this, it is possible to merge the doublets (or multiplets) into a single peak. This is done by a 
process called decoupling. Signals can be decoupled by applying a continuous external 
RF field to the nucleus that is not observed (let's say nucleus 8). This causes a continuous 
exchange between the energy states of the coupled nucleus B, which averages out their 
influence on the nucleus of interest A , resulting in collapsing the doublet into a single peak: 
a singlet (Fig. 2 .6B ). In practice, heteronuclear decoupling during acquisition is achieved 
by alternately sampling and applying an inversion pulse to the not observed spin, thereby 
refocusing the heteronuclear J-couolina.
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Figure 2 .6 : A) Energy levels o f a single spin system and its corresponding spectrum. B) Energy levels o f a 
two spin system and its corresponding J-coupled spectrum.
2.6  Echo formation
W hen w e w ant to observe a signal, w e need to perturb the net magnetisation with an RF 
pulse. A  pulse sequence is a set of RF pulses in a specific order that manipulate the net 
magnetisation. The two most elementary pulse sequences are the pulse acquire sequence 
and the spin echo.
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Pulse acquire uses only one RF pulse that rotates the net magnetisation aw ay  from its 
equilibrium orientation (aligned with the direction of B0) into the transverse plane. In the 
case the flip angle, a, is 9 0 ° , the observed transverse magnetisation is maximal. W hen  
simultaneously recording the x and y components of the transverse magnetisation a com­
plex signal is obtained f(tj. The Fourier transform of this signal reveals the spectrum of the 
resonance frequencies that are present in this signal.
In a spin echo experiment 10, two RF pulses are applied. If the two pulses are applied in 
succession with a time delay t  between them, three N M R  signals can be observed (Fig. 
2 .7 ) .  After each pulse, a FID will follow as described above, but now also a third signal 
will form at time 2 t  after the first RF pulse. This signal is called the spin echo (SE). Once  
in the transverse plane, the net magnetisation decreases due to T2 and T2*  relaxation. 
However, with a spin echo it is possible to obtain information about only the T2 of the 
sample. The first RF pulse creates transverse magnetisation. During the first delay t , the 
magnetisation starts to loose phase coherence, because besides intrinsic T2 relaxation the 
spins also experience a variety of magnetic fields and therefore they precess with many 
different frequencies. After the first delay t ,  the second RF pulse is applied which rotates 
the magnetisation 1 8 0 ° around the y-axis (Fig. 2 .7 ) .  During the second t  delay, the spins 
will be aligned again at the y-axis and the effect of B0 inhomogeneities (that causes T2*  
relaxation) is cancelled: the signal has only decreased due to true T2 relaxation.
The above explanation holds for single, uncoupled spins. The situation is more complicated 
for coupled spins. Let's have a look at the two-spin system AX (Fig. 2 .8 ). After the first RF
90v°
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Figure 2 .7 : Schematic representation o f a spin echo formation o f uncoupled spins. The spins are excited 
after which they dephase in the transverse plane due to B0 inhomogeneities and frequency offsets during the 
first half o f the echo time. After a 180° refocusing pulse the magnetisation is mirrored along the y  axis after 
which the spins rephase during the second half o f the echo time, due to the same B0 inhomogeneities and 
frequency offsets. A t the echo time, the rephasing is complete and a spin echo is formed.
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Figure 2 .8 : Schematic representation o f a spin echo formation o f coupled spins. For simplicity the effects o f 
B0 inhomogeneities have been omitted (they w ill be refocused (figure 2.7)). After excitation the spins o f a 
doublet signal w ill precess in the transverse plane a t their specific Larmor frequencies, with a difference o f 
J Hertz. The subscripts on the frequencies give the corresponding energy transitions levels from figure 2.6. 
The 180° pulse mirrors the spins along the y  axis but simultaneously inverts the population o f the coupled 
spins. Because o f this dual effect on the coupled spins, the evolution due to J- coupling w ill not be refocused 
at the top o f the spin echo and w ill generate an echo time dependent phase difference.
pulse the same happens as described above: the two spins start to dephase. For coupled 
spins, the frequency offsets can be expressed in terms of the J-coupling constant: half of the 
spins are precessing with a frequency of J /2  H z faster and half of the spins are precessing 
with a frequency of J /2  H z slower than the centre frequency of spin A and spin X. The 1 80 °  
pulse rotates the magnetisation around the y-axis, analogue to the situation for uncoupled 
spins. The 1 8 0 ° pulse however, has an additional effect for the coupled spins: it inverts 
the spins populations between the energy levels 1 and 2 , and 3 and 4 , which causes in­
terchange of energy transitions AE and AE}4 and consequently of resonance frequencies. 
Spins that precessed J /2 H z  faster before the 1 8 0 ° pulse will precess J /2 H z  slower after the 
1 8 0 ° pulse and vice versa. The acquired phase difference between the two lines belonging 
to one resonance at the top of the echo is A<j> = n JTE. So, during a spin echo the frequency 
offset and B0 inhomogeneities are refocused for both coupled and uncoupled spins, but 
for coupled spins the evolution due to J-coupling is not refocused. Therefore, the spectrum 
will look different from a spectrum for an uncoupled spin and its shape will depends on the 
echo time (2 t ) and coupling constant. As an exam ple, the spectrum of lactate at different 
echo times is displayed in Figure 2 .9 .11
2.7  Radiofrequency pulses
This paragraph will focus on the radiofrequency pulses that are used in MR experiments. 
RF pulses form an essential part of any sequence and the performance of a sequence is 
influenced by the choice of RF pulse.
The simplest RF pulse is the hard pulse or square pulse. W hen a hard RF pulse is applied  
perpendicular to the main magnetic field B0, the magnetisation will start to rotate. The 
angle of this rotation, or flip angle of the RF pulse, is given by:
X
Magnetisation in xy-plane
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Figure 2 .9 : J-coupling pattern o f lactate (1 ,3ppm j a t d ifferent echo times. The signal a t 2ppm  is o f  the 
uncoupled spins o f  acetate and is used as a reference signal, (figure adapted from 1')
6 =  yBtT (Eq. 2 .2 6 )
W here  t  is the duration of the pulse (pulse length) and B, is the RF magnetic field. The pulse 
length is inversely related to the bandwidth of the excitation (Fig. 2 .1 0 ) , the shorter the pulse 
the broader the bandwidth. The flip angle is achieved for spins at the Larmor frequency. 
Therefore, if spins resonate at different frequencies, due to for exam ple inhomogeneities 
of the main magnetic field, the behaviour of the pulse starts to deviate. In that case, the 
effective RF magnetic field of the pulse, Be, will be the true B, plus an extra component due 
to the off-resonance effect. This causes the effective field to be tilted out of the transverse 
plane towards the z ' axis over an angle.
A  sine pulse with infinite duration (the pulse according to the functions sin(nx)/nx which 
is the inverse Fourier transform of a step function) could produce an ideal slice selective 
excitation. Because of finite time dimension, it is usually truncated at a zero-crossing which 
leaves the so-called five, seven or nine-lobe sine pulse (Fig. 2.1 0C  shows a nine-lobe 
sine pulse). An easy approach towards frequency selective excitation is obtained using a 
Gaussian RF pulse shape since its Fourier transform is also a Gaussian. Important param ­
eters to describe RF pulses are its pulse length, its bandwidth and the power at which the RF 
field is applied. Several examples of rectangular and sine pulses are given in Figure 2 .1 0  
where the relation between these three parameters becomes clear.
2.7.1 Adiabatic RF pulses
The performance of all these pulses is rather sensitive to magnetic field inhomogeneities of 
the main magnetic field B0 as well as the RF field B, itself. This can be problematic when
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coils with inhomogeneous B , fields are used e.g. for in vivo MR experiments. To deal 
with inhomogeneous B , fields, adiabatic RF pulses can be used. These pulses generate a 
uniform flip angle over the entire field of view  of the coil irrespective of the used power 
of B , (as long as it is above a certain threshold). Adiabatic pulses operate according to 
the adiabatic principle, which means in this case that they change the effective RF field 
slow enough for the net magnetisation to follow it, in other words; the bulk magnetisation 
remains aligned with Beff. This is achieved by a sweep in frequency and phase that gener­
ates a moving effective RF field according to:
A
k | =  5 ,2(o +i
' Aco(t) Y
7V ' /
(Eq. 2 .2 7 )
Frequency [Hz]
Figure 2. 10: Behaviour o f RF pulses.
A) Hypothetical shape o f an 1 1-lobe- sine RF pulse 
(solid line), and a rectangular pulse (dashed line).
B) Slice excitation profiles o f a rectangular pulse 
with a power o f 260H z (yB 1) and different pulse 
durations: in black (solid line) an excitation profile  
o f a 500ms pulse; this pulse does not reach a full 
90° rotation, M z  does not reach 0. The dashed 
line represents the excitation profile o f 1000ms 
pulse with the same power; M z  goes to zero but 
over a rather small bandwidth (~200H z). The dot­
ted line is the excitation profile when the pulse 
length is 2000m s; M z  is inverted but note that the 
side-lobes become larger. C) Slice excitation o f a 
9-lobe sine pulse, the profiles are more square-like 
than the profiles o f the rectangular pulses. The pul­
se (black line) has a bandwidth o f 4000H z, a pul­
se duration o f 2ms and a power o f 1200Hz (yB 1). 
When doubling the pulse length and leaving the 
power unchanged, the bandwidth is reduced to 
2000H z and M z  goes to -1 instead o f 0, resulting 
in an inversion pulse (dotted line). When the po­
wer is reduced to 600Hz, a pulse with a flip angle 
o f 90° and a bandwidth o f 2000H z is obtained 
(dashed line, M z goes to 0).
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W h e re  both the frequency and the B, field are now time dependent. To be able to better 
follow the rotations of the effective RF field, w e will have to make use of a second rotat­
ing fram e, x" ,y" ,z" . In this second rotating frame the vector BJt) will be continuously 
orientated along the x" direction and the frame rotates around the first rotating frame 
with an angular velocity of da(t)/dt, where
a.(t) =  arctan A co(t) (Eq. 2 .2 8 )
Because Be depends on time w e can combine Eq. 2 .2 7  and 2 .2 8  to obtain the resulting 
effective RF field:
(Eq. 2 .2 9 )Be'U) = \Bc B: +
r d a (t) v  
ydt
W hen applying this effective RF field, the net magnetisation will start to rotate around it, 
analogue to the situation in which a B, applied along the x-axis will cause the net mag­
netisation to rotate into the xy plane. As long as the rotation of the Be' is slow enough 
for the net magnetisation to keep following the Be', the adiabatic  condition is said to be 
fulfilled:
d a (t)
ydt
<K (Eq. 2 .3 0 )
Classical ad iabatic pulses are ad iabatic  inversion pulses, or ad iabatic full passage 
pulses (AFP), and excitation pulses or ad iabatic half passage (AHP) pulses ,213. They 
both start from longitudinal magnetisation and sweep their frequency (or phase) and RF 
amplitude B, to reach the desired flip angle of the Be and thus the rotation of the net 
magnetisation. The off resonance perform ance of the AHP pulse is not optimal. Spins 
that do not resonate at the resonance frequency, a>o, do not obtain a full 9 0 °  rotation. 
During an AFP pulse, off resonance rotations of the effective field are still completely 
refocused when the frequency is between B0-co/y and -B0-co/y. For larger off resonance 
effects, Mz returns during the pulse to its initial orientation. A  convenient property of AFP 
pulses is that when applying two identical AFP pulses after each other, the effective field 
is inverted, the spins are refocused and Mx and My return to their initial orientation ,4'15. 
This technique is w idely  used in applications for in vivo MRS, for exam ple, three pairs of 
AFP pulses can select a 3D  volume in a single acquisition. The frequency and amplitude 
modulation of a classical hyperbolic secant AFP pulse are shown in Figure 2.1 1.
A  draw back of classical adiabatic pulses is that they cannot achieve a plane rotation of 
magnetisation. This problem is solved by the concept of BIR-4 (8, Insensitive Rotation with 
4  segments) pulses ,6. BIR-4 pulses consist of 4  AHP pulses that are combined to rotate to 
a certain preset arbitrary flip angle (Fig. 2 .1 2 ). The first and fourth, as well as the second 
and the third, are each other's mirror image. The phase between the segments is not 
continuous; in fact, the two phase shifts determine the flip angle of the pulse by:
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Figure 2 .1 1 : Modulation functions and simulations o f two 5  ms adiabatic full passage pulses. The RF 
amplitude (A) is given by hyperbolic secant functions by  Bt(t)=Btmcixsech(l3t") with n= 0.5, or 1 Where n= 1 
corresponds to the classical hyperbolic secant function. B) Simulated slice inversion profile. C) Frequency 
modulation o f the pulse (frequency sweep), (figure adapted from 5)
AO, = 180  + ^ - and A®2 = -(1 8 0  + | )  (Eq- 2 -3 1 )
Using equation 2 .3 1 ,  an adiabatic excitation pulse of any flip angle can be designed. 
In case the adiabatic condition is fulfilled (Eq. 2 .3 0 ) ,  the power and the duration of the 
pulse have a strong influence on the pulse profile of the pulse. Therefore, before using any  
of these RF pulses one should carefully examine the available RF power and used pulse 
duration, and choose the correct values to fulfil the adiabatic condition in the desired field 
of view  of the coil.
2 .7 .2  Radiofrequency pulses and SAR (Specific Absorption Rate)
In essence an RF pulse is a time varying electric magnetic field within the radio  fre­
quency range (M H z). This can cause heating of the sample, analogue to the heating of 
food in a m icrowave. The amount of effective energy deposition due to RF radiation is 
called specific absorption rate (SAR), measured in W a tt/k g . The amount of pow er that 
is absorbed by the body depends on the physical properties of the body and the SAR 
is quadratica lly  dependent on both the frequency and B, am plitude. Exact calculation  
of the pow er deposition can be com plex because of spatial variations in tissue resistiv­
ity and B, magnetic field strength 1718, however the above statement can give a quick 
qualitative insight into pow er deposition. To prevent too much heating of living tissue,
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Figure 2 .1 2 : The RF amplitude, phase and frequency o f a BIR-4 pulse. The two discontinuous phase shifts 
determine the flip angle o f the pulse (figure from G arw ood et a l 31 j
very strict international guidelines w ere introduced that prescribe how much heating 
of the human body is a llow ed . These guidelines dictate, that any hottest spot may 
never be heated more than one degree and e .g . for the head a maximum of 1 O W a tt/ 
kg pow er is a llow ed (International Commission on non-ionizing Radiation Protection 
(ICNERP) guidelines ,9).
In in vivo MRS (see next section), the RF pulses that are used in the sequence are  
responsible for the pow er deposition. In general, ad iab atic  pulses need more pow er 
than conventional pulses, causing a lot more heating than conventional pulses, which  
can become problem atic especially when used at higher frequencies. For exam ple, the 
resonance frequency at 3 Tesla of proton is almost 2 .5  times as high as the resonance 
frequency of phosphorous (Table 2 .1 ) ,  so the RF pulses given on the proton frequency  
will generate more pow er deposition than RF pulses on the phosphorous frequency, 
making the amount of proton RF pulses in a sequence often the limiting factor with 
respect to the maximum allow ed body heating.
2.8 Magnetic Resonance Imaging
W ith M agnetic Resonance Imaging (MRI) the MR signal is used to form images from a 
sample. In 1 9 7 3  Lauterbur 20 reported the first reconstruction of a proton spin density 
map of an object using N M R . In the same year, Mansfield and Grannell 21 independently 
reported the Fourier relationship between the spin density and the N M R  signal acquired 
in the presence of a magnetic field gradient. Instead of using the differences in resonance 
frequencies to determine the chemical properties of the sample (as in MR Spectroscopy), 
these differences w ere used to depict the location of one signal.
M agnetic field gradients are used in MRI to make the resonance frequency dependent on
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the location. The Larmor frequency of a spin is directly proportional to the external magnetic 
field acting upon it. By applying a field gradient Cz on top of the static magnetic field B0, the 
spins will resonate at different frequencies depending on their spatial location (Fig. 2 .1 3 ). 
Thus, any difference in frequency can directly be mapped back to a position.
An MR image is usually a two- or three-dimensional image. A  two-dimensional image is typi­
cally obtained from a slice of the sample or subject. First w e need to make sure that only this 
particular slice from the object is responsible for the MR signal. This is done by applying a 
gradient Gz, during a shaped excitation RF pulse (Fig. 2 .1 3 ). The gradient causes the spins 
to precess at a Larmor frequency that depends on their position along the z-axis, given by:
ffl(z) = y(B0 +  zG; ) = co0 +  yzG. (Eq. 2 .3 2 )
The RF pulse has a specific shape and bandwidth Au>, such that only the spins that have 
a Larmor frequency in a well-defined range (Acoj enter resonance. The range of these 
frequencies together with the applied gradient strength determine the slice thickness by:
Az =  ^  (Eq. 2 .3 3 )
jG 2
Figure 2. 13: Slice selection in practice. The bandwidth o f the RF pulse selects a different slice with a dif­
ferent thickness depending on the gradient strength.
The bandwidth of the pulse is determined by its pulse shape and duration (RF pulses will 
be discussed in the next section). The centre frequency of the RF pulse determines the slice 
position along the z-direction (or the direction in which the field gradient is applied). By 
choosing the right combination of RF pulse bandwidth, gradient orientation and strength, 
any slice with an arbitrary thickness, position and orientation can be excited. The strength 
of the gradient is typically in the order of m T/m . The main magnetic field strength is in the 
order of one Tesla for clinical use.
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N ow , w e need to spatially encode the spins in the excited slice of the sample. The encod­
ing along the x-direction is usually called the "frequency encoding direction". In this direc­
tion the spatial information is added to the spins by means of a gradient. The linear field 
gradient G x is applied, while the signal is being acquired (Fig. 2 .1 4 ) . Due to the presence 
of G x the spins will have a frequency that depends on their position along the x-direction. 
The MR signal will contain a spectrum of frequencies that is proportional to the strength of 
the gradient G x. Spatial encoding in the remaining (y) direction is done by the so called 
"phase encoding". The spins will get a specific phase that depends on their location along 
the y-direction. This is done by applying a short gradient, G , before the MR signal is ac­
quired (Fig. 2 .1 4 ) . During this short gradient the spins will obtain different frequencies that 
are again determined by their position. W hen the gradient is turned off, all spins resonate 
at the same frequency again , however, they have accumulated a space dependent phase 
difference, which they keep. This phase difference is given by:
A < P ( y )  =  yGrrpc,y (Eq. 2 .3 4 )
W here , Tpg is the time that the phase encoding gradient is applied.
In the y-direction there is no frequency encoding, therefore, a single phase encoding step 
is not sufficient to localise the origin of the spin. This is w hy the phase encoding is repeated 
for the number of acquisitions that is needed to sample all points along y-direction, each 
time with a slightly different amplitude of G  .
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Frequency encoding G x
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Figure 2. 14: Pulse scheme o f a spin echo sequence. During the 90° RF pulse a slice encoding gradient is 
turned on, note that this is followed by a negative gradient, the so-called slice-rephase gradient, which assu­
res that the spin dephasing during the gradient is compensated or refocused. Between the 90° and the 180° 
pulse the phase and frequency encoding gradients are applied. The phase encoding gradient is stepwise 
increased or decreased for every acquisition. During the acquisition o f the signal the readout gradient is 
applied. Note that also during the 180° pulse, a slice selection gradient is turned on.
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The step from 2D  to 3D  imaging is now easy to understand. To achieve spatial resolution 
in the z-direction w e can replace a series of slice selective experiments by a scheme in 
which always the same thick slice (slab) is excited. Analogue to the primary phase encod­
ing a second phase encoding gradient is applied but now in z-direction. This gradient Gz 
is stepwise increased by a secondary phase encoding loop for the number of steps that 
are desired in the z-direction.
Figure 2 .1 5 : Plot o f k-space in 2  and 3 dimensions o f the MR image on the right. The T¡-weighted MR image 
is a saggital cross-section o f the human head, more particular the head o f the author o f this thesis.
2.8.1 Spin echo MRI in k-space
K-space is used to represent frequency and phase encoding in Fourier domain and can be 
helpful in understanding imaging sequences. In k-space, k is equivalent to inverted distance 
22'24. This is relevant since gradients encode distance as frequency, thus inverted frequency 
or time-domain signals can be directly plotted in k-space. Formally, in the presence of a 
gradient G , k can be defined as:
kx =yj'^G x(t)dt =  yGxt , and (Eq. 2 .3 5 )  
K = y j ‘0 G:,(t)dt =  yGyt (Eq- 2 .3 6 )
The position of the magnetisation can now be related to k according to:
m(x,y) = —  j JM T(kx,kr)e(k'x+kyy)dkxdky ( ^  2-37)
2k  k k
W h e re  AAT is the transverse component of the net magnetisation. Therefore, k-space is a 
plot where for each phase encoding step the acquired signal is plotted on one horizontal 
line (Fig. 2 .1 5 ) .  This makes k-space a convenient tool to look at how the MR signal is ac­
quired during a pulse sequence, since every point in k-space is a combination of phase 
and frequency encoding gradients.
Consider the k-space trajectory for a spin echo MRI sequence. The spin echo sequence 
uses signals from spin echoes to build up the image. Recall that a spin echo is formed by 
two RF pulses, a 9 0 °  pulse followed by a 1 8 0 °  pulse with equal time delay between the 
centre of the two pulses and between the centre of the 1 8 0 °  pulse and the formation of
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the echo (Fig. 2.7). During each spin echo one k-space line is acquired while the frequency 
encoding gradient, or readout gradient is applied (Fig. 2.14).
In more detail, the following path is described in k-space during a spin echo (Fig. 2 .16). At 
the beginning of the sequence we are in the centre of k-space, then after the first RF pulse a 
frequency encoding gradient [kx] and a phase encoding gradient (/cy) are applied (together 
they result in /c ), this moves the k-vector along the line number 1 in Figure 2 .16 . The 1 80° 
pulse then mirrors the k-vector such that it ends up at position number 3 (Fig. 2 .16), then 
finally during the echo the readout gradient is applied and the k-vector moves along the 
horizontal line during acquisition when every t milliseconds a sample from the spin echo 
is obtained. These steps are repeated, each time beginning from the centre of k-space, but 
with varying the kx and kyl by changing the gradient strength, until all required lines of 
k-space are acquired (start over from arrow 4 in Fig. 2.16).
k y
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Figure 2 .16 : Representation o f the buildup o f k-space during a spin echo sequence.
2.9 Localised MR Spectroscopy
After we described how the MR signal is formed and how we can encode spatial infor­
mation in this signal, we w ill explain how an MR spectrum is obtained from a specific 
area or voxel. There are several ways to select a volume of which a spectrum w ill be 
obtained. Roughly we can distinguish two types of techniques: one called constructive 
localisation in which only the area of interest is excited, and one called destructive 
localisation in which the entire field of view of the RF coil is excited but all unwanted 
magnetisation is removed.
The latter one is often done using outer volume suppression 25. To suppress the signal 
from regions outside the region of interest a gradient is applied during an RF pulse that 
excites the magnetisation and it is followed by a second gradient that dephases all mag­
netisation in this slice such that no signal w ill be formed. This technique is used with a
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number of different combinations of RF pulses and gradients such that the magnetisation 
can be suppressed in any arb itrary region. However, this is not the technique used in it 
thesis and therefore not discussed in further detail.
2.9.1 Constructive lo ca lisa tion
Two forms of constructive localisation used in this thesis are described here. The first 
method (PRESS) is a so-called single shot localisation. The second (ISIS) uses multiple 
scans to select the volume of interest.
The PRESS (point resolved spectroscopy 26) localisation method uses frequency selective 
RF pulses in the presence of a B0 magnetic field gradient, according to the same principle  
that is used for slice selection in magnetic resonance imaging (see Figure 2.17). When 
using three orthogonal slice selective RF pulses, the sequence is capable of three- 
dimensional localisation (Fig. 2 .17 ). As explained before, a spin echo signal w ill be 
formed with a delay of 2 i} after the first 1 80° pulse. N ow  a second 1 80° frequency 
selective RF pulse is applied that refocuses the magnetisation after a delay of 2 i2, thus 
the final spin echo is formed after a time delay of 2 i}+2 i2. The first spin echo contains 
a signal that comes from a column, which is a volume that consists of the intersection of 
the two slices that were selected with the 90° and the first 1 80° RF pulse. The second 
spin echo contains a signal from a cube that consists of the intersection of the three 
slices in orthogonal directions. Magnetisation outside this volume of interest (VOI) did 
not experience all three pulses and w ill dephase rapidly. Any imperfections of the pulse 
angles (not exactly 90° or 1 80°) w ill result in undesired transverse magnetisation. This 
transverse magnetisation is present as FID and might later be refocused to form an echo. 
These unwanted signals are dephased by applying so-called crusher gradients around 
the 1 80° pulses (Fig. 2 .17).
TE
90° 180 180°
Figure 2. 17: PRESS pulse sequence for the localisation o f a 3D volume. The shaded areas are two pairs o f  
crusher gradients surrounding the 180° refocusing pulses to destroy undesired coherences.
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The ISIS (image selected in vivo spectroscopy 27) method uses 8 sequences to acquire 
signal from a three dimensionally localised volume (Fig. 2 .18). It uses frequency selective 
inversion pulses and an addition-subtraction scheme to select the volume of interest.
180°  180°  180°
(ON/OFF) (ON/OFF) (ON/OFF) 9 ° °
RF — '
G / \
q / \
y
/ \ _
Exp 1 OFF OFF OFF +
Exp 2 OFF OFF ON -
Exp 3 OFF ON OFF -
Exp 4 ON OFF OFF -
Exp 5 OFF ON ON +
Exp 6 ON OFF ON +
Exp 7 ON ON OFF +
Exp 8 ON ON ON -
Figure 2. 18: Pulse sequence for 3D ISIS localisation. In each o f the 8 experiments a different combination 
o f the three 180° pulses with slice selection gradients is applied. The right column indicates the phase o f 
the receiver gain, +=0°, - = 180°.
When an even number of 1 80° pulses is applied, the desired magnetisation is rotated to 
the positive longitudinal axis prior to excitation and w ill add to the signal from the localised 
volume. When an odd number of 180° pulses is applied, the desired magnetisation is 
inverted and needs to be subtracted during data collection. There are several factors that 
influence the quality of volume selection in the ISIS sequence, such as frequency offsets and 
imperfect pulse angles. However, the advantage of the technique is that signal acquisition is 
done immediately after excitation, hence it is insensitive to T2 relaxation, volume selection 
is done prior to excitation, thus it may be placed in front of any other sequence.
2 .9 .2  Spectroscopic im ag ing
Spectroscopic imaging is used to localise multiple MR spectra within one volume in one 
measurement. The principle of spectroscopic imaging is very similar to phase encoding in 
magnetic resonance imaging. B0 gradients are applied in between the signal excitation 
and acquisition to encode spatial information. The gradient causes a phase shift to the 
spins that w ill not be refocused and therefore encode the FID or echo with spatial informa­
tion. This principle is extended in three dimensions and the number of measurements is 
increased with the number of encoding steps in each dimension.
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Since spectroscopic imaging is analogue to MRI, we can also apply the k-space theorem to 
look at the signal. The spectra of a sample F(a>) are obtained by the Fourier transform of the 
total signal S((j and equals the sum of the spectra from individual volume elements f(x,co)dx 
according to:
F(co) = j “  S(t)e~iMdt = ƒ" f(x,ca)dx (Eq. 2.38)
Spatial information is obtained by application of a phase encoding gradient, which induces a 
phase shift (4<j) = yxGt  (Eq. 2.34)) on each elementary volume element (called voxel). Applying 
the k-space theorem from Eq. 2.35 and 2.36, equation 2.38 becomes:
F(Gx,(0) = J f(x,co)e~'nG'ldx = j  f{x,(o)e~,k‘dx (Eq. 2.39)
Again this term can be inverse Fourier transformed to obtain the dependency of the individual 
spectra fon  the entire sample in the presence of a gradient:
f{x,co) = \°°J(kx,co)e+iYk'xdkx (Eq- 2.40)
This can be expanded to three dimensions by varying orthogonal gradients in a series of 
experiments:
f ( x ,y ,z ,w )  = j  j  ^ F (kx,ky,kz,co)e+,nkx:‘+k''y+k‘z)dkxdkrdkz (Eq. 2.41)
One Fourier transform of this four dimensional data set Sfk^k^k^t) results in a set of phase en­
coded MR spectra Flk^k^k^co) . To obtain the localised spectra the data set needs to be Fourier 
transformed in the three spatial dimensions.
Equation 2.41 suggests that the signal is continuously sampled in k-space over an infinitively 
long period, however in practice this is not the case. The signal is acquired over a finite period 
at discrete k-space positions and can be spatially resolved using discrete Fourier transform. The 
gradient increments determine the digitisation rate and the spatial frequency (or k-domain). Ac­
cording to the Nyquist sampling criterion, the maximum phase shift between two gradient incre­
ments over the entire field of view (FOV) equals 2n, leading to the minimum size of the FOV:
2k = y  ■ FOV ■ AG -t o rFO V = lK  = —  (Eq. 2.42)
7 • AG-1 Ak
When the field of view is smaller than the area that generates a signal, these signals 'fold  
in" or "w rap around" into the FOV at the opposite side. Therefore, spectroscopic imaging 
is often preceded by a localisation method such as PRESS to remove the signal from outside 
the volume of interest.
The nominal voxel size is equal to FOV /N , where N  is the number of gradient increments. The 
actual voxel size can substantially differ from this nominal voxel size due to the characteristics
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of the Fourier transform. The Fourier transform of a series of discrete sample points is a point 
spread function (PSF), as indicated in Figure 2.1 9 28. This point-spread function is always pres­
ent in MR data and in general all techniques requiring Fourier transformation. However, the 
effects of the PSF become more pronounced in spectroscopic imaging due to the limited num­
ber of phase encode steps. The PSF causes the neighbouring voxels to contribute to the signal 
from one voxel. By applying an apodisation function after the signal acquisition, the shape of 
the PSF can be influenced (Fig. 2.1 9 28). If apodisation is used, averaging k-space according 
to a weighted function increases sampling efficiency and optimises SNR per unit time.
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2.10 Chemical shift displacement errors in MRSI
An often-underestimated problem with proton MRSI is the chemical shift artefact or chemi­
cal shift displacement error (CSDE). Because signals with different chemical shifts ex­
perience different slice selections, the combination of the bandwidth of the RF pulse, 
the chemical shift of the metabolite of interest and the strength of the selective gradient 
define the exact slice selection for every individual signal. For example, the chemical 
shift between water and N-acetyl-aspartate (a neuronal marker in the brain) is 2 .7  ppm. 
This is equal to a frequency difference of 340H z at 3T. This frequency difference induces 
a difference in slice position of a slice-selective excitation between water and N-acetyl- 
aspartate. When an RF pulse with a bandwidth of 1500 Hz is used, a gradient strength 
of 2 2 .4  mT/m is necessary to select a slice of 10mm thickness. In this case the spatial 
difference between water and N-acetyl-aspartate w ill be 2 .2  mm, or 22%  of the slice 
thickness. W ith a trend toward signal excitation with large body coils, which limits the 
available pulse power, the bandwidths of conventional RF pulses become quite small and 
the CSDE becomes larger.
As the chemical shift (in Hertz) increases with magnetic field, the CSDE at 3T may
A
kx
B
Voxel
Figure 2 .19 : A j Discrete averaging schedule for k-space weighted acquisition (dashed linej that approximates 
a gaussian function (solid linej. Bj Point spread function fo ra  non-apodised MRSI experiment (dashed linej and 
an apodised MRSI experiment (solid linej. Note that the voxel size becomes a little larger due to the weighted 
averaging, but the contribution from neighbouring voxels is significantly reduced, (figure adapted from 28j
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become very large if unaccounted for. One solution to this problem is deliberately choos­
ing the excited volume to be in the order of 20% larger than the VOI, and suppressing the 
unwanted signals in this border inside the VOI with saturation pulses. A  different solution 
to this problem can be found in using RF pulses with large bandwidths to excite and refo­
cus the MR signals of interest themselves (constructive localisation), instead of suppressing 
unwanted signals from the border zone and outside of the VOI.
Adiabatic RF pulses have large bandwidths, and were orig inally introduced in MR to 
overcome 8,-field inhomogeneities during signal inversion. In 1991 a continuous train 
of seven of these AFP RF pulses 17 was suggested for 3D volume excitation (single-shot 
adiabatic localised volume excitation (SADLOVE) 29. This further evolved into sets of 
refocusing pulses with highly rectangular slice profiles. This method, which produces a 
spin echo for a 3D volume with three pairs of RF pulses 30 is better known as localised 
adiabatic selective refocusing (LASER) 31.
A  disadvantage of the LASER sequence compared to a PRESS sequence is the increased 
echo time due to the large number of RF pulses that is used. Moreover, with non-selective 
excitation, all tissue inside and outside the VOI is excited, thus demanding quite some 
crushing gradients to suppress signals outside the VOI. In the next section a new sequence 
is described that uses the advantages of the LASER volume selection, but significantly re­
duces the CSDE at 3T whilst retaining a short echo time.
2.11 Semi-LASER MRSI with short echo time
This section provides a short description of the semi-LASER MRSI sequence 32, which is the 
method used in this thesis for 1H MRSI of the human brain at a 3T MR system.
Semi-LASER MRSI is a method of volume selection, in which the first three pulses of the 
original fully-adiabatic sequence 30 are replaced by a non-adiabatic Shinnar-Le-Roux opti­
mised 90° slice-selective excitation pulse. In this way an echo time down to 30  ms can be 
realised at 3T (Fig. 2 .20). The sequence is further extended with phase-encoding steps for 
3D spectroscopic imaging. The maximum amplitudes and rise times of the gradient set of 
the MR system are exploited in designing the position, amplitude, and duration of crusher 
gradients to suppress unwanted FIDs, stimulated echo and spin-echo signals. The RF power 
remains within SAR limits.
By using adiabatic refocusing pulses with large bandwidths, the CSDE is reduced to less than
1 0% of the slice thickness, when defined as the relative difference in slice position between the 
water resonance (4.7 ppm) and lipid-CH3 (0.9 ppm) resonance (Fig. 2.21). In comparison, 
the corresponding CSDE of e.g., a PRESS sequence with conventional refocusing pulses with 
a bandwidth of 1.3 kHz at 3T is 36%, and even at a field strength of 1.5T the CSDE of these 
pulses would still be 1 8%.
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Figure 2 .20 : Diagram o f the semi-LASER spectroscopic imaging pulse sequence. An initial slice-selective Shinnar- 
Le-Roux optimised 90° excitation pulse is followed by two couples o f slice-selective adiabatic full-passage 180° 
refocusing pulses, thereby producing a spin echo a t TE = 2t2 + 2t4. Large crusher gradients (2.5 ms o f 24  mT/m, 
excluding ramps) are positioned around the final AFP pulse, with the phase encoding gradients superimposed 
on the final crusher. For simplicity, crusher gradients that are needed around the other AFP pulses are not shown 
in this figure. The WET-water suppression and outer volume saturation (OVS) modules are not drawn to scale.
Figure 2 .2 1: Conventional PRESS compared to the semi-LASER pulse sequence in a healthy volunteer. The 
CSDE o f the water signal in a volunteer with the conventional PRESS pulse sequence (A) and the semi-LASER 
approach (Bj, when the carrier frequency is positioned a t 2 .2  ppm. Transverse T2-weighted TSE images o f 
the brain o f a healthy volunteer are overlaid with colour-coded images o f the integral o f the unsuppressed 
water signal o f the MRSI experiment. The white box indicates the VOI, either selected with the PRESS pulses, 
or with the semi-LASER volume selection. Spectral maps with ra n g e -1 .0  to 4 .0  ppm o f the water-suppressed 
PRESS (C) and semi- LASER (Dj sequence show the residual lip id  signals in voxels on the left posterior side 
o f the brain, just outside the VOI. A ll voxels within one spectral map are identically scaled, but the scale o f 
the PRESS spectral map (C) is three times larger than the semi-LASER spectral map (Dj.
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Figure 2 .22 : 3D MRSI o f the frontal part o f the brain o f a healthy volunteer. In (A) one partition o f the 3D  
FOV o f the MRSI matrix is outlined in ye llow  and overlaid on a transverse T2-weighted TSE image. In the sa­
g ittal image inset, the position o f this partition within the VOI in white is indicated. Outer volume saturation 
(OVS) slabs were positioned around the brain (dashed bars). The spectra from voxels inside the blue box 
are overlaid onto the T2-weighted image in a spectral map (Bj with range 1 .0 -4 .3  ppm.
As shown in the measurements of a healthy volunteer (Fig. 2.21), the relatively small CSDE 
of the semi-LASER sequence results in voxels with full excitation of all signals of interest almost 
throughout the VOI. In addition it reduces the risk of exciting lipid signals from regions just out­
side the VOI (e.g. subcutaneous lipids around the skull), which can wrap around or spread into 
the VOI. Even in more challenging regions of the brain (e.g. above the sinuses as displayed 
in Fig. 2.22), localisation and spectral quality of 3D MRSI with the semi-LASER sequence re­
main sufficient, although magnetic field inhomogeneity problems at that location remain visible 
through unsuppressed water residuals (negative peaks at left side in MR spectra in Fig. 2.22B).
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Magnetic Resonance 
Spectroscopy of human 
brain tumours
Abstract
Patients with brain tumours have a high mortality. There have been extensive studies of brain 
tumours in the field of biochemistry, immunology, genetics and imaging. Unfortunately, 
most types of brain tumours cannot be cured. In particular the treatment of glia l tumours has 
not improved much over the last decades. This chapter briefly describes the most important 
biological features of brain tumours, how brain tumours are diagnosed and how brain 
tumours are commonly treated. An overview of the current state of MRI and MRS findings 
in brain tumours is also provided since that is required to understand the remainder of this 
thesis. In section 3.3 the general results of research on brain tumours using 'H  MRS and 
MRSI are discussed. Contributions to brain tumour research from MRS of other nuclei such 
as 3,P and ,3C are described in sections 3 .4 and 3.5.
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3.1 Glial brain tumours
The term "brain tumour" refers to a collection of intracranial neoplasms (newly formed 
tissue inside the skull) each with their own biology, prognosis and treatment. This chapter 
focuses on glia l brain tumours, which arise from the brain tissue itself and are the main 
type of tumour studied in this thesis. G lia l brain tumours, or gliomas, arise from glial cells. 
Since there are different types of glial cells, the tumour can be from astrocytic (from the 
astrocytes, star shaped cell supporting the neurons), o ligodendroglial (from the oligoden­
drocytes, small cells that produce myelin), or ependymal origin (from the ependymen, cells 
that form the endothelia of the brain).
3.1.1 Ep idem io logy o f g lia l b ra in  tum ours
Gliomas account for more than 70%  of all brain tumours and the most frequent and most 
malignant type is Glioblastoma Multiforme (GBM) (65% of all brain tumours) 1. Although 
the prevalence of GBM is high among brain tumours, they are relatively uncommon. In 
Western Europe and North America they occur in only 2-5 per 100 ,000  persons per 
year 2, in contrast to lung, breast and colorectal cancer that have an annual incidence 
in Western Europe of 63, 85, and 72 per 100 ,000  persons respectively 3. However, 
gliomas have a disproportionately high morbidity and mortality 1. The median survival 
time is only 12 to 15 months for patients with GBM and 2 to 5 years for patients with 
anaplastic gliomas 4.
3 .1 .2  H is topa tho logy  and  b io lo g y  o f g lia l tum ours
Besides ependymomas, gliomas can be classified into three main subtypes according to 
their histopathology: astrocytic, o ligodendroglial and mixed oligo-astrocytic tumours. The 
names are derived from the resemblance of the tumour cells to the normal astrocytes and 
oligodendrocytes in the brain. Astrocytes are star-shaped cells (Fig. 3.1C), they perform 
many functions, including biochemical support of endothelial cells that form the blood-brain 
barrier, provision of nutrients to the neurons, neurotransmitter cycling, and maintenance of 
extracellular ion balance. Astrocytes also have a principal role in the repair and scarring 
process of the brain and the spinal cord follow ing traumatic injuries. Oligodendrocytes 
support the axons in the brain by insulating them in a process called myelination. The ge­
netic aberrations underlying astrocytic and oligodendroglial tumours are different. About
60 to 70% of oligodendroglial tumours carry loss of chromosomal arms 1 p and 1 9q 56, 
whereas astrocytic tumours often show amplification of chromosome 7  and loss of chromo­
some 10 2. The discrimination between these tumour subtypes has major implications for 
the prognosis of the patient since those with 1 p /1 9q loss often show better survival rates 
and better response to chemotherapy 7'8.
The World Health Organisation 2007  classification of brain tumours 2 contains four ma­
lignancy grades for glia l brain tumours, with the non-diffuse pilocytic astrocytoma as the 
least aggressive and the GBM (grade 4) as the most malignant one. The grade of the
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brain tumour increases with the level of cell density and mitotic activity (cell multiplica­
tion). In addition, microvascular proliferation and necrosis emerge in high-grade gliomas 
and these two phenomena are used for grading of glial tumours 2. Most human tumours 
grow  as a solid-like mass around which blood vessels are formed to provide the tumour 
with nutrients. In the core of these tumours often necrosis (cell death) occurs due to lack 
of blood supply. Diffuse infiltrative growth of tumour cells, when cells spread out in the 
tissue, is almost unique for gliomas. Only very few non-glial tumour (such as small cell 
lung carcinoma, lymphoma) show occasionally infiltrative-like growth. In gliomas, the cells 
preferentially invade the normal brain tissue along the myelinated axons in white matter 
tracts 9. Gliomas can arise in white and gray matter and tumour cells extensively infiltrate 
from the originating area into the surrounding brain. They can occupy more than one lobe 
of the brain and cross the corpus callosum 2 (Fig. 3.1 A). It is not known what exactly initi­
ates migration of glioma cells resulting in infiltrative growth of the tumour. The genotypes of 
gliomas are very heterogeneous and it is therefore very unlikely that one particular genetic 
aberration causes this growth pattern in all gliomas. Furthermore, when gliomas grow fast, 
their cells w ill also form a bulky mass in which necrosis can occur due to lack of oxygen 
and nutrients.
Figure 3 .1 : A) Saggital cross-section o f the brain. B) The cerebrum, including the names o f the brain lobes. 
C) Schematic representation o f an astrocyte and one axon.
3 .1 .3  Treatment
The fact that g lioma tumour cells infiltrate the brain makes it d ifficu lt to develop an 
effective treatment, since the surrounding brain is very susceptible to therapy-induced 
damage and neurons have very little capacity to repair themselves (in contrast to many 
other organs). The optimal treatment procedure for low-grade gliomas remains to be 
defined. Although these patients survive for several years, the tumour w ill sooner or 
later progress to a more malignant type and w ill lead to death of the patient. In young 
patients, treatment w ith radiotherapy or chemotherapy of low-grade gliomas w ill of­
ten be postponed until clin ica l or rad io log ica l progression occurs to prevent therapy- 
induced cognitive decline 6. Furthermore, surgical resection of low-grade tumours is 
associated w ith a better outcome and the extent of the surgical resection is positively  
associated w ith survival time10.
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Patients with GBM should be treated without delay and surgery is the first step of treatment. 
If the condition of the patient does not allow such an extensive surgical intervention, only a 
biopsy will be taken to confirm the diagnosis. In the other cases surgery aims for complete re­
section, however, this will never be achieved in the case of gliomas due to the widespread in­
vasion of tumour cells in the surrounding brain. Nevertheless, there is a relation of the extent 
of resection of the tumour and prognosis of the pa tien t11. Radiotherapy after surgery can fur­
ther inhibit tumour growth, although it remains difficult to spare the healthy part of the brain. 
The success of chemotherapy is hampered by the heterogeneity of gliomas. Furthermore, in 
areas where the original tissue architecture is more or less intact, the blood brain barrier is 
an obstacle to the optimal delivery of chemotherapeutics to diffuse infiltrative tumour cells.
In addition to surgery, radiation therapy and chemotherapy, patients often receive treatment 
to relieve symptoms. For example, corticosteroids are given to reduce the oedema that causes 
a lot of pressure in the brain. Despite all this aggressive treatment, death is usually caused by 
cerebral oedema due to further infiltration and consequently increased intracranial pressure.
3.2 Clinical diagnosis of gliomas
Symptoms that arise from gliomas vary with tumour size and location. Symptoms can be 
either focal or generalised neurological symptoms. The generalised symptoms reflect an 
increased intracranial pressure. Patients may suffer from headache, nausea and vomiting. 
Focal symptoms such as hemiparesis (partial paralysis) and aphasia (decreased ability to 
express yourself by speech or written language), reflect the location of the tumour u . The 
most prevalent symptom is the progressive failure in neurological or mental functioning due 
to involvement of the temporal and frontal lobe of the brain (Fig. 3.1 B) 412.
In current practice, the diagnosis of a brain tumour in patients presented with the above-men- 
tioned symptoms is typically achieved by an MRI examination followed by a histopathologic 
review of a tissue sample taken during surgery The histopathology is considered to be the 
ground truth since it reflects the true status of the tissue. The final diagnosis is always made 
in a multidisciplinary review including the clinical state of the patient, the histopathology of 
tissue specimens and imaging (in mosteases MRI) of the tumour.
Unfortunately, MRI alone cannot distinguish between all tumour types and malignancy grades 
(Fig. 3.2). Low-grade gliomas are typically hypointense lesions on T, weighted images and 
show oedema and hyperintensity on T2 weighted images (Fig. 3.2). On T, weighted images 
with intravenous administered contrast agent, low-grade gliomas usually do not show con­
trast enhancement, which is more typical for high-grade tumours. W ith 'contrast enhance­
ment' we refer to the hyperintense appearance of tissue on a T, weighted MR image. The 
contrast agent that is taken up by the tissue (or leaks out of the blood vessel) causes a short 
T, relaxation time for water proton spins and because of the relative short repetition time
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used in the T, weighted MRI sequence the tissue with contrast agent w ill have a high signal 
intensity. High-grade gliomas appear more heterogeneous and are often accompanied by 
more severe oedema. They often also show areas of necrosis (hypo intense or black on T, 
weighted images), surrounded by the proliferating part of the tumour that is often contrast 
enhancing because of increased vascularisation and leaking blood vessels. The extent of 
tumour infiltration is often underestimated on conventional T, and T2 weighted images, since 
it is not possible to differentiate between oedema and infiltrating tumour. Although a glial 
tumour is well known to extend beyond the MRI-lesion, the contrast enhancing part of the 
tumour is w idely used as the target for surgery resection or for planning radiation therapy.
New MR modalities such as diffusion and perfusion weighted imaging that highlight prop­
erties more related to the function of the tissue, may contribute to better radiological clas­
sification and delineation of gliomas, as well as assist in identification of the best location 
for a biopsy. MR spectroscopy is also used to this end since it allows obtaining metabolic 
information from tissues. There is large potential for MRS to reveal tumour biology and me­
tabolism in vivo  in a non-invasive w ay  which may improve tumour diagnosis and monitoring 
of treatment response. In this thesis new MRS methods are developed and tested in patients 
with brain tumours to improve the understanding of infiltrative glial tumour growth and the 
3  non-invasive diagnosis of brain tumours.
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Figure 3 .2 : Conventional MRI o f brain tumours a t 3T. Tt weighted images without Gd contrast administra­
tion are displayed on the left, Tt weighted images with Gd contrast in the middle and on the right T2 weigh­
ted images are shown. A-C) patient with GBM. D-Fj patient with metastases. G-l) patient with low-grade 
astrocytoma. J-Lj patient with meningioma.
3.3 ’H Magnetic Resonance Spectroscopy of human brain 
tumours
The 1H MR spectrum of the normal human brain with a fit of the resonances of several 
metabolites is displayed in Figure 3.3 to facilitate the interpretation of the remainder of 
this chapter. A  few abbreviations for metabolites are also displayed at their corresponding 
peak in the spectrum.
The resonance marked with NAA consists of signals from n-acetylaspartate and n-acetylas- 
partateglutamate, which are markers for viable neurons. The main function of glutamate 
(Glu) is that of a neurotransmitter and Glu is also part of the oxidative energy metabo­
lism. Creatine (Cr) is involved in the energy metabolism. The resonance marked with Cho 
consists of signals from choline (Cho), phosphocholine (PC) and glycerophosphocholine 
(GPC), which are markers for cell density and cell integrity. The role of myo-inositol (ml) in 
the brain is rather unclear. It is mainly found in glial cells and therefore considered to be a 
marker for glial proliferation. The ml also functions as an osmolyte. Besides the clear and 
high resonances of these metabolites, there are also a number of macromolecules and lip­
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ids (summarised by the resonance profile marked with MM) present in the brain. Because 
of the short T2 relaxation time of macromolecules and lipids, their signals are broad and 
contribute to the uneven baseline (Fig. 3.3).
NAA: n-acetylaspartate 
Glu: glutamate 
Cr: creatine 
Cho: choline 
ml: myo-inositol 
MM: macromolecules
datapoints
---fit
---baseline
------ MM
residue
Figure 3 .3 : ]H M/? spectrum measured with a short echo time (30ms) o f g ray matter o f the normal human 
brain at 3T. A  fit to the spectral data and the corresponding residue is also shown.
The area under the resonance peak is a measure for the tissue concentration of that specific 
molecule present in the assessed volume. When comparing MR spectra of different patients 
or different regions in the brain it is common to normalise the spectra to the water signal or 
to use ratios of metabolites peaks that are present in the spectrum (for example the ratio of 
choline peak area to creatine peak area). Normalisation to the water peak allows to ob­
tain absolute tissue levels taking into account water content and relaxation times. Ratio's of 
metabolite (signals) is convenient because they do not depend on for example differences 
of voxel volume and B, or B0 homogeneity between voxels and between measurements of 
different patients.
3.3.1 D iffe ren tia tion  be tween tum ou r types
1H MRS of single voxels localised inside the core of the tumour (often contrast enhanc­
ing in higher grades or metastases), has been used to establish in vivo  MR spectral 
profiles o f specific tumour types ,3. Average metabolite profiles from short and long 
echo time MR spectra were derived from these measurements (Fig. 3 .4 13), and one 
can clearly see differences between the profiles of tumours and of normal brain. D if­
ferences between some types of tumour however, are less pronounced (e.g. GBM and 
metastasis).
W hen accounting for the low  number o f patients included in these average MR profiles
Gray matter
NAA
frequency shift [ppm]
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Figure 3 .4: Mean and standard deviation o f MR spectra from a single voxel inside a brain tumour (STEAM
30 ms echo time, 1.5T). Voxels were chosen in the lesion on T2 weighted im agesavo id ing  obvious areas 
o f necrosis and oedema, (figure adapted from 13j
and the heterogeneity amongst g lia l tumours, it is even harder to find significant differ­
ences of the MR profile between tumour types. In particu lar the differentia tion between 
GBM and metastases is difficult. These two types of tumour are also hard to distinguish 
on conventional MRI (Fig. 3.2A-F), therefore MRSI has been used to improve the non- 
invasive diagnosis o f these tumours. This w ill be discussed in more detail in chapter 5.
NAA Cho
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A few conclusions can be drawn from the characteristic MRS(I) signals o f brain tu­
mours. In most cases a decrease of the signal intensity level o f n-acetyl-aspartate (NAA) 
is detected for all tumour types. Loss of neuronal in tegrity is usually mentioned as being 
the cause of the decreased NAA  concentration in the brain . NAA  is a marker for v i­
able neurons, and it is not present in tumour tissue ,314. An increased level o f lip ids is 
generally found in tumours w ith necrotic tissue ,3. Lipids are present due to breakdown  
of the membranes of dead cells ,5. Also high, but variab le , levels o f lactate (Lac) have 
been found in tumours w ith a high malignancy grade ,4. Choline (Cho) is considered to 
be a marker of accelerated cell pro liferation and high levels o f choline have often been 
found in tumours ,617. Also levels o f the ratio o f Cho to N AA  can vary strongly w ithin  
(tumour) tissue ,819. Creatine is involved in energy metabolism in the human brain and 
is often assumed to remain constant in each tissue type even under pathological condi­
tions. It increases significantly from the cortica l white matter to g ray matter and cerebel­
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lum of the healthy human brain 20 21. In tumours the creatine level may be decreased 
due to a higher metabolic activity 22, however, vary ing levels of creatine in tumours have 
been reported 23. For instance, it also may be increase due to gliosis.
The presence of some other metabolites seems to be more specific for certain brain tu­
mours. When compared to normal brain tissue, increased levels of myo-inositol (ml) have 
often been detected in low-grade astrocytomas ,3'24'25 as well as a decrease of ml in menin­
giomas ,3. Myo-inositol appears to be a key osmolite 26'27 and it is also used as a 'building 
block' in cell membranes and the myelin structure of glial cells. Therefore, ml is also involved 
in glial proliferation 25. This explains its absence in meningiomas, which do not arise from 
glial cells but from the meninges (set of membranes that surround the brain).
High levels of glycine (Gly) have been found in vivo  in astrocytomas and GBM 2830 and also 
in tissue specimens of primary and recurrent brain tumours 31. Glycine functions mainly as 
neurotransmitter and neuromodulator in the brain 30. Although the MR signal of this metabo­
lite overlaps with the MR signal of myo-inositol, it has been shown -with methods developed 
for the evaluation of G ly concentration- that the level of G ly present in high-grade and low- 
grade tumours is different30'31.
Elevated levels of alanine (Ala) have commonly been found in meningiomas ,3*32'33. Also 
higher levels of glutamate (Glu) have been found in meningiomas. Considering both high 
levels of Glu and Ala supports the hypothesis that meningiomas have an altered energy me­
tabolism: e.g. a partial aerobe oxidation and anaerobe glycolysis ,3*33'34.
3 .3 .2  Potentia l fo r  tum ou r g rad ing
As explained in section 3.3 .1 , metabolic changes have been related to tumour grade. Me­
tabolites such as choline and myo-inositol have been associated with cell proliferation. This 
was a reason to investigate the relation between the levels of these metabolites and ma­
lignancy grade of the tumour since tumours cells often have a high level of proliferation. 
It was found that the levels of choline and myo-inositol are higher in tumours with a higher 
malignancy grade 35_37. The level of glycine has also been related to the grade of the tumour, 
however, the exact role of glycine in brain tumours has sparsely been evaluated 24.
Another important feature of malignant tumour types is the presence of lipids. Lipids accumu­
late in the brain due to necrosis (cell death) and a relation has been found between lipids 
and features of tumour malignancy such as necrosis 38.
From animal studies, it has been shown that aggressive tumours grow very fast, creating a 
hypoxic environment in which cells cannot produce energy via an aerobic pathway. This 
forces the tumour cells to use the comparatively inefficient glycolytic pathway to produce
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energy, resulting in the accumulation of lactate, which is the end product of glycolysis, in the 
brain. The combined signal of lactate and lipids has also been used to discriminate between 
high-grade and low-grade tumours 35 36 For example, the lactate level in regions with abnor­
mal blood perfusion has been used to discriminate between grade 3 and grade 4 gliomas 39.
3 .3 .3  Detection o f tum ou r cell in f iltra tio n  b y  MRS
Glial tumour cells infiltrate into the entire brain as explained in section 3.2 .1 : tumour 
growth exceeds the extent of the lesion visible on T1 and T2 weighted MR images. Since 
MRS can detect changes in tumour cell metabolism, it appeared very interesting to see if 
MRS could reveal tumour growth beyond the MRI lesion in the infiltrated part of the brain. 
To test this hypothesis, the first step to be taken was to prove that voxels with abnormal MR 
spectra contained tumour tissue.
In several studies metabolite levels have been related to the presence of tumour cells in 
different brain tissue. This has been done by relating deviations from specific metabolite 
ratios (for example the ratio of Cho to NAA) to the presence of tumour cells in a tissue bi­
opsy sample obtained from the same location as recorded by in v/VoMRS 40. Also the level 
of choline in MR spectra has been related to tumour cell density of the biopsy specimens 
from similar locations 41. These results were very promising with respect to using the level 
of choline to predict tumour presence, despite potential problems such as inaccurate co­
registration of the location from which the tissue specimens and MR spectra were obtained, 
and the difference in volume of biopsies and MRS voxels.
A  study investigating the correspondence of the area with elevated choline versus the 
area of abnormality on T, and T2 weighted MR images of glial tumours, showed that these 
regions usually do not correspond 42. In particular, when the hyperintense area on a T2- 
weighted image (this is often oedematous tissue that possibly contains tumour cells) was 
used to define the tumour volume, the total volume of the tumour would be larger than when 
the abnormal level of choline and NAA  were used to define the volume of the tumour. But 
simultaneously, there would be areas with abnormal choline and NAA  level that extend 
beyond the hyperintense area on T2-weighted imaging (oedema). This effect was present 
in grade 4 gliomas and even more pronounced in grade 3 gliomas 42. This implies that 
the region of T2 hyperintensity does not include all areas of the tumour tissue. In addition, 
according to the same study, contrast enhancement on T, weighted images suggested a 
lesser extent and a different location of gross disease than spectroscopic abnormalities 
(based on Cho and NAA) 42.
Apart from choline, only a few other metabolic changes have been observed in the periph­
eral zone of glial tumours. Unfortunately, these changes are not very obvious and therefore 
the peripheral tumour zone remains an ongoing subject of research. Chapter 5 deals with 
the spectroscopic abnormalities of the peripheral zone of g lia l tumours.
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3.3.4 Prediction of treatment outcome and treatment monitoring
Several studies have tried to relate 'H MRSI parameters to the survival time of the patient 
43'47. However, the large variety of disease history, age, neurological performance and 
treatment of the patients, make these studies very complex. Nevertheless, the extent of 
abnormal ratios of Cho to NAA in the brain has been related to patient survival 47, as well 
as the total creatine signal in the tumour (normalised to the level in the contra lateral brain) 
48, and the ratios of choline to creatine, and creatine to NAA 44. Unfortunately, due to the 
different study designs, it is difficult to compare the results of these studies and so far no 
highly specific and highly sensitive 1H MRSI markers for survival time of the patient have 
been identified. Currently, clinical parameters such as the age of the patient and the Kar- 
nofsky score are prognostic factors. These factors have been determined from large-scale 
clinical trials 49 50. It would be of interest to evaluate the addition of multiple MR parameters 
to these factors.
3.4 MRS of 31P containing compounds in brain tumours
The energy metabolism of tissue is typically studied with 31P MRS by investigating the 
signals of phophocreatine (PCr) and adenosinetriphosphate (ATP). Furthermore, the intra 
and extracellular pH value can be monitored via the position of the signal of inorganic 
phosphate (Pi), The metabolism of membranephospholipids can be studied by the phos- 
phomonoester (PME) signals of phosphoethanolamine (PE) and phosphocholine (PC), and 
by phosphod¡ester (PDE) signals of glycerophosphoethanolamine (GPE) and glycerophos- 
phocholine (GPC) (Fig. 3.5).
frequency shift [ppm]
Figure 3 .5 : 31P MR spectrum o f a single voxel o f 190cc in the normal human brain at 3T. ISIS localisation 
and 'H  decoupling was used.
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A  number of studies have been performed on experimental tumours (grown in animals and 
cells) to investigate the effect of oxygenation, pH value and energy metabolism on tumour 
growth 51. In general a low ratio of ATP to Pi has been observed in hypoxic (low oxygen 
level) tumours. In tumours, hypoxia develops slowly as the tumour growth pushes cells 
away from blood supply. Eventually the hypoxic situation can become chronic. How the 
levels of PCr, ATP and Pi are related to oxygenation and whether this is driven by an acute 
or chronic environmental status has been studied in animal experiments. Since tumour 
hypoxia was not a topic of this thesis, no further review about findings in this area of MR 
research w ill be given.
In the f irs t31P MRS measurements of human brain tumour tissue, strong signals in the reso­
nance frequency region of PME and PDE were observed 52. Further NMR analysis revealed 
that the PME resonances mainly comprised signals of phosphoethanolamine (PE) and phos- 
phocholine (PC), and that the PDE consisted mainly of glycerophosphoethanolamine (GPE)
Figure 3 .6 : Semi-LASER ]H MRSI and *sRINEPT31P MRSI from a patient with GBM at 3T. A : a ]H MRSI with 
an enlarged MR spectrum o f a voxel inside the tumour. This spectrum reveals a large total choline resonance. 
B: 31P MRSI from only the PME and PDE in the normal appearing brain tissue (NABT) and the tumour. When 
comparing the MR spectrum from the NABT and the tumour, a different pattern o f PE, PC, GPE and GPC is 
observed. (*selective refocused insensitive nuclei enhanced polarisation transfer, see chapter 6 and 7 j
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and glycerophosphocholine (GPC) 53. These choline and ethanolamine compounds are 
involved in the biosynthesis of phosphatidylcholine and phosphatidylethanolamine, two 
major phospholipid components of the eukaryotic cell, which are involved in membrane 
structure, signal transduction mechanisms and lipoprotein metabolism 53. Since the metabo­
lism of membranephospholipids in tumours is disrupted, it is likely that this is reflected in the 
amounts of these compounds. For example, a switch from a metabolic state of high GPC 
and low PC towards a state of low GPC and high PC has been detected in breast tumour 
cell lines 54. Accordingly, in brain tumour specimens, a higher PC/GPC ratio has been 
found in glioblastoma compared to low-grade astrocytomas ,9. Despite the rather varying 
levels of PC and GPC measured in brain tumour cell lines, the ratio of the two compounds 
was at least two-fold higher in the tumour cell lines than in normal cell cultures 53.
In a review of 1H and 31P MRS studies of tissue samples of human tumour and in vivo  
measurement on patients with tumours a few conclusions were drawn ,4: 1) the most fre­
quently observed 31P MR signals in human cancers other than brain  were high PME and 
high PDE; 2) a decrease of PME signal intensity or ratio of PME to PDE, measured in vivo  
in cancers, were early indicators of the response to chemotherapy or radiation therapy; 3) 
brain tumours had elevated choline signal in 1H MRS. However, in 31P MRS measurements 
of human brain tumour tissue the spectrum did not differ from those of normal brain tissue 
3  in any consistent manner, except for a lower PDE signal and a higher pH value (measured 
__  with MRS) in the tumour tissue ,4.
_o So far only few 31P MRS studies examined human brain tumours in vivo  in patients. As
u  mentioned before, the results of these studies are rather inconsistent; in the tumour both
increased levels of PME 55 as well as decreased levels of PME 56 were reported, which is 
probably due to the low SNR obtained at the field strength of 1.5 T. As seen in the previ­
ous section, 1H MRS has frequently been used to study brain tumours in vivo, and in these 
studies the choline resonance is often of particular interest (Fig. 3.6). However, the PME 
and PDE components contribute to the choline resonance identified in 1H MR spectra of 
the human brain. The resonances of PC, PE, GPE and GPC add 83% to 95% to the " total 
choline " signal at 3.2ppm, with contributions of PE and GPE that are 10-fold lower than 
those of PC and GPC due to J-coupling 57. The advantage o f 31P MRS above 1H MRS is that 
the phosphorylated choline compounds and the equally relevant phosphorylated ethanol­
amine compounds can be studied separately (Fig. 3.6). The potential of 3,P MRS to study 
the resonances of PE, PC, GPE and GPC individually in vivo  in human brain and in brain 
tumours w ill be explored in chapter 6 and 7.
3.5 MRS of 13C containing compounds in brain tumours
W hile 31P MRS can be used to examine the high energy phosphate status of tissue, ,3C 
MRS can be used to study the glucose metabolism dynamically, e.g. how the tissue pro­
duces energy. Since the natural abundance of ,3C is very low (Table 2.1 , chapter 2), the
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application of a natural body compound enriched with ,3C is often used. For instance, it 
is possible to infuse ,3C-labelled glucose in the blood and fo llow  the uptake and metabolic 
conversion of this glucose into the brain (Fig. 3.7). By examining the intensity of metabo­
lites with ,3C-labels at specific positions in the molecule, it is even possible to model the 
fluxes of metabolites from the blood into the neurons and glial cells 58'59.
Warburg 60 discovered in 1 931 that tumour cells have a preference to produce energy via 
glycolysis, rather than via aerobic energy metabolism (which in principle releases much 
more energy) even in the presence of oxygen. This has long been seen as a curious by- 
effect of tumour metabolism, but recently, interest in this aspect of energy metabolism of 
tumours has increased again 70. ,3C MRS provides a tool to study the glucose metabolism 
in vivo, and this has been exploited in a number of preclinical studies of glioma cell lines
61 and tumours grown either subcutaneously in mice 62,63 or intra-cranially in rats 64'67. In 
all these studies a significant amount of lactate was formed in the tumour (cells) after ad­
ministration of ,3C-labelled glucose. Since lactate is the end product of glyocolysis, high 
lactate levels imply a high glycolytic activity of the tumour cells. Furthermore, MR signals 
of labelled glutamate and glutamine have been observed in tumours, thus the tumour cells 
also use the tricarboxylic acid (TCA) cycle to produce energy, though at a slower rate than 
normal cells do 63'64'66'67.
Glu4 Glc: glucose 
Glu: glutamate 
Gin: glutamine 
Asp: aspartate 
Lac: lactate
frequence shift [ppm]
Figure 3 .7 : ]3C MR spectrum (ISIS localisation, volume o f 125cc) o f a normal human brain after admini­
stration o f l - ]3C-glucose a t 3T. Numbers behind the abbreviation o f the metabolite indicate which C-atom is 
labelled with ,3C due to the conversion o f glucose labelled a t position 1 ( l - ,3C-glucose).
As already briefly noted in section 3 .3 .2 , lactate is commonly detected in human brain 
tumours by 1H MRS ,3,68. The production of lactate in tumours has been related to tumour 
malignancy, however the amount of lactate as measured by 1H MRS is not only a function 
of specific cellular production and tumour hypoxia, but also of lactate accumulation in 
cystic lesions and draining of tumour tissue. Therefore, the sheer presence of lactate is of
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limited value as a biomarker for malignancy grading in individual tumours 67'69. The assess­
ment of the kinetics of lactate production may be better suited for this purpose as it is more 
likely to reflect the intrinsic cellular glycolytic capacity. Furthermore, this assessment may 
help to unravel the role of glucose metabolism in human tumour growth and the response 
of tumours to therapy. Currently, the only method for the direct assessment of lactate pro­
duction in vivo  is ,3C MRS, but it has never been applied to a patient with a brain tumour. 
In this thesis, the first results of a measurement using ,3C MRS with infusion of ,3C-enriched 
glucose in a patient with a brain tumour (Fig. 3.8) are presented in chapter 8.
Glu4
Glc
90 m inutes o f 13C glucose
3
No 13C glucose
90 65 40 15
frequency shift [ppm]
Figure 3 .8 : Several ]3C MR spectra o f a patient with GBM during intravenous infusion o f l - ]3C-glucose. The 
bottom spectrum is the MR spectrum o f natural abundance ,3C in the tumour. In this spectrum only signals 
from lipids (in the necrotic part o f the tumour) are visible. (ISIS localisation, volume o f 50cc)
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Abstract
Purpose: To assess the reproducibility of 1H-MR spectroscopic imaging (MRSI) of the human 
brain at 3T with volume selection by a double spin echo sequence for localization with 
adiabatic refocusing pulses (semi-LASER). M ateria ls and Methods: Twenty volunteers in two 
different institutions were measured twice with the same pulse sequence at an echo time 
of 30ms. MR spectra were analyzed with LCModel with a simulated basis set including an 
experimentally acquired macromolecular signal profile. For specific regions in the brain 
mean metabolite levels, within and between subject variance, and the coefficient of variation 
were calculated (for taurine, glutamate, total N-acetylaspartate, total creatine, total choline, 
myo-inositol+glycine and glutamate+glutamine). Results: Repeated measurements showed 
no significant differences with a paired t-test and a high reproducibility (CoV ranging from 
3-30% throughout the selected volume). Mean metabolite levels and CoV obtained in 
similar regions in the brain did not differ significantly between two contributing institutions. 
The major source of differences between different measurements was identified to be the 
between subject variations in the volunteers. Conclusion: We conclude that semi-LASER 
1H-MRSI at 3T is an adequate method to obtain quantitative and reproducible measures of 
metabolite levels over large parts of the brain, applicable across multiple centres.
70
'H MRSI of the human brain at 3T; reproducibility and variance in a dual centre setting
Introduction
In clin ical applications of proton MR spectroscopic imaging ('H-MRSI) point resolved 
spectroscopy 1 (PRESS) is the most commonly used method to select a volume of interest 
(VOI). However, with the introduction of MR systems at higher magnetic field strength the 
chemical shift displacement error (CSDE) of the slice selective refocusing pulses can no 
longer be overlooked. This can be solved by using pulses with large band widths, though 
this comes at the expense of higher peak power. To avoid high peak power longer pulses 
are chosen but this lengthens the minimal echo time. Recently, a 'H-MRSI sequence was 
developed based on PRESS localization, combining adiabatic slice selective refocusing 
pulses 2 as applied in the LASER sequence (/ocalization by adiabatic selective refocusing 
3) with conventional slice selective excitation. This so-called semi-LASER sequence 4 can 
be applied to the brain with an echo time of 30  ms. Its band width of 5kHz for the 
adiabatic refocusing pulses restricts the chemical shift displacement error (CSDE) at 3T 
to 1 2% over 5 ppm, whereas the CSDE of PRESS with conventional slice selective pulses 
(bandwidth of 1.3 kHz) at 3T and 1.5T is 48%  and 24% respectively4. Therefore, semi- 
LASER enables acquisition of high quality spectra of individual voxels in almost the entire 
VOI. W ith the small CSDE and sharp selection profiles of the adiabatic refocusing pulses, 
the VOI can be positioned close to the skull, w ithout causing contamination of voxels 
within the VOI with signals from subcutaneous lipids. The adiabatic refocusing pulses 
are tolerant to B, inhomogeneities as well, which is a benefit at higher field strengths. 
The four adiabatic refocusing pulses in the semi-LASER sequence are expected to affect 
the spectral shape of J-coupled spin systems 4, which has to be taken into account when 
processing spectra with algorithms using prior knowledge of spectral shape such as 
LCModel 5.
In clin ical MR spectroscopy, knowledge of metabolite levels, their distribution and the 
variation w ith in and between subjects in the normal human brain is necessary to distinguish 
significant differences in metabolite levels w ithin one patient or between patients and 
healthy subjects. To be of value in clin ical diagnosis, the changes in metabolite levels 
caused by diseases have to be larger than the bio logica l variation of these metabolite 
levels and larger than changes in metabolite levels that occur due to imperfections of 
the measurement method. Information on the between subject variance is important 
in diseases that may affect larger parts of the brain, such as multiple sclerosis and 
Alzheimer 6,7, when an internal reference to normal tissue is missing. The variation of 
metabolite levels in the human brain has been determined with single voxel spectroscopy 
8,0 and 'H-MRSI 11-13 at various magnetic field strengths. Also, the reproducibility or an 
analysis of variance of conventional PRESS ^-M RSI at 1 .5T 14-16 and of single voxel 
PRESS MRS at 3T has been reported 1718. However, recent advances in ^-M RSI at 3T 
with the introduction of the semi-LASER sequence invoke the need for an estimate of the 
reproducibility of 1 H-MRSI at 3T as well as evidence of robust performance of the semi-
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LASER sequence independent from institution and MR spectroscopist, to determine if this 
new technique could be used as a clinical standard for the near future
Therefore, the aim of this study was to determine the reliability and reproducibility of 
assessing metabolite levels in the human adult brain by the semi-LASER sequence with a 
short echo time at 3T. Data sets were acquired in two independent centers using the same 
protocol to evaluate the reproducibility of the sequence in a dual center setting.
Materials and Methods
The contributing institutions were the Radboud University Nijmegen Medical Centre in 
the Netherlands (RUN-MC), and the Norwegian University of Science and Technology in 
Norway (NTNU).
Hardware and subjects
All investigations were performed on 3T whole body MR systems (TIM Trio, Siemens 
Medical Solutions, Erlangen, Germany). The body coil was used for excitation of the MR 
signal and a receive-only 1 2-channel array head coil driven in CP mode was used for 
signal reception. Metabolite levels in the brain were investigated in 10 healthy volunteers 
in each institution. To determine the reproducibility of the semi-LASER sequence, the 10 
volunteers were measured twice in RUN-MC. In NTNU 10 other volunteers were also 
examined twice. The age of the volunteers was 35 ± 1 2  years in RUN-MC and 23 ± 3 
years in NTNU. The measurements were conducted in compliance with the regulations of 
the local institutions human ethics committee.
MRI and MRS protocol
T2-weighted anatomical reference images were acquired with the follow ing parameters: 
Field of view 230  x 173 mm, matrix size 448 x 297 , resolution 0.51 x 0 .58 mm, 26  
slices, slice thickness 5 mm, repetition time (TR) 4040  ms, effective echo time (TE) 1 02 ms, 
Turbo spin echo train length: 9 echoes. The images were positioned in the axial plane 
above the corpus callosum. The plane was parallel to the line that crosses the pia mater 
and the frontal part of the corpus callosum (Fig. 4 .1 , saggital view). Subsequently, the 
MRSI measurement was planned on the T2-weighted images and shimming was performed 
with an automated phase map shim procedure to optim ize first and second order shim coil 
currents followed by manual adjustments in approximately 5 minutes.
The semi-LASER pulse sequence was used for MRSI with an echo time of 30  ms, and a 
repetition time of 2 000  ms. A  matrix of 20  x 20  voxels (Field of View (FOV) 1 6 .0 x 16.0  
cm) was positioned in an axial plane in the brain above the corpus callosum, which 
crosses the corona radiata. The other measurement parameters were: VOI of 1 00 x 1 00  
x 10 mm (VOI was 60 x 60 x 10mm for the reproducibility measurements in NTNU)
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Figure 4 .1 : Position o f the 2D MRSI volume o f interest and saturation slabs in the brain o f a healthy volun­
teer. In the ax ia l image the voxels that were chosen to determine the metabolite levels, Regions o f Interest 
(ROI), are indicated with numbers 1 to 8. The white circle around voxel 1 approximates the true voxel size. 
The data obtained from ROI number 5  and 6 is used to approximate o f metabolite levels in pure white mat­
ter and pure gray matter, respectively. For the reproducibility analysis o f repeated measurements in RUN- 
M C the same ROIs were chosen as indicated in this figure. For the reproducibility analysis o f the repeated 
measurements in NTNU 6 ROIs were used. These 6 ROIs were comparable to number 1-5 and number 6 
was chosen three rows below number 3.
nominal resolution of 8 x 8 x 1 0 mm, spectral resolution of 2 Hz/po in t, carrier frequency 
was set to 2.2 ppm, circular k-space acquisition with 2 weighted averages. The water 
signal was suppressed by a slightly modified WET (water suppression enhanced through
I I  effects) scheme ,9. The final gradient spoiler of this scheme has a high amplitude and 
short duration, leaving time for 5 optional outer volume saturation slabs (nine-lobe sine RF 
pulses) before the 90° excitation of the MRSI sequence. These saturation slabs were placed 
around the VOI over the skull. The acquisition time was 1 1 minutes. The MRSI measurement 
was repeated with a one-average acquisition without water suppression to acquire a water 
reference data set (acquisition time 9 minutes).
All MRSI data was filtered in the two spatial dimensions with a Hamming filter. Before 
Fourier transformation the data was zero filled to a 32 x 32 matrix. The combination of 
the weighted acquisition and filtering of k-space reduced contamination from neighboring 
voxels, but, it increases the real voxel size (defined at 50% of slice profile height) by a 
factor of 1.57 in both spatial directions 20. The true voxel size can be best approximated  
by a circle with a diameter o f 12.5 mm in a slice of 1 0 mm thickness.
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M acrom o lecu la r MRS p ro file  o f the  b ra in
To obtain an MRS profile of the macromolecules in the brain a separate measurement was 
done on a healthy volunteer using a similar method as has been described before for MRS 
in the brain 21 •n . For this purpose an inversion pulse was applied before the excitation pulse 
in the semi-LASER sequence. W ith an inversion time of 500  ms, most signals from the main 
metabolites were nulled and a spectrum of the macromolecules was obtained. N ine voxels 
containing a mix of gray and white matter were averaged. From this signal the residues 
from water, the methyl group of creatine and the methyl group of N-acetylaspartate were 
removed. The time domain signal was zero filled to match the dwell time of the simulated 
MR spectra for the LCModel basis set. This final result was included as macromolecular 
signal profile in the LCModel basis set (see below).
S im u la tions o f MR spectra fo r  basis set
1H MR spectral profiles were simulated for each relevant compound by NMRSIM (version 
4 .6 .a. Bruker Biospin Inc.) with the semi-LASER pulse sequence at an echo time of 30  
ms, for glycerophosphocholine (GPC), choline (Cho), phosphocholine (PC), creatine 
(Cr), phosphocreatine (PCr), glutamate (Glu), glutamine (Gin), taurine (Tau), myo-inositol 
(ml), glycine (Gly), glucose (Glc), N-acetylaspartate(glutamate) (NAA(G)), alanine (Ala), 
y-aminobutyrate (GABA), aspartate (Asp), glutathione (GSH), lactate (Lac), succinate (Sue), 
guanidoacetate (Gua), pyruvate (Pyr), sc///o-lnositol (Scyllo), and acetate (Act). We used 
chemical shift constants and coupling constants as reported by Govindaraju et al 23. All 
simulated spectral profiles together with the measured macromolecular signal served as the 
basis set to fit measured in vivo MR spectra by LCModel (version 6.1-4F) 5.
LCModel ana lys is
All voxels inside the VOI selection volume were analyzed by LCModel. The signal of 
water in the unsuppressed MRSI was used by LCModel for eddy current correction and 
quantification. For this quantification we assumed an average tissue water content in the 
brain of 64% (35.6 m o l/l in white matter, LCModel manual). Furthermore, with TE = 
30 ms and TR = 2000  ms the T2 and T1 relaxation have to be taken into account for 
quantification. A  variety of T1 and T2 relaxation times of several metabolite and water 
proton spins in the brain at 3T have been reported for different locations and tissue types 
2226 yye calculated correction factors, f, for the signal intensities of individual metabolites 
as compared to the water signal intensity for white matter using equation [1] with T1 
relaxation times of 832, 1 350, 1240, 1080, 1010 and 1170 ms for w a te r26, NAA, Cr, 
Cho, ml, and Glu 25 respectively, and T2 relaxation times of 80, 295 , 1 56 , 1 87, 200  ms 
for w a te r26, NAA, Cr, Cho 25, Glu 24 and assuming a T2 relaxation time of 1 70  ms for ml.
f  attenuatirnmetabome (1 -  e F ,T r')e F IT"e' [Eq. 4.1 ]
attenuatim water ( i _ e K IT"lU)e~r  /T"2U
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The correction factors derived from these calculations varied between 1.06 and 1.16. 
Since the reproducibility results are not influenced by this attenuation factor, we used a 
general correction factor of 1.12, which accounts for an average of 12% attenuation of 
metabolite signals as compared to that of water.
Regions o f in te rest
To compare metabolite levels in the brain both institutions selected the same volume of interest in 
10 volunteers as shown in Figure 1. In this volume, 8 regions of interest (ROIs) were chosen to 
assess these levels in different locations of white and gray matter (Fig. 4.1). Tissue levels of the 
sum of NAA and NAAG (NAA+NAAG), total creatine (sum of Cr and PCr), total choline (sum of 
Cho, GPC, and PC), the sum of myo-inositol and glycine (ml+Gly), Tau and Glu were determined. 
The data from ROI number 5 (Fig. 4.1) was used to approximate metabolite levels of pure white 
matter, the data from ROI number 6 in the same figure served as a measure of pure gray matter.
Repeated measures were done between at least 1 day and at most 4 months after the first 
measurement. Subject were positioned supine and with the head in the middle of the head coil in 
the same way as done in the first measurement. Eight ROIs (Fig. 4.1) from the data of repeated 
measurements performed in RUN-MC, were used for the reproducibility analysis. The dimensions 
of the VOI in the repeated measurements that were performed at NTNU were 60 x 60 x 10 
mm and 6 ROIs were chosen similarly as shown in Figure 1 to calculate the reproducibility from.
Statistica l ana lys is
For each ROI, mean and standard deviation of Tau, Glu, total Cho, total NAA  (NAA+NAAG), 
total Cr, m l+Gly and G lx (Glu + Gin) were calculated. The differences between metabolites 
levels in comparable voxels of each site were tested with a one-way analysis of variance 
(ANOVA) (Graphpad Prism 4). A  segmentation of the ROI in partial volume of gray matter, 
white matter and CSF was performed when the metabolite levels differed between sites. 
This segmentation was done manually on the T2 weighted images using Siemens Syngo 
software for visualization of the ROIs.
Furthermore, in each voxel of the VOI the coefficient of variation (CoV) was calculated. 
The CoV was defined as the standard deviation of differences between the first and second 
measurement (Dk) divided by the mean value of all measurements (M) in each voxel, for 
each metabolite level 27 or:
I  Wk- D ?  _  -| n
J tL ---------------100 and D  =  — \ D k [Eq. 4.2]
M  n  k=
where k is the volunteer number, and n is the total number of volunteers (per contributing 
centre).
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To assess the reproducibility for each metabolite in each ROI a paired t-test and a test-retest 
reliability test were performed (SPSS 1 6.0.01). The reliability test used a two-way random model 
analysis of variance (ANOVA), with the subjects and the repeated measurement as factors of 
variance and it also includes a random noise term. From this the within subject variance o2with.n 
(repeated measurements) the between subjects variance (subject to subject) and the
intraclass correlation coefficient (ICC) were calculated. The overall measurement variance can 
be expressed as:
° 2 = '^between + ^within + ^ ra n d o m , [Eq. 4.3]
where a2 , reflects variance due to randomness. We defined the ICC, k to reflect the partrandom be ween I
of the total variance that is caused by subject to subject effects, and the ICCwithin to represent 
the part of the total variance that is caused by the differences of the repeated measurement by 
the following equations:
ICC, k = MS, /  (MS, k + MS + MS , ) * 100% [Eq. 4.4]be Kveen between7 » between within random* l i j
ICC = MS /  (MS, k + MS . + MS , ) *100%  [Eq. 4.5]Within within7 » between within random* l i j
MS is the mean square, which represents the sum of squares (a2) divided by the number of the 
deqrees of freedom. For the sake of completeness, the ICC , can be calculated from Eq.l '  random I
4.4 and Eq. 4.5, beinq 1 00% minus ICC, k and ICC ,,., thus the sum of three ICCs equalsI '  between within' I
1 00% by definition.
Results
All measurements were completed according to the protocol described in the methods section. 
Shimming resulted in consistent water line widths over the entire VOI. The line width of water 
proton spins of individual voxels inside the VOI were 5.8 ± 07 Hz for the RUN-MC cases 
(n=1200, 120 voxels per volunteer) and 5.5 ± 0.5 Hz for the NTNU cases (n=1200, 120 
voxels per volunteer).
Fitting MR spectra b y  LCModel
By visual inspection, the LCModel fit residuals of MR spectra obtained by the semi-LASER 
sequence consisted essentially of noise only (Fig. 4.2). The metabolites as well as the 
macromolecular signals were properly fitted by the model spectra. The CRLB (in percentage) 
for the major brain metabolites, tNAA, tCr, tCho and ml+Gly in all ROIs in RUN-MC were 3.0  
± 0.5, 3.9 ± 0.8, 5.1 ± 0.9, and 5.2 ± 1.0 respectively. In NTNU the CRLB for tNAA, tCr, 
tCho and ml+Gly in all ROIs were 3.3 ± 0.8, 4.1 ± 1 .1 , 5.6 ± 2.6, and 6.0 ± 1.5 respectively. 
The CRLB for Glu was 14.9 ± 5 .6 [%] in RUN-MC and 14.3 ± 6.3 [%] in NTNU. Also the 
macromolecular profile had a good fit (CRLB<20%) in data from both institutions. The CRLB for 
Tau in all ROIs was much higher; 43 ± 27  [%] in RUN-MC and 36 ± 29 [%] in NTNU.
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Figure 4 .2 : Two voxels o f a semi-LASER measurement a t 3T from one volunteer. Top: MR spectrum o f white 
matter (ROI 5  in Fig. 4. 1) with the fit by LCModel. Bottom: MR spectrum o f g ray matter (ROI 6 in Fig. 4. 1) 
with the LCModel fit. The raw  orig ina l spectrum (data points), the LC M odel fit, and the fit residual are shown 
as well as the estimated baseline and the macromolecular profile (MM).
Despite the possible mixed tissue content of gray matter, white matter, and cerebrospinal fluid 
(CSF) in individual voxels, the measurements allowed the detection of regional differences in 
metabolite content of brain tissue (Fig. 4.3). For example, the metabolite map of glutamate 
showed differences in metabolite levels between gray and white matter and a metabolite map 
of total choline compounds also showed differences between regions of the brain (Fig. 4.3).
Figure 4 .3 : Metabolite maps o f total Choline (A) and Glutamate (Bj in one o f the healthy volunteers. The 
maps are overlaid on a T2 weighted MR image. Note the differences in metabolite levels in gray and white 
matter and differences between frontal and parietal brain tissue.
The resonances of ml and G ly strongly overlap but have a different number of protons 
contributing to the signal. Although a difference in the apportionment of signal between 
them w ill lead to differences in the reported sum, we evaluated the sum of ml and Gly. 
The difference between the concentration ml (when G ly is excluded from the basisset) 
and ml+Gly was on average only 2 .5%  + 3% (with a maximum difference of 1 5%) in the 
normal human brain, where the concentration glycine is very low (<1 mM).
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Table 4.1: Mean and standard deviation of metabolite levels in 8 locations in the brain (mM*).
RUN-MC (n=10)
ROI tau Glu tCho tNAA tCr ml +Gly Glx
1 1.0 ±0 .6 4.9 ±0 .7 2.2 ±0 .4 10.2 ±0 .9 6.1 ±0 .7 6.5 ± 1.2 6.8 ± 1.4
2 0.8 ±0 .4 4.8 ±0 .6 2.1 ±0.3 9.4 ± 0.6 6.1 ±0 .5 6.5 ± 1.1 6.6 ± 1.0
3 2.1 ±0 .6 8.1 ± 1.0 2.0 ±0.3 9.2 ±0 .4 7.3 ±0 .7 7.3 ±0 .7 11.1 ± '1.4
4 1.4 ±0 .5 4.2 ±0 .9 2.0 ±0 .4 11.4 ± 0.9 5.8 ±0 .5 6.1 ±0 .7 5.9 ±0 .9
5 0.9 ± 0.5 3.8 ±0 .8 2.0 ±0.3 10.1 ±0 .4 5.6 ±0 .2 5.9 ±0 .4 5.2 ± 1.2
6 2.3 ±0 .5 9.1 ±0 .7 1.4 ±0.2 10.4 ±0 .7 7.8 ±0 .5 6.8 ±0 .6 12.4 ± '1.1
7 1.5 ±0.3 5.0 ± 1.0 2.0 ±0.3 10.8 ± 1.3 6.4 ± 0.6 7.1 ±0.8 7.2 ± 1.2
8 1.1 ±0 .4 4.6 ± 1.6 1.8 ±0.2 9.7 ±0.3 6.1 ±0 .6 6.5 ±0.5 6.5 ± 1.7
NTNU (n=10)
ROI tau Glu tCho tNAA tCr ml +Gly Glx
1 0.8 ±0 .6 5.0 ± 1.1 2.1 ±0.3 9.7 ±0 .4 6.2 ±0 .5 5.8 ±0 .9 6.6 ± 1.4
2 0.8 ±0 .7 5.2 ± 1.6 2.3 ±0.5 10.2 ±0 .7 6.4 ± 0.6 6.4 ± 1.3 7.2 ± 1.6
3 1.8 ±0 .6 9.6 ± 1.1 2.1 ±0.3 9.4 ± 0.6 7.7 ± 0.6 7.3 ±0 .9 12.0 ± '1.3
4 0.8 ±0 .7 5.4 ±0 .9 2.0 ±0 .4 10.0 ±0 .6 6.3 ±0 .6 5.9 ±0.8 7.3 ± 1.3
5 0.9 ±0 .6 5.2 ±0 .5 2.1 ±0 .4 10.4 ±0.5 6.3 ±0 .5 5.8 ±0 .9 6.9 ± 0.7
6 2.2 ±0 .7 9.2 ±0 .8 1.5 ±0.3 10.0 ± 1.2 7.5 ± 0.7 6.8 ±0.5 12.1 ± '1.1
7 0.9 ±0 .7 5.3 ±0 .9 2.1 ±0 .4 10.2 ±0 .6 6.4 ± 0.5 6.0 ± 1.0 7.3 ± 1.2
8 0.9 ±0 .6 5.0 ±0 .8 2.2 ±0 .4 10.4 ±0.5 6.3 ±0 .5 6.1 ± 1.0 6.4 ± 1.2
Tissue concentrations o f metabolites in the human brain obtained by semi-LASER MRSI a t 3T in 8 ROIs (Fig. 
4.1). We assumed an average tissue water content in the brain o f 64% ¡35.6 mol/l). For the signal inten­
sities o f a ll metabolites compared to the unsuppressed water signal we used a correction factor o f 1.12, 
expressing the difference in signal attenuation due to T1 and T2 relaxation o f water spins compared to those 
o f metabolites. ROI 3 and 6 contain mainly gray matter, ROI 4  and 5  contain mainly white matter. The other 
ROIs contain a mixture o f white matter and g ray matter.
Tau: taurine, Glu: glutamate,tCho: glycerophosphocholine + choline + phosphocholine, 
tNAA : N-acetylaspartate + N-acetylaspartate glutamate, tCr: phosphocreatine + creatine, 
ml: myo-inositol, G ly: glycine, Glx: glutamate + glutamine,
Com parison o f m e tabo lite  leve ls ob ta ined  in the  tw o  ins titu tions
The metabolite levels in the 8 ROIs (Fig. 4.1) in the brain that were obtained in the two 
institutions were comparable (Table 4.1). Box and whiskers plots for the metabolite 
concentration in the white matter and gray matter voxel are shown in Figure 4. The average 
metabolite levels of all ROIs are summarized in Table 4 .1 . In most ROIs no statistical 
significant differences between the two institutions occurred, except for glutamate in ROI
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number 3 ,4  and 5 (p<0.001 one way ANOVA), for NAA+NAAG  in ROI number 4  
(p<0.01 one way ANOVA) and for m l+Gly in ROI number 7  (p<0.05 one way ANOVA). 
Further analysis of these differences led us to assess for a possible partial volume effects 
in these ROIs: we analyzed the relative contributions of gray matter, white matter and CSF 
to these voxels ( see Table 4.2 ), which indeed differed between the institutions for some 
voxels ( e.g. ROIs 3, 4 and 5).
R eproduc ib ility  pe r ins titu tion
To validate the reproducibility of the MRSI plane positioning we analyzed the offset of 
the MRSI plane between the repeated measurements. This differed 1 . 9 +  1.3 mm in the 
RUN-MC cases and 1.4 + 1.1 mm in the NTNU cases. The difference in angle between 
the line from nosetip to basis cranii and the transverse plane of the MRSI between the first 
and second measurement was smaller than 5 degrees in all cases (RUN-MC 1.6 + 1.0 
degrees, NTNU 2 .7  + 1.4 degrees). Taking the size of the VOI into account this resulted in 
a deviation of the VOI tip-to-tip slice position (in feed-head direction) of 1.4 + 0.8 mm for 
RUN-MC and 1.4 mm + 0 .7  mm for NTNU. The position of the MRSI slice in the repeated 
measurements in NTNU was approximately 5 mm higher above the ventricles than the 
position of the MRSI slice in RUN-MC.
----- 1 I I I I I I------------1 I I l------------1
Tau Tau Glu Glu tCho tCho tNAA tNAA tCr tCr ml +Gly ml +Gly
metabolite
tau tau Glu Glu tCho tCho tNAA tNAA tCr tCr ml +Gly ml +Gly 
m etabolite
Figure 4 .4 : Box and whiskers plot o f metabolite levels per institution (10 volunteers per centre) in similar 
voxels that were chosen to approximate purely g ray matter* (top) or purely white matter* * (bottom) voxels. 
*voxel number 6 in Fig. 4. 1. **voxe l number 5  in Fig. 4 .1 .
RUN-MC: Radboud University Nijmegen Medical Centre
NTNU: Norwegian University o f Science and Technology in Norway
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The CoV varied per metabolite and voxel, but similarly for both institutions. The maps of 
the CoV in each voxel of the VOI of the RUN-MC cases showed almost homogeneous 
distribution of the CoV for tNAA, tCr and tCho, the CoV of Glu and ml varied more (Fig. 
4.5). The CoV of taurine varied between 30% and 80%.
Table 4.2: Segmentation of ROIs into gray matter, white matter and CSF
Site A 
Partial volume [%]
Site B 
Partial volume [%]
ROI GM W M CSF GM W M CSF
3 79.9 ± 17.0 18.6 ± 15.0 1.4 ± 4.6 86.0 ±6.8 13.9 ±6 .8 0.0
4 0.8 ± 1.0 98.7 ± 1.7 0.5 ± 1.7 3.5 ±6 .7 96.5 ±6 .7 0.0
5 0.8 ± 1.1 97.3 ± 3.4 1.9 ± 2.8 3.3 ±4 .5 96.6 ±4.5 0.0
7 9.9 ±6 .8 90.1 ±6 .8 0.0 9.5 ± 7.0 90.5 ± 7.0 0.0
Result o f the segmentation o f ROIs # 3 ,4 ,5  and 7  (Fig. 4 . 1) into partia l volume o f gray matter, white matter 
and CSF. The segmentation was done manually on the T2 weighted images.
The paired t-tests for each ROI and each metabolite did not show any significant differences 
in the repeated measurements in the RUN-MC cases. In the NTNU cases a difference was 
found for tCr in ROI 4 (p<0.001) and ROI 3 (p<0.05), and for tNAA in ROI 3 (p<0.01).
CoV tNAA CoV tCr
Figure 4 .5 : Maps o f the Coefficients o f Variation for 5  metabolites in 
each voxel in the VO I shown for the RUN-MC cases (n=10j. 
tCho: glycerophosphocholine + choline + phosphocholine, tNAA : 
N-acetylaspartate + N-acetylaspartate glutamate, tCr: phosphocre- 
atine + creatine
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Analysis of variance of repeated measurements
Box and whiskers plots summarize the ICCs, calculated using Eq. 4-5, for the between 
subject variance and within subject variance in all ROIs per institution. The box and 
whiskers plots show the range of the ICCs (each determined from repeated measures in 1 0 
volunteers) of 8 ROIs in the RUN-MC data; and 6 ROIs in NTNU data (Fig. 4.6). Although 
the ICCs vary with metabolite and ROI, some generalizations can be made. The ICCwithin 
is low for metabolites with high SNR, and the values for ICCwithin are lower in the RUN- 
MC cases than those in the NTNU cases. In both institutions the ICCbetween is high, the 
median value is above 60% for all metabolites except for glutamate and taurine of which 
the MR signals have low SNR. A  low ICCrandom remains for the main metabolites (tNAA, 
tCr, tCho, ml+Gly) and a rather hiqh ICC , for Tau and Glutamate. Indicatinq that in
\ J  random v j
the latter case it is not possible to ascribe the variance to either the differences within one 
person or between persons.
ICCbetween RUN-MC ICCwithin RUN-MC
^^between NTNU ICCwith*n NTNU
Figure 4 .6 : Box and whiskers p lot o f the ICCbsWtssn and ICC ^  o f several metabolites as obtained from the 
repeated measurements in each institution. The ranges show the calculated ICCs from 8 ROIs in the RUN- 
M C data and 6 ROIs in the NTNU  data. In both institutions ICCs were calculated from repeated measure­
ments o f 10 subjects.
As can be seen from Table 4.3 in well defined gray or white matter regions in the brain the 
ICCwith[n is below 25% for the major brain metabolites (tNAA, tCr, tCho,,ml+Gly) except for 
tNAA and tCr in gray matter in NTNU. This indicates a reproducible metabolite assessment 
in both institutions althouqh the ICC, k and ICC .... differ between metabolites and ROI.between within
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Table 4.3 : Intra class correlation coefficients in white and gray matter (%).
ROI Tau Glu
RUN-MC
tCho tNAA tCr ml +Gly Glx
W M  (5) ICCb 15.0 67.1 94.1 62.2 66.8 51.2 46.9
ICCw 64.0 10.6 2.9 11.4 4.0 23.7 5.3
GM (6) ICCb 58.0 14.0 78.2 70.7 48.8 83.5 37.8
ICCw 0.5 41.9 0.0 0.8 22.9 2.2 21.0
NTNU
ROI Tau Glu tCho tNAA tCr ml +Gly Glx
W M  (a) ICCb 39.3 46.0 72.4 82.2 91.7 85.8 41.7
ICCw 46.1 23.5 17.3 0.8 2.4 0.1 37.4
GM (c) ICCb 38.7 38.7 65.2 43.2 60.9 61.7 61.1
ICCw 28.4 46.4 18.8 51.4 33.2 24.8 3.8
Results o f the two-way random ANOVA, represented by the intra class correlation coefficients for the between 
subject variance and the within subject variance for a voxel in gray matter (GM) and in white matter (WM). As 
white matter voxel, ROI number 5  was chosen in the RUN-MC data (Fig. 4. 1); as gray matter voxel ROI number 
6 was chosen in the RUN-MC data. Similar voxels for white and gray matter were chosen in the NTNU data. 
ICCw: the intra class correlation coefficients o f the within subject variance 
ICCb: the intra class correlation coefficients o f the between subject variance
Discussion
The regional variation in the level of several metabolites in the human brain has been 
studied before using MR spectroscopy 8-,, ,3( and the average metabolite levels we found 
match with values reported in these studies. In a comparison of metabolite levels in the 
brain between subjects that were examined at different sites, it is important to take the 
location of the voxel into account. In this study no significant difference in levels of the 
main metabolites of similar ROI's between sites were detected, with some exceptions. For 
example, glutamate levels did show significant differences between institutions in three ROIs 
(#3 ,4 ,and 5). This could be due to variable partial volume effects by gray and white matter 
in the ROIs, e.g. because the VOI in the NTNU cases was positioned slightly higher above 
the ventricles as the VOI in the RUN-MC cases. RUN-MC cases had a more variable partial 
volume of GM  in ROI 3 and NTNU cases had a higher and more variable partial volume 
of G M  in ROI 4 and 5. (Fig. 4.1 and Table 4.2). Another possible cause for dissimilar 
metabolite levels between the two sites could be the difference in mean age. However, 
levels of metabolites such as NAA, Cr and Cho change at most 7% per decade 28. Since, 
the standard deviation on the age of the volunteers in RUN-MC is large, we anticipate 
that the differences due to age are exceeded by other differences between subjects. In 
both institutions similar water line widths were obtained in the VOI and the CRLB of the 
metabolite levels obtained by LCModel fits were small. All of these observations contribute
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to the conclusion that the semi-LASER sequence is a robust method for the determination of 
metabolite levels in the brain, and produces similar results in different institutions.
In this study two metabolites with very low tissue concentration and SNR were evaluated, 
taurine and glycine, as their levels may increase upon pathological conditions (e.g. 29'30). 
Thus, the measured values can serve as a reference level. We did not find any significant 
differences between the taurine levels in the two institutions in any of the ROIs. Glycine 
was evaluated together with myo-inositol in this study because the SNR of the glycine 
signal in normal human brain spectra is very low. Furthermore, the difference of the fit of 
LCModel of ml (no G ly in basis set) and ml+Gly was on average only 2.5%  + 3% and 
therefore it did not affect the measure of reproducibility.
Several studies have addressed the reproducibility of brain metabolite assessment by 1H 
MRSI ,5'16'31'32 and by single voxel 'H  MRS H 17,is,33-35  ^ a || performed at 1.5T, except for 
one study, which was performed at 3T ,8. These studies show a rather large variation in 
reproducibility results because of differences in measurement parameters such as voxel 
size and location in the brain, number of subjects and measurements, and data analysis. 
This makes a comparison cumbersome. Nevertheless, we found CoV's of tNAA , tCr, 
tCho, and Gin at 3T that were smaller or comparable to the reported values at 1.5T 
15-17,31_ |n some areas ¡n the VOI (Fig. 4.5) we obtained better results for the CoV of 
ml and in Glu than reported by others at 1 .5T that used comparable short echo times 
(about 30  ms) and volumes ,5-17'31. One of the reasons for this observation could be that 
the detection sensitivity of ml metabolite levels at 3T is improved over 1 .5T 36 which  
also contributes to a higher reproducibility. Moreover, the J-modulation reduction by the 
adiabatic refocusing pulses in the semi-LASER sequence of strongly coupled spin systems 
of various compounds such as ml and Glu, may improve their determination.
A  paired t-test is the most straightforward w ay to look at significant differences in 
metabolite levels between the repeated measurements. This test could not detect any 
significant difference in the metabolite levels in the 8 selected ROIs between the repeated 
measurements from RUN-MC, whereas by exception a significant difference in tN AA  and 
tCr in two ROIs of the NTNU data was found. Looking at the ICCwithin of these metabolites 
in these ROIs, the highest ICCwithin (71 %) is found for tCr in ROI 4 that showed the highest 
level of significant difference (p<0.001). For tCr and tN AA  in ROI 3 the ICCwithin was 
smaller, 51 % and 33% respectively, here the significance level of the t-test was also lower 
(p<0 .01 and p<0 .04  respectively). This indicates that the ICCwithin is also a measure 
for reproducibility since it is directly related to the difference between the repeated 
measurements.
In this study, the w ithin and between subject ICC vary with metabolite type and ROI. Since 
we do not expect changes in metabolite concentrations in the brain of healthy volunteers 
between the repeated measurements, the w ithin subject variance w ill be dominated by
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changes in MRSI acquisition and data analysis. Metabolites with high SNR in the MR 
spectrum such as tNAA , tCr and tCho have a lower ICC .... than ICC, k in most ROI's.I '  Within between
This indicates that the variation is dominated by differences between subjects and not by 
the measurement method. Metabolites with low SNR in the MR spectrum such as Tau and 
Glu have a ICC .... that sometimes is sim ilar to ICC, k or even hiqher. Also the ranqeWithin between v j
of the ICC values is larger for these metabolites. Apparently it is difficult to estimate the 
metabolite levels from signals w ith low SNR: either the error is appointed to differences 
within in the subject or the random error is dom inating the variance. The latter is the case 
when both the ICC, k and the ICC .... are low.between within
A major potential cause of variation (within subject variance) between repeated 
measurements in this study is the manual positioning of ROIs. Slight differences in 
location may result in different contributions of CSF, white matter and gray matter to 
the selected voxels, which in turn may affect the measured metabolite levels. To tackle 
this problem one can apply automated tissue segmentation based on MR images to 
determine the amount of gray and white matter in the voxels and use this for a correction 
of metabolite levels. However, in clin ical practice voxels w ill always contain a mixture of 
tissue types. For longitudinal studies the error introduced by the repositioning of the MRSI 
grid is of more importance, in those cases an automated repositioning algorithm 37 or a 
stereotactic repositioning method 38 may avoid differences in position of the voxels and 
improve the reproducibility of the measurements.
In conclusion, the semi-LASER sequence can be used successfully for MRSI of the human 
brain at 3T. MR spectra acquired in different institutions are comparable and the 
metabolite levels we observed fit well in the range of previously reported metabolite 
values of the human brain. Furthermore, the repeated measurements showed that the 
method is robust and reliable since the variance is mainly introduced by differences 
between subjects.
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Quantitative 1H MRSI of the peripheral oedematous region of human brain tumours as a 
non-invasive tool to differentiate between glioblastomas, metastases and meningiomas 
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Abstract
Purpose: The aim of this study was to use short echo time 1H MRSI to assess the peritumoural 
oedematous (PO) and the surrounding apparent normal (SAN) regions of brain tumours 
to 1) discriminate glioblastoma from metastases and 2) to investigate the effect of diffuse 
infiltrative tumour growth in the PO region by comparing MR spectra of glioblastoma to 
those of non-infiltrating tumours; metastases and meningiomas. Methods: A  total of 41 
patients (15 glioblastoma, 1 1 metastases, 15 meningioma) were examined with 2D or 3D 
semi-LASER 1 H MRSI at 3 Tesla and the MR spectra were analysed by LCModel. The PO 
and SAN regions were selected based on T2-weighted and contrast enhanced T1 -weighted 
MRI and after quality control of the MR spectra. Ratios of metabolites were calculated for 
every voxel of the ROI. Statistical testing between patient groups was performed on the 
entire ROI and the highest value of the ROIs with a student's t-test and a non-parametric test, 
respectively. A  leave-one-out Linear Discriminant Analysis was used to generate a classifier 
to separate glioblastoma and metastases. Results: Differences between tumour types were 
most significant when the highest values of metabolite ratios inside ROIs were analysed. 
Using the metabolite ratios with strong significant differences in the PO regions to build 
a classifier resulted in discrimination of glioblastoma from metastases with a sensitivity of 
0.95 and a specificity of 0 .78. The ratios of the signals of total choline and (myo-inositol + 
glycine) to that of total N-acetyl aspartate or toatal creatine were significantly different in 
the PO regions of glioblastoma versus that of meninigoma, most likely due to the presence 
of infiltrating tumour cells in the PO region of glioblastoma. Conclusion: Metabolite levels 
in the PO region of glioblastoma differ from those of metastases and meningiomas, which 
may be used to discriminate tumour types. An analysis of these ratios averaged over 
relatively large regions and more specific regions with most abnormal values indicates that 
tumour growth is directional.
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Introduction
The most common tumours encountered in the brain of adults are primary high grade gliomas 
and metastases 1. The overall prognosis is generally poor for patients with these tumours 2,3, 
but with correct treatment however, mean survival time can be prolonged significantly 4'5.
As treatment depends on tumour type, an accurate diagnosis is important. In current 
clinical practice, Magnetic Resonance Imaging (MRI) usually is the main imaging modality 
in the detection and diagnosis of brain tumours. The reason is that MRI can generate 
multiple contrasts that distinguishes the anatomy of different tissues in the brain, including 
abnormalities caused by tumours. Furthermore, most brain tumours have a defective blood 
brain barrier with leaky blood vessels, which can be visualised by signal enhancement on 
T1 weighted MRI with the use of Gadolinium contrast. In fact, in diffuse gliomas the most 
malignant part is indicated by this contrast enhancement and considered as the prime target 
for biopsy. Unfortunately, diagnosis solely based on standard MRI is often not conclusive and 
discrimination between glioblastoma and solitary metastases remains difficult as commonly 
both lesions show contrast enhancement with a peritumoural oedematous (PO) zone and 
variable central necrosis on conventional MR images including images obtained after contrast 
application. To differentiate between the two, diagnosis is still based on histopathology of 
tissue samples collected during biopsy or resection surgery. As both biopsy and surgery 
procedures carry risks, and the final diagnosis based on biopsies might be inaccurate due 
to sampling errors in heterogeneous tumours 6, methods for non-invasive diagnosis need to 
be improved.
Contrary to tumour cells of metastases, those of glioblastoma actively and extensively infiltrate 
in healthy brain tissue, often along myelinized axons and blood vessels 7'8. This process may 
extend centimetres beyond the hyperintensive area on post-gadolinium T1-weighted images 
and the hyperintensive region on a T2-weighted image. The success of tumour resection in 
clinical outcome depends strongly on the extent of tumour infiltration 7'9. Thus, non-invasive 
delineation of infiltrated brain tissue is expected to be a useful tool for tumour grading, 
surgery, and radiotherapy and to monitor tumour treatment.
To increase the specificity and sensitivity of standard MRI, more functional approaches are 
increasingly being added to clinical examinations of patients with tumours. These may in­
clude perfusion weighted imaging (PWI) to assess vascular functionality, diffusion weighted 
imaging (DWI) to assess tissue characteristics associated with water movement, and proton 
MR spectroscopy (MRS) to assess tissue metabolism and physiology. The latter has been 
demonstrated to be useful in the diagnosis and treatment evaluation of brain tumours ,013. 
As brain tumours are spatially heterogeneous it is becoming more common to use proton MR 
Spectroscopic Imaging (MRSI) to differentiate between tumour types and between tumour 
grades ,4'15.
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Figure 5 .1 : Schematic representation o f glioblastoma, meningioma and metastatic tumours and their sur­
rounding areas. Circles, triangles and stars represent respectively meningioma, metastatic and glioblastoma 
cells. Metastases and glioblastoma often show a necrotic core (area 4), meningiomas do usually not have 
a necrotic core. Tissue around the necrotic core is often contrast enhancing on radiological images and 
contains many tumour cells, this is represented by area 1. The contrast enhancing area is in most cases 
surrounded by oedematous regions, represented by area 2, which we refer to as peritumoural oedematous 
region (PO). In the PO region o f meningiomas no tumour cells are present, in the PO region o f metastasis 
some tumour cells might be present but are located not further away than a few millimetres from the contrast 
enhancing zone. In glioblastomas the PO region contains many tumour cells which spread out several centi­
metres beyond the contrast enhancing zone. Glioblastoma tumour cell infiltration could even extent beyond 
the PO region as depicted in area 3. Area 3 is called the surrounding apparent normal region (SAN), which 
surrounds the PO. For clarity, the term normal appearing brain tissue (NABT) is used to address the contra 
lateral brain tissue or the normal appearing brain tissue that is located more than 4  spectroscopy voxels 
away from the PO region.
Also in the differentiation between metastasis and glioblastomas the addition of MR 
spectroscopy has been explored. In most studies the contrast enhancing part of the tumour 
was analysed, but often differentiation remained problematic 101617. In a study at 1 ,5T 
field strength and 30 ms echo time it was observed that the ratio of the lipid peaks at 1.3 
and 0 .9  ppm was higher in metastases than in glioblastomas 18, which appeared to be due 
to a T2 difference for these protons 17. Because glioblastomas generally show extensive 
diffuse infiltrative growth in the surrounding brain parenchyma 8, while this is much 
more limited for metastases, an investigation of metabolic changes outside the contrast 
enhancing area may be useful for this purpose. Infiltrative growth of glioblastoma occurs 
in the peritumoural (non-enhancing) oedematous (PO) region, which appears hyperintense 
on T2 weighted MR images, and also in the adjacent surrounding apparent normal (SAN)
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brain region, which has a normal appearance on T2 and T1 weighted MR images 1119-23. 
Cells of circumscribed brain tumours like métastasés and meningiomas hardly infiltrate 
in surrounding tissue outside the tumour core, which often is characterised by contrast 
enhancing on MRI. In particular meningioma rarely infiltrates in surrounding brain 
parenchyma. Still, they often are accompanied by peritumoural oedema and therefore can 
be used as a model for pressure induced oedema and subsequent metabolic changes in 
brain tissue without infiltrative tumour growth. A  schematic overview of the typical growth 
of glioblastoma, metastasis and meningioma is shown in Figure 5.1.
So far, studies that have investigated peritumoural oedematous regions of brain tumours 
used either single voxel spectroscopy with short and long echo time 24,25 or MRSI with long 
echo time 26,27. Recently, we developed and validated a 2D and 3D 'H MRSI method at 
echo times down to 30ms, suitable for brain applications at 3T 28. This enables to detect 
metabolites with short T2 relaxation times, which could be involved in metabolic changes 
in peripheral regions of glioblastoma.
The purpose of this study was to investigate if short echo time 'H MRSI at a magnetic field 
strength of 3 Tesla can be used to discriminate glioblastoma from métastasés based on 
MR spectra from the peripheral oedematous and surrounding apparent normal regions of 
the tumour, with non-infiltrating meningiomas as a second control group. As the infiltrative 
growth of glioblastoma is heterogeneous and somewhat sparse, some areas in oedema 
around the contrast enhancing part w ill contain more tumour cells than others. Therefore we 
also evaluated the most abnormal values of metabolite levels and ratios in the peripheral 
oedema and surrounding region of the different tumours to detect metabolic differences 
caused by directional tumour infiltration. The results of our study showed that glioblastoma 
and métastasés can be discriminated using metabolic differences seen by 3D short echo­
time 'H MRSI.
Methods
Patients
All measurements were carried out after approval of the local institutional medical ethics 
committee and written informed consent was obtained from each patient before the MR 
examination. The study included 41 consecutive patients with newly diagnosed, untreated 
brain tumours. They underwent MRI and MRS investigations one day before surgery. A  
pathologist specialised in neuro-oncology (PW) examined the surgically removed tissue 
specimen to determine the tumour type. The pathology diagnosis was glioblastoma -GB- 
for 15 patients (age 54 ± 7  y), meningiomas -MENG- for 15 patients (age 58 ± 1 1 y). 
and métastasés ( 5 lung carcinomas, 2 squamous cell carcinomas, 1 breast carcinoma, 
1 rectal carcinoma, 1 melanoma, and 1 sacromatic cell carcinoma) -MET- for 1 1 patients 
(age 61 ± 1 1y).
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Data acqu is ition
All measurements were performed on a 3T whole body MR system (TIM TRIO, Siemens, 
Erlangen), a body coil was used for excitation and a 12-channel receive-only head coil 
was used for reception of the MR signal.
The MRI protocol included at least multi-slice T2-weighted MRI (resolution 0 .6x0 .6mm, 
slice thickness 5mm, 26 slices, repetition time (TR) 4040ms, echo time (TE) 102ms) and 
T1 weighted 3D rapid gradient echo MRI (resolution 1 x l x l mm, TR 2300ms, Tl 1 1 00ms, 
TE 4.71ms) after contrast administration (15ml 0 .5mM  Dotarem (Guerbet,France)). MRSI 
was performed with a semi localised adiabatic selective refocusing (semi-LASER) pulse 
sequence with a short echo time of 30ms with water suppression and fat saturation slabs 
to suppress lipid signals from the skull 29. A  volume of interest (VOI) was selected by 
excitation and refocusing of three orthogonal slices. Other MRSI parameters were: TR 
of 1000-1500ms for 3D MRSI, TR of 2000ms for 2D MRSI, carrier frequency 2.2ppm, 
hamming filtered circular k-space acquisition with 2 or 3 weighted averages). The field 
of view (FOV), matrix size and number of averages were adapted such that a nominal 
voxel size between 1-1.7 cm3 was reached within a total acquisition time of 12 minutes. 
In 7  cases -5 cases with MENG and 2 cases with MET- we obtained 2D MRSI, in those 
measurements the matrix size was larger but the acquisition time and spatial resolution 
was similar. Shimming of the B0 magnetic field was done interactively by evaluating the 
results of an automated phase map shim procedure of the VOI and, if desired, by manually 
adjusting the linear shim gradients.
Data ana lys is
All MRSI data sets were analysed using LCModel (version 6.1-4F (30). The data was fitted 
with a linear combination of model MR spectra of 22 metabolites: glycerophosphocholine 
(GPC), choline (Cho), phosphocholine (PC), creatine (Cr), phosphocreatine (PCr), 
glutamate (Glu), glutamine (Gin), taurine (Tau), myo-inositol (ml), glycine (Gly), glucose 
(Glc), N-acetylaspartate(glutamate) (NAA(G)), alanine (Ala), y-aminobutyrate (GABA), 
aspartate (Asp), glutathione (GSH), lactate (Lac), succinate (Sue), guanidinoacetate (Gua), 
pyruvate (Pyr), scyllo-lnositol (Scyllo), and acetate (Act). The model signals were simulated 
based on the semi-LASER sequence using NMRSIM (version4.6.a, Bruker, Biospin). The 
chemical shift and coupling constants as reported by Govindaraju et a l31 were used in 
these simulations. The attenuation due to the imposed TR and TE was taken into account 
in the LCModel calculations. For this purpose a correction factor was calculated based on 
the average attenuation factor of water, N-acetyl aspartate, total choline, total creatine, 
myo-inositol and glutamate in the normal brain 28,32.
We evaluated the ratios of metabolite levels and not signal integrals relative to those 
of water to avoid effects of variable water content in tissue. We included the following
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metabolites or sum of metabolites: the sum of N-acetyl aspartate and N-acetyl aspartate 
glutamate (tNAA), the sum of creatine and phosphocreatine (tCr) the sum of choline, 
glycerophosphocholine, and phosphocholine (tCho), the sum of myo-inositol and glycine 
(ml+Gly), the sum of glutamate and glutamine (Glx), lactate (Lac), taurine (Tau) and lipids 
resonating at 2 .0  ppm, 1.3 ppm and 0 .9 ppm (Lip20, Lipl 3, Lip09).
Regions of interest
To analyse the MRSI data we displayed the conventional MR images together with the 
processed spectroscopic data in a recent version of the home-built software package 
MRCAD 33 was used. W ith this software we drew regions of interest (ROIs) in each patient, 
based on the MRSI grid overlaid on T2-weighted and contrast enhanced T1-weighted 
MR images. All these ROIs were located inside the VOI of the MRSI grid (Fig. 5.2). The 
peritumoural oedematous (PO) ROI was defined as the area that was hyper-intensive on 
T2-weighted images but was located outside the contrast enhancing part of the tumour 
on T1-weighted images. The surrounding apparent normal (SAN) region was defined as
Figure 5 .2 : Example o f ROI drawing using T2 weighted images (A  and D), T1 weighted images pre contrast 
administration (C) and T1 weighted images post contrast administration (B). The inner white box indicates 
the volume o f interest (excitation volume). Voxels marked with 'o ' belong to the peritumoural oedematous 
ROI, voxels marked with 'p ' belong to the surrounding apparent normal ROI. In this patient the tumour was 
so large that we could not d raw an ROI in the contra lateral normal appearing brain tissue.
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the first normal appearing area (at most 3 voxels away from the PO ROI) on a radial line 
originating in the tumour. Only voxels that were located entirely in PO or SAN region were 
added to a ROI representing on of these regions. To prevent data overlap between ROIs, 
because of overlap of MR signal in neighbouring voxels due to filtering and zerofilling the 
spatial dimensions of the MRSI matrix, the ROIs were separated by at least the distance 
of one voxel (Fig. 5.2). Also an ROI was selected in normal appearing brain tissue, at at 
least the distance of 4  voxels away from the tumour tissue and peritumoural oedema and 
if possible contralateral to the tumour.
Q u a lity  con tro l o f ROI se lection and  MR spectra
Each voxel w ithin a selected ROI was subjected to a quality assessment sim ilar to 
procedures used in the INTERPRET and eTUMOUR projects ,2'34'35. As explained earlier, 
the ROIs were determined on T1 and T2 weighted MRI. A fter selection of an ROI, the 
tissue type of each voxel inside the ROI was reviewed based on MRI. Voxels containing 
more than one tissue type as determined from T1 and T2 weighted MR images (for 
example cerebral spinal fluid and white matter) were excluded from the ROI. All other 
remaining MR spectra were manually assessed on their quality. MR spectra with good  
signal to noise ratio, correct phase of the signal, sufficient water suppression, acceptable 
line w idth and absence of artefacts passed this check and were used in further 
processing. Subsequently, the results from LCModel per voxel in each ROI were subject 
to additional quality assessment. As LCModel is incapable to fit metabolites which are 
not present, (e.g. lactate in healthy tissue) all fits resulting in Cramer-Rao lower bounds 
(CRLB) of 999%  and a tissue concentration of 0 were included as being metabolites with 
a concentration of 0 mM. Furthermore, fits to metabolite signals with a CRLB larger than 
20%  were not included.
S ta tis tica l ana lys is
Statistical analysis of the metabolites levels in the voxels of the ROIs was performed 
with the statistical software package, SPSS 17 (SPSS Inc, Chicago Illinois). Ratios of all 
metabolites to tCr and tN AA  were evaluated. We used a Shapiro-W ilk test to assess the 
distribution of metabolite levels inside a ROI. For ROIs with normal distribution (p<0 .05), 
differences of the distribution of the metabolite ratios inside the ROIs of GB, MET and 
MENG were tested with a student t-test. Equal variances of the distributions were assumed 
unless the outcome of Levene's Test of equilibrium of variance had p<0 .05 . In non­
normal distributions the non-parametric Mann-W itney U test was used. Since the number 
of voxels appointed to each ROI differed between patients, we applied a weighting  
function for the number of voxels belonging to an ROI prior to the t-tests.
Besides testing the mean value of metabolite ratios of all voxels in the ROI, also the 
maximum value inside a ROI were pooled among patients and tested using Mann- 
W hitney U test (non-parametric test for non-normal distributed data).
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A  Linear Discriminant Analysis (LDA) was performed using Leave-one-out validation to 
generate a classifier 15 to discriminate between GB and MET by metabolite ratios. The 
calculation was performed with the statistics toolbox of M atlab  (version R 2 0 0 8 a , The 
M athworks Inc.) for the classification of 3 or 4  metabolite ratios from all voxels inside the 
oedematous ROI of all patients with GB or MET.
Results
All MR measurements w ere successfully carried out according to the protocol described 
above and all data was used for further analysis. MR spectra of PO and SAN regions from 
GB, MET and M E N G  patients generally had high signal to noise ratio and the spectral 
resolution allowed fitting of strongly coupled metabolites such as the overlapping reso­
nances of glutamate and glutamine (Glx), and myo-inositol (Tab.5.1, Fig. 5 .3 ). The mean 
and standard deviation of several metabolite ratios in the PO and SAN region are sum­
marised in table 5 .1 .
Table 5.1: Mean and standard deviation of metabolite ratios in the PO and SAN regions of brain tumours
tNAA/tCr 
mean sd
tCho/tCr 
mean sd
ml+Gly/tCr 
mean sd
Glu+GIn/ 
tCr 
mean sd
ml+Gly/ 
tNAA 
mean sd
tCho/tNAA 
mean sd
Peritumoural
Oedema
GB
MENG
MET
0.85 ±0.0 .32 0.42 ± 0 .1 7  
1.23 ± 0 .2 0  0.29 ± 0 .0 6  
1.26 ± 0 .2 6  0.35 ±0 .0 5
1.00 ± 0.46 
0.71 ± 0 .1 4  
0.63 ± 0 .1 0
1.58 ± 0.64 
1.78 ±0.51 
1.71 ± 0 .2 9
1.62 ± 1.66 
0.56 ±0.1 8 
0.51 ±0.13
0.58 ± 0.45 
0.24 ± 0.07 
0.30 ± 0.07
Surrounding
GB 1.23 ± 0 .2 0 0.36 ±0.11 0.98 ± 0.24 1.24 ±0 .3 5 0.81 ±0 .25 0.30 ±0 .10
Apparent MENG 1.35 ±0 .2 3 0.30 ± 0 .1 0 0.94 ± 0.33 1.28 ± 0 .3 9 0.70 ± 0.28 0.22 ± 0.08
Normal MET 1.34 ± 0 .2 9 0.30 ± 0.05 0.81 ± 0 .2 9 1.19 ± 0.28 0.62 ±0.21 0.23 ± 0.04
Table 5. 1: Mean and standard deviation o f metabolite ratios in the entire peritumoural oedematous and  
surrounding apparent normal ROI. A  weighting function that corrects for the number o f voxels belonging to 
an ROI was applied before statistical calculations with SPSS
Q uality  assessment and statistics
After spectral quality control, a total of 4 2 5  voxels from PO (n=21 3) and SA N  (n=21 2) 
ROIs have been used for statistical analysis. N o  significant differences in metabolite ratios 
of normal appearing brain tissue (5 1 7  voxels after quality control) were found between 
the patient groups.
The metabolite ratios inside the normal appearing brain tissue (NABT), PO and SA N  ROI 
of all volunteers w ere normally distributed according to the Shapiro W ilks test; therefore
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Figure 5 .3 : MR spectra with the fit o f LCMo- 
del o f the oedema regions in métastasés (top) 
GB (middle) and meningiomas (bottom). The 
voxel position corresponding to the spectra 
are drawn in T2 and T1 weighted images. 
The dashed line is the macromolecular MR 
profile  (mm) that was also included in the 
basis set for LCModel.
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a two tailed t-test was used (with or without equal variances assumed dependent on the 
outcome of the Levene's test) to compare mean metabolite ratio's of different tumour type 
in each ROI. W hen the highest ratio inside the ROIs w ere pooled among tumour type, 
the distributions w ere not normal and a M ann-W itney U test was used to find differences 
between tumour types.
Figure 5 .4 : Mean and 95% confidence intervals o f metabolite ratios o f the entire ROI in the three tumour 
type groups. Significant differences between tumour types, assesses by two tailed t-tests, are indicated by  
the brackets with the corresponding level o f significance jp-valuej. A  weighting function representing the 
number o f voxels inside the ROI was applied before statistical analysis.
GB versus MET
W e found significant different metabolite ratios of m l+ G ly /tN A A  and tN A A /tC r  in the 
PO ROI (all values of the voxels marked as PO ROI) between GB and MET. The ratio 
m l+ G ly /tN A A  was higher in GB with p = 0 .0 3  and the ratio tN A A /tC r  was higher in 
MET with p = 0 .0 2  (Fig. 5 .4 ). Furthermore, when evaluating only the highest metabolite 
ratio inside the ROI w e found that the mean metabolite ratio over all patients of m l+ G ly /
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tN A A , tC h o /tN A A  and m l+ G ly /tC r w ere significantly higher in the PO ROI of GB com­
pared to MET with p = 0 .0 0 2 , p < 0 .0 0 1 , and p = 0 .0 2 , respectively. In contrast, the ratio 
tN A A /tC r  was significantly lower (p = 0 .02) in the PO ROI of MET than of GB. Also the 
ratios of m l+ G ly /tN A A , tC h o /tC r and tC h o /tN A A  w ere higher in the S A N  ROI of GB  
com pared to MET (Fig. 5 .5 ). Using the highest ratio from each ROI resulted in smaller p- 
values for significant differences between GB and MET in comparison to using the mean 
of all ratios of the entire ROIs. The 9 5 %  confidence interval (Fig. 5 .4 ) of the ratios tC h o /  
tN A A  and m l+ G ly /tN A A  in the PO region of GB are larger than those of MET or M E N G  
and this characteristic feature also ap p ear in Figure 5 .5 .
The ratios of tCho, tN A A  and m l+G ly to tCr respectively, w ere used to generate a clas­
sifier to discriminate GB from MET (data from the entire ROI, Fig. 5 .4 ). W e  chose the 
ratio tC h o /tC r because choline is known to be involved in glial tumour growth and the 
other ratios w ere chosen because the t-tests showed significant differences of these ratios 
between GB and MET (Fig. 5 .4 ). A  leave-one-out validated LDA analysis was performed 
on this data set. This resulted in a sensitivity of 0 .9 5  for discriminating GB from MET with 
a specificity of 0 .7 8 . Adding a fourth parameter, for exam ple, the ratio G lu /tC r or T au / 
tCr did not further improve the sensitivity or the specificity. The plane in 3-dimensional 
space discriminating between GB and MET could be described by the equation:
| tNAA 1 ? tCho Q ^ m l + Gly Q 
tCr tCr tCr
Thus, in this index the ratio tN A A /tC r  is the m ajor factor to discriminate voxels of the PO 
region as belonging to one of these two tumour types.
GB versus MENG
W hen comparing GB to M E N G , similar results w ere obtained. The mean values of the 
ratios m l+ G ly /tN A A , tC h o /tC r, and tC h o /tN A A  in the PO ROI w ere significantly higher 
in GB compared to M E N G , and the ratio tN A A /tC r  was lower in GB com pared M E N G  
(Fig. 5 .4 ). The tC h o /tN A A  w as also significantly higher in the SA N  ROI of GB compared  
to M E N G  (p = 0 .04 ) (Fig. 5 .4 ). Com paring the highest value inside the ROIs of GB and 
M E N G  w e found significantly higher ratios of tC h o /tN A A  and tC h o /tC r in the PO and 
S A N  ROI of GB, and in only the PO ROI significantly higher ratios of m l+ G ly /tN A A , but 
lower tN A A /tC r  w ere found (Fig. 5 .5 ).
MET versus MENG
Finally w e also tested if the metabolite levels of ROIs of metastasis and meningiomas 
w ere different. The only significant differences between these tumours w ere found in an 
evaluation of the highest value of the PO region. The ratio m l+ G ly /tC r was higher and 
the ratio tC h o /tC r was lower in M E N G  compared to MET (Fig. 5 .5 ).
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Figure 5 .5 : Box and whiskers p lot o f metabolite ratios o f the maximum value inside ROIs in the three tumour 
type groups. Significant differences between tumour types, as assessed by Mann-W itney U test, are indica­
ted by the brackets with the corresponding level o f significance jp-valuej.
Discussion
Diagnostic differentiation between glioblastomas (GB) and solitary brain metastases (MET) 
often remains challenging. In this study w e used short echo-time 1H MRSI at 3T to examine  
3 regions in the brain of patients with glioblastomas and metastasis outside the G d  enhanc­
ing area to search for metabolic differences that could discriminate between these tumour 
types. As controls w e also examined these areas in patients with meningiomas (M E N G ). 
The general assumption was that tumour infiltration occurred exclusively for glioblastomas 
in the peripheral oedematous (PO) and surrounding apparent normal (SAN) tissue and this 
will cause distinct metabolic differences compared to the same tissue in metastases and 
meningiomas.
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W e normalised the levels of the evaluated metabolites as a ratio to tCr or tN A A  for each 
voxel. Although tCr and tN A A  might be heterogeneously distributed in brain and tumour 
tissue, w e assumed this method of normalisation to be more suitable than using absolute 
concentrations of metabolites in the tissue or normalising to metabolite values of contra lat­
eral normal appearing brain tissue (NABT). The reason for this is threefold. Firstly, absolute 
metabolite concentrations are calculated by scaling to the unsuppressed w ater signal of the 
same voxel. However, w e observed from unsuppressed w ater MRSI measurements that in 
general the signal of w ater was higher in tumour tissue than in normal appearing brain tis­
sue, whereas LCModel assumes a constant w ater density within a voxel, which can contain 
mixed tissue types. Furthermore, the w ater content in the brain varies between patients with 
a brain tumour according to the degree of oedema and possible treatment with steroids 
36'37. Secondly, a proper voxel in contra lateral NABT was not always available. Moreover, 
any useful clinical discriminating index with respect to normal contra lateral tissue values 
will need the inclusion of this tissue in the measurement, which may not always be possible 
in an adequate way. Thirdly, an advantage of using metabolite ratios for each voxel is that 
these are independent of coil sensitivity and local shim.
Previously, w e observed maximum variations of 15%  in the levels of tNA A, tCr, tCho and 
ml+Gly in normal brain tissue of volunteers measured with the same MRSI technique -short echo 
time semi-LASER- as used in this study32. In the present study differences of 20 %  -  3 0 0 %  were 
recorded for mean ratios of these metabolites between tissues of different tumour types and 
these thus reflect true metabolic differences between tissue types.
Different m etabolite ratios w ith  spatial variation in PO and SAN 
regions of glioblastomas.
W e found different mean metabolite ratios in the peritumoural oedematous (PO) and ad ja ­
cent surrounding apparent normal (SAN) regions of GB compared to the two other tumour 
types and NABT, using MR spectra from all voxels inside the selected ROIs. However, 
only some mean metabolite ratios (e.g. m l+ G ly /tN A A  and tN A A /tC r) reached statistical 
significance. But when pooling only the highest or lowest value of metabolite ratios in the 
PO and S A N  regions, more metabolite ratios showed significant differences between GB 
and the other tumours, in particular the tC h o /tN A A  ratio. This suggests that changes in 
metabolite levels and their underlying causes depend on their particular location, which 
might be averaged out when evaluating a large region of interest. This is expected for 
heterogeneous cellular infiltration in GB, i.e. by averaging over a large ROI, differences 
in metabolite levels due to infiltration may be obscured. Instead, by evaluating the high­
est or lowest ratios in an ROI, it is more likely to measure the most abnorm al region (the 
one that contains most tumour cells) and metabolic changes due to presence of tumour 
infiltration may become apparent. Furthermore, the standard deviation of the metabolite 
ratios per tumour type of the highest ratio of the ROI was of similar magnitude as the
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standard deviation across the entire ROI, indicating that random effects or outliers are 
not involved in the analyses of the highest values. Apparently the level of tC h o /tN A A  
can vary strongly within oedematous and peritumoural tissue 3839 and m ay depend on 
the preferred directionality of tumour growth 22.
Relative high levels of choline and low N A A  levels are commonly found in the solid or 
central part of glial tumours, which is often contrast enhancing on T1 weighted MRI ,0'40. 
In addition, in several MRS studies these metabolic changes have been observed in the 
PO region of GB (high signal on T2 w eighted images) and beyond that, in normal ap­
pearing tissue 2°-22<24<26<27<4M 2. Some of these studies obtained results reflecting directional 
glial cell infiltration.
The concept of preferred directionality of glioma cell growth has also been tested in 
diffusion tensor imaging studies. Some of those studies claim to be able to separate 
vasogenic oedem a from tumour-infiltrated oedem a based on w ater diffusion parameters 
43,44 whereas others cannot confirm these findings 45.
A  high ratio of tC h o /tN A A  in GB might reflect increased glial cell density. Choline is 
considered to be a marker of accelerated cell proliferation 46.
The increased levels of tC h o /tN A A  and m l+ G ly /tN A A  could also be related to a de­
crease of tN A A . N A A  is a marker for the presence of neurons; its level might be reduced 
in PO and S A N  regions of GB due to infiltrating glial tumour cells. Metastases do not 
grow  infiltrative, therefore, the neuronal integrity of the brain surrounding metastases is 
probably not affected and the level of tN A A  will resemble that of normal brain tissue.
It is of note that among the significantly increased metabolite ratios in the PO and SAN  
region of GB, two contain myo-lnositiol (i.e. m l+ G ly /tN A A , m l+ G ly /tC r), of which the 
resonances can only be assessed by short echo time MRSI as used in this study.
The role of ml and G ly  in brain tumours is not entirely clear. Myo-inositol is an important 
osmolyte 47'48, thus the increased ratios m l+ G ly /tC r and m l+ G ly /tN A A  could be caused 
by a different osmolytic status of oedem a accompanying brain tumour. However, myo­
inositol is also involved in glial proliferation 49, and when accom panied by increased 
tCho, the increased ratio of m l+ G ly /tN A A  and m l+ G ly /tC r ratio in PO and SA N  regions 
of GB could be explained by an increased rate of cell division and glial proliferation 
46. Interestingly, the glial increase in myo-inositol is most pronounced in low-grade as­
trocytomas and gliomatosis 4951. Recently, higher myo-inositol levels also w ere detected 
in normal appearing contralateral white matter of GB patients, possibly related to mild 
astrocytosis 52.
G lycine has a low  signal to noise ratio in the MR spectrum and is therefore not found by 
LCModel in every voxel of the ROIs, however, since the glycine level in the normal brain
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is also low 53, the presence of this metabolite itself could be of value. W e observed that 
glycine is fitted reliably (with CRLB <20% ) more often in the PO ROI of GB than in the 
PO ROI of meningiomas or métastasés. This is in agreem ent with studies that have found 
high levels of glycine in astrocytomas and GB 54'56. Therefore, glycine might serve as an 
additional marker for the presence of glial tumours. M oreover, elevated levels of glycine 
have been related to tumour malignancy 55'57.
In the studies described above tumour infiltration is characterised by (relative) metabo­
lite levels. Another w a y  to investigate metabolic involvement in tumour infiltration is by 
exam ining the entire spectra. Independent component analysis can be used to extract 
features that are typical for certain types of tissues 58'59. This has been done for MRSI 
data of glial tumours w here each spectrum was represented as a mixture of the spectral 
features of three tissue types; tumour core, infiltrative tumour, and normal brain tissue 60. 
In this study the independent component that describes tumour infiltration consisted of a 
spectrum with high choline and low N A A  signals, consistent with our findings of a high 
ratio of tC h o /tN A A  in PO and S A N  regions of GB.
Differentiation betw een glioblastom as and métastasés
In the differential diagnosis of GB and brain métastasés among other brain tumours, both 
proton single voxel spectroscopy and MRSI have been explored in a range of studies 
focussing on the central (Gd enhancing) core of the tumour ,5<,8<61-66. Using MR spec­
troscopy as the only analytical tool to differentiate GB from métastasés, rather variable  
results w ere obtained and often differential diagnosis was not very satisfactory ,2'66. The 
most discriminating factor appeared  to reside in the lipid peaks. In using the ratio of the 
lipid peaks at 0 .9  and 1 .3  ppm a sensitivity and specificity of 8 0 %  w as reached ,8. Later 
it was found that the T2 of proton spins in lipids in métastasés was longer than in GB 17, 
which may at least partly explain the variability of the results obtained at different echo 
times in other studies.
N ext to the exploration of the tumour core also attempts have been m ade to improve 
this differential diagnosis by evaluating the peripheral region ad jacent to this core, 
as GB cells g enera lly  w ill infiltrate in this region, in contrast to circumscribed tu­
mours such as métastasés and m eningiom as. This has consequences for the metabolic  
content of this region as seen by MR spectroscopy 67. Q uantitative studies on the 
metabolic d ifference between GB and METs w ere  perform ed with single voxel spec­
troscopy at interm ediate echo time 24 and with MRSI at long echo time 24*26'27; which  
limits the number of observable metabolites as com pared to shorter echo times. Data  
was analysed as m etabolite signal ratios and voxels with the most deviating ratios in 
the PO w ere  selected in the MRSI studies, com parab le  to our approach. All 3 studies 
identified the tC h o /tC r ratio as a significant factor discrim inating GB and métastasés.
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W e also observed a higher tC h o /tC r for GBs with respect to metastases and menin­
giom as in the PO and S A N  region, although it did not reach statistical significance in 
the case of PO of metastases. W h ile  the N A A /C r  ratio w as not significantly different 
from metastases in the other studies, w e  observed a significant relative decrease in 
this ratio for GB. In addition  w e detected significant differences with respect to PO  
regions in metastases, in particu lar for the ratio tC h o /tN A A , but also for m l+ G ly /tC r  
and m l+ G ly /tN A A  which have not been reported in other studies com paring GBs and  
METs, and which m ay be due to the use of shorter echo times a n d /o r  higher magnetic  
fields. Interestingly, these ratios and that of tN A A /tC r  w ere  also significantly different 
for the surrounding apparen t normal (SAN) regions indicating also neoplastic infiltra­
tion outside the PO region.
W e  assessed the sensitivity and specificity of differentiating between GB and MET using 
metabolite ratios of the PO region. Although the threshold index developed in this study, 
composed of the ratios tC h o /tC r, m l+ G ly /tC r and tN A A /tC r, to discriminate GB from 
solitary metastases gives a good sensitivity (0 .9 5 ), the specificity (0 .7 8 ) can still be im­
proved, for instance by adding other MR data. A  possibility to increase accuracy, using 
only MRS, is by combining the relevant metabolite ratios of the PO region with the lipid 
ratio of the tumour core.
Differentiation betw een glioblastom as and m eningiom as and  
betw een metastases and meningiomas
Finally, w e also compared metabolite levels in the PO and SA N  regions of GB with those 
of meningiomas. The PO and S A N  regions of meningiomas do not contain infiltrating 
tumour cells and therefore can act as a second control group for the glial infiltration. In 
general, and as expected, the metabolite ratios that differed between GB and M E N G  
w ere the same as those that differed between GB and MET and most ratios between 
METS and M E N G s w ere not different.
This confirms that differences between GB and MET or M E N G  are caused by metabolic 
changes in the ROIs of GB most likely due to tumour infiltration. The only significant dif­
ference w e observed, when evaluating the highest values of PO regions of MET versus 
M E N G , was for the ratios m l+ G ly /tC r and tC h o /tC r (Fig. 5 .5 ). In the PO region, the 
level of m l+ G ly /tC r was lower for MET, whereas the ratio tC h o /tC r was higher for MET 
than for M E N G . As both metastases and meningiomas are well-circumscribed tumours of 
which the oedematous regions do not contain tumour cells, the difference in m l+ G ly /tC r  
could be caused by a different osmolytic status of both tumour types. Astrocytic prolifera­
tion and gliosis are common features around metastastic brain tumours 68 and could also 
influence the levels of creatine, myo-inositol and choline as was shown in gliomatosis for 
a small groups of patients with gliomatosis ceribri 51.
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Conclusion
Based on the metabolite ratios tN A A /tC r, tC ho/tC r, and m l+ G ly /tC r in the peritumoural 
oedematous regions of the tumour w e w ere able to separate GB from metastases with high 
sensitivity and rather high specificity. Increased ratios of tC h o /tN A A  and m l+ G ly /tN A A  
in the PO and SA N  regions of GB have been observed when compared to meningiomas. 
These abnormal metabolite levels could point to increased membrane turnover due to the 
presence of infiltrating tumour cells in these regions. W e postulate that these metabolic dif­
ferences between tumour types are averaged out when the mean value of the metabolite 
levels of relatively large ROIs are evaluated. Inhomogeneous distribution of metabolite 
levels throughout the ROI of GB is probably caused by the heterogeneous infiltration of the 
tumour. Therefore, w e suggest evaluating also the highest values inside a region of inter­
est to distinguish between tumour type. The localisation of tumour infiltration might be of 
importance to neurosurgeons, radiologists and oncologists.
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Abstract
31P MRS in the detection of phosphocholine (PC), glycerophosphocholine (GPC), 
phosphoethanolamine (PE) and glycerophosphoethanolamine (GPE) compounds has 
shown clinical potential at 1 .5T for several human diseases.
The use of 'H  to 31P polarisation transfer can improve the sensitivity using a refocused IN ­
EPT method with a potential enhancement of 2 .4  (y]H/ y 3]p). However, in this method the 3,P 
signals of PE, PC, GPE and GPC are strongly attenuated (50%  or more) due to J-coupling 
between 31P and 1H that have similar magnitudes for homonuclear J-coupling constants in 
those metabolites. A  method to cancel the homonuclear J-coupling effects in polarisation 
transfer experiments is to apply frequency selective refocusing pulses, which becomes 
feasible at 3T due to the increased chemical shift dispersion as compared to 1 .5T.
In this study, full 1H to 31P polarisation transfer was realised using chemical shift selective 
refocusing pulses at 3T. T, and T2 values for 1H and 31P spins of PE, PC, GPE and GPC were  
measured in the human brain. A  more than twofold SNR improvement was obtained com­
pared to an optimised d irec t31P MRS method. As shifted RF pulses w ere used, this method 
can be applied on a broadband clinical MR system with a single RF system.
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Introduction
Phosphorus MR spectroscopy has been w idely applied in the examination of tissues in 
humans such as brain, muscle, liver and tumour. The information content of an 31P MR spec­
trum of these tissues can be roughly divided in signals arising from compounds involved in 
energy metabolism, such as ATP, phosphocreatine (PCr) and sugar phosphates (SP), and 
from compounds involved in phospholipid metabolism such as the phosphomonoesters 
phosphocholine (PC), phosphoethanolamine (PE) and the diesters glycerophosphocholine 
(GPC) and glycerophosphoethanolamine (GPE). Abnormal or characteristic levels of the 
latter group of compounds have been observed for several diseases ranging from brain 
disorders' to cancer2. In particular abnormal phospholipid metabolism in tumours has at­
tracted much attention for therapeutic and diagnostic purposes and is typically reflected 
in relatively high signals for phosphomonoester and choline compounds in 31P and 1H MR 
spectra respectively2'7. For practical and sensitivity reasons 1H MRS has been used most 
extensively in the clinic to assess the level of choline compounds in tumours. However, the 
choline resonance may be quite variable as the intensity of this signal also depends on 
other conditions such as cell density. As the ratios of phosphorylated compounds such as 
PC and GPC may be specific biomarkers for tumour presence and malignancy2 8 their sep­
arate detection would be desirable, but unfortunately the resonances of these compounds 
are difficult to resolve in 1H MR spectra obtained in vivo. W ith 31P MR spectroscopy their 
separate detection is possible, although at a lower sensitivity and with some contamination 
of resonances from other phosphomonoester and diester substances. The use of this ap­
proach has been limited to a small number of institutes because 31P MRS possibilities are 
not commonly available on clinical MR systems.
Several techniques have been proposed to improve the 31P sensitivity, for example using 
1H decoupling9, Nuclear Overhauser Enhancement (N O E )10, 1H to 31P cross polarisation" 
or polarisation transfer12. In theory, the maximum enhancements of Y]h/ y 31P (i.e. 2 .4  fold) 
can be obtained with cross polarisation and polarisation transfer techniques. These tech­
niques transfer the polarisation of the excited 1H spins through J-coupling (JpH) to the 31P 
spins during a period TE]H, with an efficiency proportional to the function c o s (ji x TE]H x  
JPH). Due to the small J-coupling constants of 3,P spins to 'H  spins, the optimal duration TE]H 
of polarisation transfer is relatively long, which causes signal loss due to T2 relaxation. 
M oreover, homonuclear J-couplings (JHH) to the 3,P coupled 'H  spins reduce the polarisa­
tion transfer even further, proportional to the function sin(jt x  TE]H x  JHH). As the J-coupling  
constants between 3,P and 'H  have similar magnitudes for homonuclear J-coupling con­
stants in PC, PE, GPE and GPC (JHH « J PH, Fig. 6 .1 ), the sensitivity enhancement can even 
be negative when using these techniques. Conventional polarisation transfer methods can 
account for the homonuclear J-couplings by optimizing inter-pulse timings like in refocused 
insensitive nuclei enhanced by polarisation transfer (RINEPT), but the maximum obtainable  
enhancement is still less than 5 0 %  of the potential enhancement12,13.
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Figure 6.1: Partial chemical structure o f the molecules PE, PC, GPE and GPC including chemical shift values 
o f the 'H  spins o f  1CH2 and 2CH2 group and their J-coupling constants.
A  method to actually cancel homonuclear J-coupling effects in polarisation transfer experi­
ments is to apply frequency selective refocusing pulses during spin evolution. These pulses 
need to selectively refocus the homonuclear coupled spins to decouple them from the spins 
that are coupled to the 31P spin, which can only be accomplished if the chemical shift differ­
ence between the homonuclear spins is larger than the bandwidth of the selective refocus­
ing pulse. Due to the increased spectral dispersion of the spin resonances at 3T compared 
to lower B0 fields, the refocusing pulse may be sufficiently selective to cancel the effects of 
homonuclear couplings for the molecules of PE, PC, GPC and GPE simultaneously.
Neglecting T, and T2 losses, the intrinsic SNR gain of INEPT with chemical selective refo­
cusing pulses compared to direct 31P detection would be 2 .4  fold for PE, PC, GPC and 
GPE. As the echo-time in the INEPT sequence is long due to the relatively low J-coupling 
constants, T2 relaxation effects need to be taken into account in the assessment of the 
overall SNR gain. The effect of large T, differences between 31P spins and 1H spins may 
compensate for SNR losses due to T2 relaxation, and even enhance the SNR per unit of 
time as shorter repetition times (TR) in the INEPT could be used.
Apart from 1H to 31P polarisation transfer at the highest clinically available B0 field strength 
to maximize SNR, optimised RF coils can also be used to further enhance the sensitivity 
o f 31P MRS. For ,3C MRS it has been shown that circularly polarised RF surface coils can 
provide higher SNR than volume resonators as well as linearly polarised surface coils14. In 
addition, as the tissue load dominates for surface coils, 1 H-blocking circuits with negligible 
losses can be inserted inside the conductors of the 31P coil, which allow  these coils to be 
used in combination with any 1H resonator.
In this study the implementation of chemical shift selective refocusing pulses into optimised 
echo times of an INEPT sequence is demonstrated to achieve full 1H to 31P polarisation trans­
fer in PC, PE, GPE and GPC. This method is implemented on a clinical 3T broadband MR
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system with a single transmit RF system15 using an optimised 31P RF coil for the human brain. 
The SNR enhancement of this method is compared to d irec t31P detection and conventional 
INEPT, including measured values of T, and T2 of the molecules PE, PC, GPE and GPC lo­
calised in human brain. W ith this optimised setup the metabolites PE, PC, GPE and GPC can 
be spatially resolved at a resolution of 2 4  ml within a measurement time of 1 6 .5  minutes.
Methods
All measurements were performed on a broadband clinical 3T MR system with a single 
transmit channel (Siemens Magnetom Trio with TIM, Erlangen, Germany). An optimised coil 
concept was used for 31P MRS of the human brain consisting of a quadrature birdcage 
resonator as a ’ H transmit receive coil and two slightly overlapping surface coils operating 
in quadrature as a 31P transmit receive coil14. The 31P elements are anatomically shaped to 
cover about 5 0 %  of the human brain, and have 1H blocking circuits inside the conductors to 
enable free positioning of these elements to any region of the brain inside the 1H resonator 
without electromagnetic couplings. The coils were interfaced to the MR system using home- 
build transmit/receive switches with integrated preamplifiers (Advanced Receiver Research, 
USA), small band quadrature hybrids and 1H cable traps for all coil elements. MR thermome­
try in phantoms was performed to validate the compliance to RF power deposition guidelines 
as described in a previous study14. The single transmit channel was passively split in order to 
separately transmit with the coil elements tuned to the different frequencies15.
In a polarisation transfer method like RINEPT the optimised spin evolution time of 1H 
spins (TE1 H) that attribute to the 31 P signal is inversely related to the J-coupling constant 
between the 31 P and 1H spin (JPH), assuming no homonuclear J-coupling (JHH). In the 
middle of TE1 H, a 1 8 0 °  pulse is applied to refocus chemical shift evolution. A  scheme of 
the new RF pulse sequence of the selectively refocused INEPT (sRINEPT) is shown in Figure
A
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Figure 6.2: Pulse sequences o f refocused INEPT wifh chemical shift selective refocusing pulses (a), conventional 
refocused INEPT jbj and direct31P (cj, all applied on a single transmit channel (pulses are applied sequentially with 
A, = 1.3 ms and A2 = 2.3 ms). An ISIS sequence was added to enable spatial localisation together with WALTZ16 
for 'H  decoupling. The RF pulses at the 3'P Larmor frequency are all adiabatic consisting o f a segmented BIR4 
(1-4) pulse at a flip angle o f0 °  followed by a BIR4 pulse at a flip angle o f 180° for the (s)RINEPT sequences and 
adiabatic full passage (AFP) for spin inversion and half passage (AHP) for spin excitation in the direct31P sequence.
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6 .2 A . The addition of two selective refocusing pulses to the established RINEPT sequence 
overcomes the effect of homonuclear J-coupling between the two C H 2 groups in all four 
molecules of interest. If no 1H homonuclear J-coupling effects would be present, RINEPT 
can be used for 1 H to 31 P (J = 6 .3  Hz) polarisation transfer with a TE1 H of 8 0  ms (i.e. 
1/2J) followed by 31 P spin refocusing at an echo time (TE31 P) of 3 4  ms (i.e. optimised 
for PC and PEI 3). However, coupling between the protons of 1 C H 2 and 2 C H 2  (J= 6 Hz) 
cancel out efficient polarisation transfer, hence a non-selective 1 H refocusing pulse was 
used in combination with 2 selective refocusing pulses on the 2C H 2 proton spins within the 
TE]h of 8 0  ms. Rectangular RF pulses w ere used for non-selective ’ H spin flips. W ALTZ16 
1H decoupling was applied during 31P MR signal detection using the 1H volume coil for 
transmitting the homogeneous B, fields. As the B, field obtained with the 31P coil is not 
homogeneous, adiabatic (BIR4) RF pulses w ere used for all 31P flip angles operating at a 
yB1 value of at least 1 5 0 0  H z (within the region of interest) and a bandwidth of 2 5 0 0  Hz. 
All RF pulses are applied sequentially using a small echo shift to allow  polarisation transfer 
on a single RF channel15.
The selective 1H refocusing pulse was designed using the Shinnar-Le-Roux algorithm16 so 
that only the 2C H 2 protons are affected. For PE, PC, GPC and GPE the chemical shifts of the 
proton spins of the ’C H 2 group that are coupled to the 3,P spin are 3 .9 8 , 4 .2 8 ,  4 .31  and 
4 .0  respectively. These proton spins also have homonuclear couplings to the proton spins 
of the next 2C H 2 group with chemical shifts of 3 .2 2 , 3 .6 4 , 3 .6 6  and 3 .2  respectively (Fig. 
6 .1 ). In order to selectively refocus the homonuclear coupled proton spins (2C H 2) from the 
31P coupled proton spins f C H 2) of all of the four molecules simultaneously, the frequency 
resolution of the required refocusing pulse must be 3 .9 8 -3 .6 6  = 0 .3 2  ppm. The duration 
of the refocusing pulse is set to 3 2  ms, which fit into the optimised inter-pulse delays. The 
frequency profile of the selective refocusing pulse was simulated using the Bloch equations. 
The sRINEPT method was compared to a conventional RINEPT sequence optimised for
4.5 4 3.5 3
1H chem ical sh ift (ppm )
Figure 6. 3: Frequency profile o f the selective refocusing pulse, simulated using the Bloch equations. The 'H  
chemical shifts o f the spins o f PE, PC, GPE, GPC that couple to the 31P nuclei (HJ are unaffected by this RF 
pulse, whereas the spins that reduce the polarisation transfer effect (H^J are affected.
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maximum sensitivity of PE, PC, GPE and GPC; i.e. without the selective refocusing 
pulses and at a TE]H of 3 0  ms (Fig. 6 .2 b ). Using both of these methods, 3 ,P MR signals 
of PE, PC, GPE and GPC w ere obtained from a localised volume in the p arie ta l/o c - 
cipital lobe of all 5  healthy volunteers (age 2 6 -3 2 , 3 male and 2  fem ale) using an ISIS 
localisation scheme ( 4 x 6 x 8  cm3) prior to the polarisation transfer (TR = 2  s, 12 8  
averages, 2 0 4 8  data points, 5  kHz bandw idth). Volunteers gave informed consent, 
and the study w as approved by the local ethical committee.
In order to take into account the effect of the T, values of the 31P and 1H spins in PE, PC, 
GPE and GPC within the human brain at 3T, localised inversion recovery experiments 
w ere perform ed in another 5  healthy volunteers (age 2 6 -3 3 , 4  male and 1 fem ale); 
using both the RINEPT method and the d ire c t31P method. F o r31P, an ad iab atic  full pas­
sage inversion pulse was used prior to the ISIS localisation, ad iab atic  90°-excitation  
pulse and 31P acquisition to obtain 31P MR spectra at four different inversion de lay  times 
(Tl = 0 , 1 .5 , 3 and 9  s; TR = 2 0  s, 2 0 4 8  data points, 5  kH z bandw idth) for each vol­
unteer. W ith  the RINEPT method, the inversion pulse was app lied  on the 1H spins prior 
to the ISIS localisation (Tl = 0 , 0 .5 ,  1 .5  and 3 s; TR = 10  s, 2 0 4 8  data points, 5  kHz 
bandw idth). As the 31P MR spectra obtained with the RINEPT method contained well 
resolved resonances of PE, PC, GPE and GPC without baseline contam ination of other 
resonances, the line-width of the lorentzian fit to these well resolved resonances was  
used as prior knowledge to fit the resonances obtained with the direct 3,P method using 
¡M R U I. For each m etabolite and for each volunteer, the T, value w as determined by 
fitting the lorentzian fit results as a function of the different Tl's to a mono-exponential 
(2 param eter) function.
To determine the amount of T2 losses, during TE3]p, in the assessment of the overall gain  
of RINEPT in comparison with direct 3 ,P M R spectroscopy, the T2 values of 3,P spins 
w ere measured. An additional BIR4 1 8 0 °  pulse w as added to the localised RINEPT 
method in order to obtain 31P MR spectra at 5  different extended TE3]p's (0, 2 0 ,  4 0 ,  6 0 ,  
8 0  ms; TR = 2s, 2 0 4 8  data points, 5  kHz bandw idth) of the same volunteers that w ere  
used in the measurement for the comparison between sRINEPT and RINEPT method. The 
integrals from the Lorentzian line fits to these spectra w ere fitted to a mono exponential 
decay function to determine the T2 values of 31P spins for PE, PC, GPE and GPC for 
each volunteer.
The perform ance of the sRINEPT method was also com pared to the conventional RINEPT 
method using quantum mechanical simulations as a function of TE]H. Both sequences in­
cluding its shaped RF pulses have been implemented in X W IN N M R  (Bruker, G erm any) 
to simulate the evolution of the spin systems of PE and PC, using the literature values for 
hetero and hom onuclear J-coupling constants as well as the chemical shifts17.
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Spatial mapping of phosphorylated metabolites is commonly done with 3D  31P MR spectro­
scopic imaging. The sRINEPT sequence has been extended with phase encoding gradients 
positioned prior to 3,P signal acquisition for this purpose. 3D  3,P MR signals at the SNR op­
timised TR of 1 .2  times the average T, of the appropriate spins were acquired from the hu­
man brain of a healthy volunteer (age = 3 3 , male) using both the d irec t31P method (TR = 8 
s) as well as the sRINEPT method (TR = 1.5 s). In both measurements, a FOV of 1 6  cm was 
used for all dimensions and 8 x 8 x 8  spherical k-space encodings. Hamming filtering was 
applied in the spatial domain of k space using weighted acquisition (25 averages of the 
centre of k-space) for the sRINEPT method and 1 spherical k-space acquisition for the direct 
31P method, resulting for both methods in an effective voxel volume of 2 4  ml (i.e. spherical 
volume at a diameter of 1 .7 8  x  1 6 0  /  8 mm). W a ltz l 6  'H  decoupling was applied during 
acquisition in both measurements, with a measurement time of 1 6 .5  minutes each.
Figure 6 .4 : Schematic overview o f the used RF coil 
setup including a transversal Spin Echo MR image 
o f the human brain obtained with the volume coil. 
The location o f the ISIS volume for a ll Tt, T2 and SNR 
measurements is indicated by the black box.
Results
For every volunteer measurement, all coil elements w ere manually fine-tuned and matched 
to 5 0 Q  at the corresponding Larmor frequency and connected to the MR system within 5  
minutes, including automated frequency alignment and RF power adjustments for the 1H 
nucleus. The spin-echo images obtained with the 1H volume coil did not show any distortion 
close to the location of the 31P conductors indicating negligible electromagnetic coupling 
between the 1H and 31P coils. These images w ere used to position a voxel of 8 x  6  x 4  cm3 
inside the human brain (Fig. 6 .4 ). A  3D  B0 phase-map shim, performed with two iterations, 
resulted in absolute line-widths of the w ater resonance of 17  H z (±1 Hz) for all volunteers 
at the selected region. The frequency setting of the 31P carrier was automatically calculated 
from the aligned 1H w ater resonance, and the 31P RF power was set to a fixed value based 
on phantom measurements, performed at equal electromagnetic loading conditions as for 
the human head; i.e. 6 5 0  W  for a maximum yB, of 1 5 0 0  H z in the centre of the selected
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voxel. The relatively high B, field strength and bandwidth of the RF pulse result in a flat 
excitation profile in the relatively small chemical shift region of 2  to 8 ppm (i.e. 3 5 0  Hz). 
A  localised direct 3,P MR spectrum with WALTZ1 6  1 H decoupling obtained from the brain 
of a healthy volunteer shows 1H decoupled resonances of PE, PC, GPE and GPC next to 
inorganic phosphate (Pi), phosphocreatine (PCr), adenosine-tri-phosphate (ATP) and some 
less resolved resonances of other compounds (Fig. 6 .5 A .). At the same location a conven­
tional RINEPT as well as the sRINEPT pulse sequence w ere used to acquire 31P MR spectra 
using a single RF transmit channel. O nly resonances of PE, PC, GPE and GPC w ere detec­
ted, and all are in phase, indicating accurate timing of the RF pulses (Fig. 6 .5B  and C). A  
clear gain in signal intensities of 2 8 %  on average (Table 6 .1 ) was observed in the sRINEPT 
measurement compared to conventional RINEPT.
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Figure 6.5: 3,P MR spectra obtained with a d irec t3,P (a), conventional RINEPT (b), or sRINEPT (c) acquisition 
method. The spectra obtained with the RINEPT and sRINEPT are obtained with equal scan parameters (TR = 
1.5 s, 25 6  averages) and displayed without any data filtering. The d irec t31P method (TR = 2 0  s, 32  avera­
ges) was used to obtain MR signals from an equal region in the brain o f the same volunteer to demonstrate 
the different spectral profile in comparison to the data obtained with the (s)RINEPT methods. In addition, 
the residual signal after subtracting the orig ina l signal with its Lorentzian lines fit is shown on top o f each 
spectrum (3-fold amplified). Note that the residual signal obtained with the (s)RINEPT method resembles 
uniform noise in contrast to non-uniform noise o f the direct 3IP method.
The spectral analyses of direct 31P MRS is hampered by overlapping resonances of other 
compounds as can be seen from the residual signals after subtraction of the Lorentzian line 
fits to the original data that resemble non-uniform noise in contrast to the residuals obtained 
with the (s)RINEPT methods (Fig. 6 .5 ). Prior knowledge from the sRINEPT measurement 
was used to fix the linewidths of the Lorentzian line fits to the resonances of PE, PC, GPE 
and GPC. In addition, a broad resonance was fitted underneath the resonances of PE and 
PC to remove the contribution of other compounds to the fits of PE and PC. All polarisa-
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tion transferred MR spectra w ere fitted to Lorentzian lines without any baseline correction 
or prior knowledge. The averaged spectra of all volunteers at different inversion times 
are shown in Figure 6 .6  using either the direct 31 P method or the conventional RINEPT 
method, whereas the results of the fits are summarised in Table 6 .1 . The intrinsic signal 
gain obtained with the conventional RINEPT method compared to the direct 31 P method is 
determined using the data of the inversion recovery experiment at Tl = 0  (Table 6 .1 ). On  
average, the Tl of the 31 P spins is more than 4-fold longer than the Tl of the 1 H spins 
of the corresponding metabolites. Taking into consideration the additional SNR gain per 
unit of time obtained from the differences in Tl (i.e. V(T1 31 P /T l 1 H)) as well as the gain  
obtained with the sRINEPT method compared to the RINEPT method, the overall gain in
PE
GPC
I PC
3s
0.5s
ppm
Figure 6.6: 3,P MR spectra obtained from inversion recovery experiments at different inversion times using 
either the direct 3'P fleftj or the RINEPT (rightj method. Note that inversion o f the spins using the direct 3'P 
method occurs at a substantially longer inversion time in comparison with the RINEPT method.
SNR using the sRINEPT compared to the direct 3,P method is 1 .6  to 2 .6  fold (Table 6 .1 ). 
The T2 values of the 31P spins measured in all of the volunteers w ere relatively large com­
pared to the TE3]p (Table 6 .1 ). Because of its ease in spectral analyses, a RINEPT method 
was used to determine the T2 of the four metabolites of interest. Com pared to a d irec t31P 
method the TE3]p of 3 4  ms of the (s)RINEPT methods contributed to a loss of 2 0 %  for GPE, 
17%  for GPC and 10%  for PC and PE (Table 6 .1 ).
The evolution of the spins of PE and PC has been simulated during the sRINEPT sequence 
as well as the conventional RINEPT sequence as a function of TE]H. W ithout taking T2 losses
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into account, the optimum TE]H for a conventional RINEPT method is 3 0  ms to obtain maxi­
mum signal intensity. This maximum intensity is still 5 0 %  lower compared to the maximum 
intensity obtained with the sRINEPT method at the optimum TE]H of 8 0  ms (Fig. 6 .7 ).
The T2 of the 1H spins is more difficult to obtain, as apart from T2 relaxation, also homo- 
nuclear J-couplings affect signal intensities at different echo-times. In addition, the T2 could 
only be obtained indirectly (through polarisation transfer) as the resonances of 1H spins 
of these metabolites in the 1H MR spectrum completely overlap with many resonances of 
other compounds. Nevertheless, 31P MR data was obtained at different 1H echo times (i.e. 
3 0  ms and 8 0  ms) as well as 31P MR data as a free induction decay, this is at an echo-time 
of 0  ms (d irect31P). Using these data and correcting for the expected sensitivity gain due 
to polarisation transfer and homonuclear J-coupling effects, signal attenuation during TE]H 
due to an apparent T2 of the 1H spins of PE is calculated. For PE this apparent T2 of the 
'C H 2 is 1 2 0  ± 9  ms
Figure 6 .7 : Quantum mechanical simulations o f the sensitivity o f RINEPT and sRINEPT signal intensities 
for phosphocholine (PC) and phosphoethanolamine (PE) as a function o f TEIH. Although the optimum inter- 
pulse timing (TE]H) is longer for the sRINEPT (about 80 ms) than for the RINEPT (30 ms), the intrinsic signal 
intensity is doubled.
The 3D  31P MR spectra obtained from the human brain demonstrate that 1H to 31P po­
larisation transfer at the highest B0 field strength now clinically available, using sensitivity 
optimised RF coils, gives excellent results (Fig. 6 .8 ). Signals from PE, PC, GPE and GPC 
can be detected at high SNR from 2 4  ml volumes within 1 6 .5  minutes of acquisition time. 
Com pared to the 3D  data obtained with the direct 3,P MR acquisition at the same spatial 
resolution and within the same acquisition time, the SNR of the spectra obtained with the 
sRINEPT approach is substantially improved.
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BFigure 6 .8 : Spectral maps o f a transversal slice from the 3D datasets obtained with either the direct 31P 
method (A) or the sRINEPT method (B). Each 3D dataset was acquired in 16.5 minutes with a FOV o f 16 
x  16 x  16 cm3 and 8 x 8 x 8  spatial encoding, using WALTZ16 'H  decoupling, 4k data-points in spectral 
domain a t a bandwidth o f 10 kHz. Note the excellent SNR gain o f the sRINEPT method compared to the 
direct 3]P method.
Table 6.1: Relaxation Times of 1 H and 31 P Spin Systems and Gain Values in the Detection of PE, PC, 
GPE, and GPC in the Human Brain at 3T Using Either the Direct 31 P Method, the Conventional RINEPT 
Method, or the RINEPT Method
PE PC GPE GPC
Intrinsic gain conventional RINEPT/ direct 3,P 0.9 0.5 0.8 0.9
Gain sRINEPT /conventional RINEPT 1.3 (±0.04) 1.6 (±0.4) 1.1 (±0.06) 1.1 (±0.08)
T, 1H [seconds] 1.5 (±0.04) 1.2 (±0.13) 1.2 (±0.14) 1.2 (±0.03)
T, 31P [seconds] 6.7 (±0.5) 5.3 (±1.4) 7.8 (±0.9) 7.0 (±0.5)
T2 31P [milli seconds] 263 (±21) 263 (±53) 147 (±12) 171 (±13)
SNR Gain sRINEPT/direct 3,P 2.6 1.6 2.2 2.4
The spectra obtained in a ll volunteers with the direct 3]P method were averaged due to low  SNR. A ll other 
values were determined for each volunteer and displayed as the average value including its standard devi­
ation (sdj. The overall SNR gain o f the sRINEPT compared to the direct 3]P is calculated using the intrinsic 
gains and the square root o f the ratio between the different T '^s.
Discussion
The results of this study demonstrate that efficient polarisation transfer between 'H  and 
3,P spins is feasible using selective refocusing for spin systems that have homonuclear 
J-coupling constants similar to hetero nuclear J-coupling constants (such as PE, PC, GPE 
and GPC). Com pared to conventional polarisation techniques like RINEPT that have opti­
mised inter-pulse timings for the detection of these metabolites, the new sRINEPT method 
is about 3 0 %  more effective. A part from this SNR enhancement by the new selectively 
refocused sRINEPT method, two other factors contribute to the reported SNR in this study. 
Firstly, the higher field strength of 3T com pared to the conventionally used 1 .5T systems 
for 'H  to 3,P polarisation transfer is expected to increase the SNR by a factor of two. 
And secondly, the optimised RF coil that is used in this study consists of a quadrature
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coil concept that is shown to enhance the SNR another 4 0 %  compared to conventionally 
used linear RF coils. Altogether w e have demonstrated that SNR of the resonances of 
some key phosphorylated metabolites (PE, PC, GPE, GPC) can be boosted substantially, 
which enables their detection in relatively small voxels of 2 4  ml within clinically accept­
able measurement times.
Although the quantum mechanical simulations show that full polarisation transfer of 'H  to 
3,P spins in PE and PC simultaneously is possible at 3T using spectral selective refocusing, 
the measured signal enhancement with respect to direct 3,P acquisition is significantly 
less than 2 .4 . As the simulations did not include signal attenuation due to T2 relaxation 
during TE]H and TE3]p of the (s)RINEPT method, these relaxations w ere determined to ac­
count for these losses. The T2 signal attenuation of the 3,P spins can easily be determined  
from the spin echo acquisitions at different echo times. The results of these measurements 
showed that this T2 relaxation can be attributed to an average attenuation of 1 6%  during 
the TE3]p of the (s)RINEPT methods. The T2 of the 'H  spins is determined only for PE, as 
the method to obtain this data assumes accurate knowledge of the spin evolutions and is 
sensitive to SNR. Com pared to GPE and G PC, the spin system of PE is simpler (includes 
less assumptions on accurate knowledge of J-coupling constants and chemical shifts), 
and in comparison to PC, the SNR of PE is substantially higher. The calculated T2 value 
of 1 2 0  ms is smaller than T2 values of the 'H  spins of the methyl groups of this molecule 
(1 9 7  ms18), which can be expected from the lower rotational and translational mobility 
of the 'C H 2 protons. The apparent T2 of 1 2 0  ms leads to a signal loss of 4 9 %  during the 
TE]H of 8 0  ms in the sRINEPT, or 22 %  during the TE]H of 3 0  ms in the RINEPT method.
Most of the SNR gain per unit time can be attributed to the differences in T, relaxation of 
'H  and 3,P spins when comparing direct 3,P with 'H  to 3,P polarisation transfer methods. 
The more than four-fold lower T, values of 'H  spins com pared to 3,P spins of PE, PC, GPE 
and GPC allow  for a more than twofold higher SNR in polarisation transfer compared  
to direct 31P acquisition. Additionally, the corresponding shorter TR allows for a better 
acquisition weighting in chemical shift imaging as more acquisitions can be used in the 
same scan-time to optim ally w eight the k-space trajectory according to a Hamming fil­
ter19. Rather than using five (i.e. T, 31P/ T 1 ]H) averages of the entire k-space in the sRINEPT 
method, 2 5  averages can be obtained from the centre of k-space within the same acqui­
sition time com pared to a single acquisition in direct 3,P MRS.
O ne of the main potential advantages of 3,P MRS is that some compounds, which play  
a key role in the abnorm al phospholipid metabolism of tumours and other diseases (PE, 
PC, GPE and GPC) can be observed separately, which is very difficult to do with 'H  MRS 
due to spectral overlap. The sRINEPT method has an additional editing advantage in the 
selective detection of these phosphorylated compounds of which the signals overlap with
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those of other phosphor compounds in direct 3,P MRS, e.g . sugar phosphates (SP)2021, 
although at a lower relative intensity. The resonances of these other compounds are  
completely absent in spectra obtained by the sRINEPT method, resulting in well-resolved 
resonances, which can be easily analysed by robust fitting without the need of prior 
knowledge. This advantage w as immediately imminent by the necessity to use prior 
knowledge of the spectra obtained with RINEPT methods to fit Lorentzian lines to the 
resonances obtained by d ire c t31P MR measurement, and may have lead to an underes­
timation of the SNR gain of PC.
Although it is demonstrated here that this 31P MRS method can provide information from 
relevant metabolites with a potentially sufficient SNR at clinically relevant voxel sizes and 
within acceptable measurement times, the non-availability of the acquisition method may 
ham per its use in the clinic. As the RF architecture of clinical MR systems is generally  
designed to operate at different magnetic field strengths, it is capab le  of broadband use 
and therefore it is relatively inexpensive to provide d ire c t31P MRS as an option. Never­
theless a second RF channel is usually not availab le  disabling the use of conventional po­
larisation transfer techniques. The results of this study show that the application of shifted 
RF pulses in 'H  to 31P polarisation transfer techniques is feasible allow ing these methods 
to be used with a standard single RF channel. Therefore w e believe that this optimised 
3,P MRS acquisition can become availab le on all clinical MR systems with only minor 
modifications of the RF architecture. This, combined with a volume 1H coil, a sensitivity 
optimised 3,P coil, automated frequency and RF pow er adjustments and shimming, will 
make the use of these 31P MRS protocols as simple as 1H MRS and data interpretation 
even easier.
Conclusion
This study showed that phosphorylated compounds in choline and ethanolam ine metabo­
lism can be monitored at 3T with substantially higher sensitivity com pared to previously 
applied 3,P MR techniques. At this field strength the 'H  spins of these metabolites that 
generally cancel the effect of polarisation transfer due to homonuclear J-coupling can be 
selectively refocused without affecting the 1H spins that attribute to this transfer. Therefore, 
full 'H  to 3,P polarisation transfer is possible for PE, PC, GPE and GPC simultaneously.
Although T2 relaxation during the relatively long echo times of the new sRINEPT method 
accounts for a substantial signal attenuation, the more than four-fold lower T, of the 1H 
spins com pared to the T, of the 31P spins can be translated in a more than twofold higher 
SNR com pared to direct 3,P methods. In combination with the absence of any signal 
overlap, detection of the resonances of PE, PC, GPE and GPC becomes feasible at small, 
clinically relevant voxels, enabling the use of MRSI to detect spatial differences of these 
metabolites as well.
Efficient 'H  to 31P polarisation transfer on a c lin ical 3T MR system
Finally, w e have demonstrated an implementation of the method that uses shifted RF 
pulses so that the sRINEPT technique can be applied on a clinical broadband MR system 
with a standard single RF channel. This will facilitate the use of the new method for the 
improved detection of the potential biomarkers PE, PC, GPE and GPC at clinical institu­
tions.
Acknowledgements
The authors wish to thank Jack van Asten for his help with the quantum mechanical 
simulations. This project is partially supported by N W O - IN /0 2 - 1 4 /0 3 4 .0 2 .0 0 5 ,  EC 
project eTUM O UR: FP6-2002-LIFESCIHEALTH 5 0 3 0 9 4 ,  Siemens, N C I R O lC A l 1 8 5 5 9  
and Z O N -M W  VENI (TS) 0 1 6 .0 5 6 .0 3 6 .
6
127
References
1. StanleyJA, Kipp H, Greisenegger E, MacMaster FP, Panchalingam K, PettegrewJW, Keshavan 
MS, Bukstein OG. Regionally specific alterations in membrane phospholipids in children with 
ADHD: An in vivo 3,P spectroscopy study. Psychiatry Res. 2006 ; 148(2-3):2 17-21
2. Podo F. Tumour phospholipid metabolism. NMR Biomed. 1 999; 12(7):4 1 3-39
3. Negendank W. Studies of human tumours by MRS: a review. NMR Biomed. 1 992;5(5):303-24
4. Negendank W G , Padavic-Shaller KA, Li CW, Murphy-Boesch J, Stoyanova R, Krigel RL, Schilder 
RJ, Smith MR, Brown TR. Metabolic characterization of human non-Hodgkin's lymphomas in vivo 
with the use of proton-decoupled phosphorus magnetic resonance spectroscopy. Cancer Res. 
1995;55(15):3286-94
5. Arias-Mendoza F, Payne GS, Zakian KL, Schwarz AJ, Stubbs M, Stoyanova R, Ballon D, Howe 
FA, Koutcher JA, Leach M O , Griffiths JR, Heerschap A, Glickson JD, Nelson SJ, Evelhoch JL, 
Charles HC, Brown TR. In vivo 31P MR spectral patterns and reproducibility in cancer patients 
studied in a multi-institutional trial. NMR Biomed. 2006 ; 1 9 (4 ):5 04 -l2
6. Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, W ilkins P, Opstad KS, 
Doyle VL, McLean MA, Bell BA, Griffiths JR. Metabolic profiles of human brain tumours using 
quantitative in vivo 'H magnetic resonance spectroscopy. Magn Reson Med. 2003;49(2):223- 
32
7. Heerschap A. In Vivo Magnetic Resonance Spectroscopy in Clinical Oncology, chapter 1 3 from: 
Cancer Drug Discovery and Development In Vivo Imaging of Cancer Therapy. Humana Press 
Inc. Totowa, NJ, 2007
8. Glunde K, Ackerstaff E, M ori N, Jacobs M A, Bhujwalla ZM.Choline phospholipid metabolism 
in cancer: consequences for molecular pharmaceutical interventions. Mol Pharm. 2006  Sep- 
0c t;3(5):496-506
9. Luyten P, Bruntink G, Sloff F, Vermeulen J, van der Heijden J, den Hollander J, Heerschap A. 
Broadband 1H decoupling in human 31P NMR spectroscopy. NMR Biomed. 1 989; 1 (4): 177-83.
10. Brown TR, Stoyanova R, Greenberg T, Srinivasan R, Murphy-Boesch J. NOE enhancements and 
T, relaxation times of phosphorylated metabolites in human calf muscle at 1.5 Tesla. Magn 
Reson Med. 1 99 5 ;33(3):4 1 7-21.
1 1. Mancini L, Payne GS, Leach M O. Implementation and evaluation of CSI-localised J cross­
polarisation for detection of 3,P magnetic resonance spectra in vivo. Magn Reson Med. 
2005;54(5): 1065-71
12. Gonen O, Mohebbi A, Stoyanova R, Brown TR. In vivo phosphorus polarisation transfer and de­
coupling from protons in three-dimensional localised nuclear magnetic resonance spectroscopy 
of human brain. Magn Reson Med. 1 997;37(2):301-6.
13. Mancini L, Payne GS, Leach MO.Comparison of polarisation transfer sequences for enhance­
ment of signals in clinical 3,P MRS studies. Magn Reson Med. 2003;50(3):578-88
14. Klomp DW, Renema W K, van der G raaf M, de Galan BE, Kentgens AP, Heerschap A. Sen- 
sitivity-enhanced 13C MR spectroscopy of the human brain at 3 Tesla. Magn Reson Med. 
2006;55(2):271-8.
Efficient 'H  to 31P polarisation transfer on a c lin ical 3T MR system
15. Klomp DW, Kentgens AP, Heerschap A. Polarisation transfer for sensitivity-enhanced MRS using 
a single radio frequency transmit channel. NMR Biomed. 2 0 0 8 ;2 1 (5):444-52
16. Shinnar M ., Leigh J.S. Inversion of the Bloch Equation. J Chem Phys (1 993) 98(8): 6121-6128.
17. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for 
brain metabolites. NMR Biomed. 2000;1 3(3): 129-53
1 8. M lynarik V, Gruber S, Moser E. Proton T (1) and T (2) relaxation times of human brain metabo­
lites at 3 Tesla. NMR Biomed. 2001 ;14(5 ):325-31.
1 9. Pohmann R, von Kienlin M. Accurate phosphorus metabolite images of the human heart by 3D 
acquisition-weighted CSI. Magn Reson Med. 2001 ;45 (5 ):817-26.
20. Glonek T, Kopp S. Ex vivo P-31 NMR of lens, cornea, heart and brain. Magn Reson Imag. 
1985;3:359-76
21. Robitaille PL, Robitailie PA, Brown GGJr, Brown GG. An analyses of the pH-dependant chemical 
shift behavior of phosphorus-containing metabolites. J Magn Reson 1991; 92:73-84.
6
129

7
31P Magnetic Resonance 
Spectroscopic Imaging with 
polarisation transfer of 
phosphomono and - diesters 
at 3T in the human brain: 
relation with age and 
spatial differences.
Published in: NMR in Biomed, 2010, Jul 28. [Epub ahead of print]
3,P MRSI w ith po larisation transfer o f phosphomono and  -diesters a t 3T in the human
bra in : relation with age and  spatia l differences. 
J.P. Wijnen, T.W.J.Scheenen, D.W .J.KIomp, A . Heerschap
Abstract
Tissue levels of the compounds phosphocholine (PC), phosphoethanolamine (PE) glycero- 
phosphocholine (GPC), and glycerophosphoethanolamine (GPE) can be studied by in vivo 
phosphorus MR spectroscopy (3,P MRS). However, the detection of the signals of these 
compounds suffers from low sensitivity and contamination by underlying broad resonances 
of other phosphorylated compounds. Improved sensitivity without this contamination can 
be achieved with a method for optimal polarisation transfer of 1H to 31P spins in these 
molecules called sRINEPT (selective refocused insensitive nuclei enhanced polarisation 
transfer). The aim of this study was to implement a 3D  MR Spectroscopic imaging (MRSI) 
version of sRINEPT on a clinical 3T MR system to obtain spatially resolved relative levels of 
PC, PE, GPC and GPE in the human brain as a function of age, which can be used as a 
reference data set for clinical applications. G ood signal to noise ratios w ere obtained from 
voxels of 1 7  cc of the parietal and occipital lobes of the brain within a clinically acceptable 
measurement time of 1 7  minutes. A  total of 1 8 healthy subjects of different ages (16 -70  
years) w ere examined with this method. A  strong inverse relation of the PE/GPE and P C / 
GPC ratio with age was found. Spatial resolution was sufficient to detect differences in me­
tabolite ratios between white and gray matter. Moreover, w e showed the feasibility of this 
method for clinical use in a pilot study of patients with a brain tumour. The sRINEPT MRSI 
technique enables exploration of phospholipid metabolism in brain diseases with a better 
sensitivity than was possible with e a r lie r31P MRS methods.
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Introduction
The tissue levels of some phosphorylated compounds involved in energy and membrane 
metabolism in the human brain can be investigated in v ivo  with phosphorus magnetic 
resonance spectroscopy (3,P MRS). High energy phosphate metabolites such as adenosi- 
netriphosphate (ATP) and phosphocreatine (PCr) have been studied in brain diseases like 
Parkinson's disease 1, A lzh e im e r2, depression 3 and tumours 4'6.
Abnorm al metabolism of phospholipids occurs in several brain pathologies and 3,P MR  
signals for phosphocholine (PC), phosphoethanolamine (PE) glycerophosphocholine 
(GPC), and glycerophosphoethanolamine (GPE) have been studied, in particular in re­
search on neoplastic lesions 5,7 and cognitive diseases such as schizophrenia 8. For 
exam ple, decreased levels of phosphomonoesters (PME) and increased levels of phos- 
phodiesters (PDE) have been found in the brain of schizophrenic patients 89. Elevated 
PME levels w ere found in patients with Alzheim er disease ,0. In brain tumour cells a 
substantial higher P C /G P C  ratio (>2 times) as com pared to normal white matter cells 
has been reported, as well as elevated levels of PME in patients with brain tumours 7.
M an y  3,P MRS studies of the human brain have been performed on 1 .5  T clinical MR  
systems. To cope with the relatively low sensitivity o f 31P MRS at this field strength, large 
voxels had to be chosen (~ 4 0 -l OOcc is commonly used at 1 .5T) making it impossible to 
study spatial heterogeneity within the brain, e.g . between gray and white matter, and 
in pathological tissue such as brain tumours. Spectral resolution at 1 .5T may be insuffi­
cient to discriminate PE from PC and GPE from G PC, hence these resonances w ere often 
combined as phosphomonoesters and phosphodiesters, respectively ,0. Finally, the MR  
signals of PME and PDE are affected by broad resonances of phosphorylated proteins 
and other phospholipids, making correct fitting of these signals more complex. Given all 
these complications, the use o f 31P MRS to detect PME and PDE as biomarkers for tumours 
and other diseases has been largely replaced by the more sensitive and easy detection 
of choline compounds by 1H MRS some 2 0  years ago. However, with in v ivo  1H MRS it 
is not possible to resolve the different components building up the total choline signal in 
the MR spectrum and therefore does not enable to study the role of PC and GPC alone. 
Thus, the need to detect signals of the different phosphorylated choline and the equally  
relevant phosphorylated ethanolam ine compounds at better spatial and temporal resolu­
tion remains.
W ith  the availab ility  of clinical 3T MR systems, the higher SNR of 3,P signals can be used 
to reduce voxel size. In addition the increased chemical shift dispersion at 3T results in 
better distinction between PE and PC and between GPE and GPC signals. By the imple­
mentation of 'H  decoupling and Nuclear Overhauser Enhancement 11'13, the resolution 
and SNR of 3,P resonances is further improved. Finally, the sensitivity of 3,P MRS can be
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enhanced by polarisation transfer, in which the high sensitivity of protons is used to increase 
the magnetisation of nuclei with a low gyromagnetic ratio such as phosphorous ,4'15.
Recently, w e developed a 'H  - 31P polarisation transfer method that increases the SNR 
of the PME and PDE signals up to a factor 2 .4  compared to direct 3,P MRS detection 
,6. This selective refocused insensitive nuclei enhanced by polarisation transfer (sRINEPT) 
technique only selects signals of 3,P spins that are coupled to proton spins, i.e. those of 
PE, GPE, PC and G PC, therefore resulting in an MR spectrum with a flat baseline without 
signals of other phosphorylated compounds.
The main aim of this study was to implement a 3D  MR Spectroscopic imaging (MRSI) ver­
sion of sRINEPT on a 3T MR system to acquire a clinical reference data set of spatially 
resolved relative levels of PC, PE, GPC and GPE in the brain of healthy humans.
To this end w e performed 3D  sRINEPT MRSI examinations, in clinically acceptable mea­
surement times, as a function of age and analysed the data from 3 different regions: one 
dominated by gray and one by white matter and one in the cerebellum. W e  also demon­
strate what spatial resolution with equal SNR is achievable at longer measurement times. 
And finally, in a pilot study, w e demonstrate clinical feasibility of the method in patients 
with a brain tumour. The results show that relative PME and PDE levels change as a function 
of age and vary with brain tissue type.
Methods
Subjects
All measurements w ere carried out in compliance with the local institutional medical 
ethics committee and written informed consent was obtained before the measurement. 
Eighteen healthy volunteers - 6  fem ale, 1 2 male - participated in this study, age 1 6 to 7 0  
years. Additionally, three patients with a brain tumour w ere exam ined using sRINEPT 3,P 
MRSI. The patients had different tumour types and age; a glioblastoma multiforme (GBM) 
in a 5 9  year old male, a grade 3 astrocytoma in a 3 0  year old fem ale, and a grade 2 
oligodendrogliom a in a 3 8  year old female.
31P MRSI
MR imaging and spectroscopy w ere performed on a 3T MR system (Tim TRIO, Siemens, 
Erlangen, Germ any) with a broadband single RF transmit channel, and a quadrature 3,P 
transmit-receive half-volume coil inserted in a circularly polarised birdcage 'H  head coil 
(transmit -rece ive). The half-volume 3,P coil was optimised for the occipital lobe and part 
of temporal and parietal lobes of the human brain 17 (Fig. 7 .1 ).  The sRINEPT sequence 
16 was combined with spatial localisation by applying phase encoding gradients before 
acquisition of the signal (Fig. 7 .2 ). A  2-step phase cycling scheme was implemented to
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eliminate residual signals from 3,P spins not coupled to 'H  spins. WALTZ1 6  'H  decoupling 
was applied during the 3,P MR signal detection. The field of view, matrix size and 
number of acquisition-weighted averages w ere adapted to obtain a real voxel size of 
approxim ately 17 .5cc  (spherical volume) within a total acquisition time of 1 7  minutes 
(TR 1 .5  s).
To explore the possible spatial variation of the level of PME and PDE in g ray  and white 
matter of the brain w e obtained sRINEPT 3,P MR with com parable signal to noise in 
smaller voxels by an additional measurement of 9 0  minutes on one of the volunteers. In 
this measurement the real voxel size was reduced to a sphere of lOcc.
Figure 7 .1 : RF probe for 1H /3,P MRS o f the human brain. A  ’H volume birdcage co il with a circularly 
polarised 31P coil insert positioned close to the head.
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Figure 7 .2 : Pulse sequence o f sRINEPT MRSI with chemical shift selective refocusing pulses applied on a 
single transmit channel. The RF pulses a t the 3,P Larmor frequency are a ll adiabatic, starting with a segmen­
ted BIR4 pulse (segments are numbered 1-4) a t a flip angle o f 0° followed by a BIR4 pulse at a flip  angle 
o f 180°. The second ’H-9CP pulse was phase-cycled together with the phase o f the receiver to get rid  o f 
residual signal o f uncoupled 3]P spins. WALTZ16 decoupling was applied during 3]P signal detection.
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Before every measurement, the 1H birdcage coil and the 31P half volume coil were manually 
tuned and matched to 5 0 Q  at the corresponding Larmor frequency and connected to the 
MR system within 5  minutes. Routine system-automated frequency alignment and RF power 
adjustments for the 1H nucleus was done before starting the first imaging measurements. 
An automated 3D  B0 phase-map shim was performed with two iterations. The carrier 
frequency of the 31P transmit signal was automatically calculated from the aligned 1H w ater 
resonance, and the 31P RF power was set to a fixed value based on phantom measurements 
to assure the threshold of the minimal B, field for the adiabatic RF pulses was met for the 
region of interest.
Data analysis
All data was analysed with JMRUI 3 .0  software ,8. Resonances were fitted with AMARES 19 
to Gaussian line shapes with equal line widths (applied from the line width of PE). Although 
a uniform B, field is obtained for 1H spins and adiabatic RF pulses have been applied on 
the 31P spins, the absolute signal intensities of the 31P metabolites are still a function of the 
B, reception profile of the 31P coil setup. To avoid influence of B, inhomogeneities of the 
receive 31P half volume coil, ratios of the different metabolites w ere calculated. From each 
volunteer non-overlapping voxels w ere selected in the cerebellum, gray matter (G M ), and 
white matter (W M ) of the occipital-parietal lobe of the brain (Fig. 7 .3 ).
Figure 7 .3 : Voxels selected in the cerebellum (a) and the cerebrum (white matter and g ray matter) o f the 
brain (bj. The white circle indicate the real voxel size, the squares indicate the nominal voxel size according 
to the matrix size. Due to the combination o f the circular weighted k-space averaging and the Hamming 
filter the real voxel size is a sphere with diameter o f approximately 1.78 times the length o f the squares 38.
Statistical analysis
Statistical analysis of the data was performed with GraphPad Prism (version 4 .0 0  for 
W indow s, GraphPad Software, San Diego California USA). Two tailed paired t-tests were
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used to assess differences in metabolite levels between different brain tissue types. A  linear 
regression analysis was used to assess the relation of age with the metabolite levels.
Results
After magnetic field shimming of the region of interest, a volume of approximately 200cc, 
absolute line-widths of the w ater resonance of 1 9  ± 1 .4  H z w ere obtained for all volunteers 
in the parietal/occipital part of the brain. This resulted in a line-width of the individual 31P 
resonances of approximately 14 Hz.
a
Figure 7 .4 : a) Spectral map o f sRINEPT MRSI overlaid on a T2-weigthed image o f the brain. Signals o f 
PE, PC, GPE and GPC are well separated and detectable over a large part o f the brain in the standard 
measurement, b j MR spectrum o f a voxel consisting o f mainly g ray matter. The real voxels are spheres o f  
approximately 18cc.
W ith the sRINEPT sequence in MRSI mode w e routinely acquired 31 P MR spectra of voxels 
covering a large part of the human brain showing well resolved signals of PE, PC, GPE 
and GPC without contributions of other broad 31 P signals (Fig. 7 .4 ). W e  refer to these 
measurements that were obtained within ~ 1 7  minutes and that have a resolution of 17 .5  
cc, with the term 'standard measurements'. From the standard measurements w e evaluated 
the ratios PE/GPE and PC /G P C  in different brain areas and as a function of age. The 
voxels that w ere chosen as gray matter voxels consisted for 86%  ± 9%  of gray matter and 
8%  ± 5%  of white matter (Fig. 7 .3 b ). Occasionally, the gray matter voxel was chosen 
somewhat more in the direction of the cerebellum, resulting in a small partial volume of
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cerebellum o f 6% ± 1 0% in four volunteers. The voxels that were chosen to represent white 
matter consisted for 52%  ± 1 0% of white matter, 35%  ± 1 2% of g ray matter and 12% ± 
1 1% of cerebral spinal fluid. The voxels in the cerebellum were not segmented.
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Figure 7 .5 : Bland and Altman plots o f the difference in metabolite ratios in white matter and g ray matter 
in each volunteer.
Taking all standard measurements of the volunteers together, no significant differences 
were found between metabolite ratios of voxels in G M , W M  and cerebellum (p>0.05 
unpaired t-test). However, an analysis per person showed small differences between gray 
and white matter. A  paired t-test (paired per person) showed a significant higher ratio of 
PE/GPE in g ray matter than in white matter (p=0.03). N o significant differences in the ratio 
PE/GPE were found between white matter and cerebellum (p=0 .56) and between gray 
matter and cerebellum (p=0.05). The ratio PC/GPC was significantly higher in the cerebel­
lum when compared to g ray matter and white matter, p values were respectively p=0 .002  
and p < 0 .0 0 1 . W e also found a higher ratio of PC/GPC in g ray matter compared to white 
matter, but this did not reach statistical significance (p=0.08). The differences between 
white and g ray matter are also shown in a Bland and Altman plot (Fig. 7.5). The 95%  
confidence interval for the differences between white and g ray matter of PE/GPE and P C / 
GPC are -0 .77  to 0 .43  and -0 .28 to 0.1 8 respectively. The most pronounced difference 
between g ray and white matter was observed in the ratio PE/(GPE+GPC). A  paired t-test 
of this ratio resulted in a significant higher value in g ray matter compared to white matter, 
w ith p < 0 .0004 .
W ithout sacrificing SNR it was possible to measure a 3D 3,P MRSI data set with voxels hav­
ing real volumes o f 1 Occ in 90  minutes (Fig. 7 .6a ,b ). M app ing  of the parameter that best 
separates g ray and white matter, PE/(GPE +GPC), clearly showed the spatial variation of 
the combination of these compounds in the brain (Fig. 7.6c).
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Figure 7 .6 : a) Spectral map o f 3]P sRINEPT MRSI in the brain o f the 90-minutes measurement, b j Enlarged 
MR spectra from the gray and white matter. The SNR, defined as the peak integral divided by the standard 
deviation o f the noise, o f PE and GPC were approximately 2 .0  and 1.8 respectively in the voxel o f 10 cc, 
and 3.1 and 2 .4 , respectively, in the voxel o f 18 cc (Fig. 7.4). c) Colour map o f the ratio PE/(GPE +GPC) in 
the brain o f a healthy volunteer, obtained from the MRSI with a spatial resolution o f 10 cc (real voxel size). 
The differences between the metabolite levels in g ray and white matter become visible.
The ratios of PE/GPE, P C /G P C  and PE/GPC w ere inversely related to the age of the 
volunteer: the older the person, the lower the metabolite ratio. W e found a significant 
non-zero slope after linear regression analysis (p = 0 .0 0 0 1 , Figure 7 .7 ) and the slopes of 
PE/GPE and P C /G P C  w ere significantly different (p < 0 .0 0 0 1 , F-test). The ratio G PE /G P C  
remained almost constant with varying age (Fig. 7 .7 a ). The same regression analysis was 
also applied to the PE/GPE and P C /G P C  levels in voxels of gray matter, white matter and 
cerebellum separately (Fig. 7.7b-d ). The decrease per decade of the levels of PE/GPE  
and PC /G P C  in different brain tissue and their r2 measures for the goodness of the linear 
regression fit as well as the mean and standard deviation of these levels in different age  
groups are summarised in Table 7 .1 .
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To test the clinical feasibility of the method to detect abnormal levels of phosphorylated 
brain metabolites w e performed a pilot study on 3 patients with a brain tumour using 3D  
sRINEPT 31P MRSI. MR spectra of the patient with a G B M  showed an increase in PE/GPE  
and P C /G P C  in the tumour compared to the normal appearing part of the brain (Fig. 7 .8 ). 
Averaged over 5  independent voxels in the tumour the ratios of PE/GPE and PC /G P C  
were 4 .4  ± 1 .9  and 1 .4  ± 0 .4 2  respectively, whereas these ratios w ere 1.3 ± 0 .2 8  and 
0 .2 8  ± 0 .4  in regions contra lateral to the tumour. The GPE signal was almost absent in 
the MR spectra of the grade 2  oligodendrogliom a, leading to high values for the ratio PE/ 
GPE inside the tumour (7.8 ± 5 .3  in 5 independent voxels), the PC /G P C  was somewhat el­
evated in the tumour (0 .4 2  ± 0 .0 1 ). In the grade 3 astrocytoma the metabolite ratios were  
also different from those in healthy volunteers of similar age. Averaged over 4  independent 
voxels the ratio PE/GPE and P C /G P C  w ere 0 .9 8  ± 0 .2  and 0 .2 8  ± 0 .0 4 ,  respectively 
in the tumour and 1 .5 2  ± 0 . 1 0  and 0.11 ± 0 .0 3  in voxels contralateral to the tumour. In 
these three cases the metabolite distribution was more heterogeneous in tumour tissue than 
in the normal tissue, which is reflected in the relatively larger standard deviation of the 
metabolite ratios in the tumour voxels as compared to those in voxels with normal tissue.
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Figure 7 .7 : Linear regression o f metabolite ratios as a function o f age. a) Regression o f PE/GPE, P C / 
GPC, GPE/GPC and PE/GPC. A ll slopes except for GPE/GPC are significant. Data points are mean and 
standard deviation o f 5  independent voxels in the brain (2 in W M , 1 in GM, 3 in cerebellum), b-dj Linear 
regression o f metabolite ratios o f PE/GPE and PC/GPC as a function o f age in voxels selected in: white 
matter (bj, g ray matter (c) and cerebellum (d). The significant non-zero slopes are marked with an asterisk.
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Table 7.1. Summary of metabolite ratios and age dependency
Change in metabolite level per decade [%]
brain tissue PE/GPE r2 PC/GPC r2
GM -7.3 0.58 -6.4 0.15
W M -8.1 0.60 -4.0 0.03
Cerebellum -5.8 0.35 -9.2 0.20
All selected -6.9 0.46 -6.1 0.10
Mean and Standard deviation of voxels in GM, WM, Cerebellum
Age [y] PE/GPE [-] PC/GPC [-1
23.2 ± 5 .2 2.12 ± 0 .3 0 0.40 ± 0. 17
34.2 ± 5 .5 1.71 ± 0 .2 9 0.31 ± 0 . 12
58.8 ±7.1 1.43 ± 0 .2 0 0.30 ± 0 . 11
Changes in metabolite ratios PE/GPE and PC/GPC as a function o f age, and the mean and standard de­
viation o f a ll evaluated voxels in a ll subjects assessed in three age groups. R2 indicates the goodness o f the 
linear regression fit, R2 equals 1 i f  the fit is perfect.
Figure 7 .8 : sRINEPT 3,P MRSI from a patient with a GBM. MR spectra o f the tumour and o f contra lateral 
brain are enlarged. In these spectra the differences in metabolite ratios are obvious.
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Discussion
In this study w e successfully implemented a 1H to 31P polarisation transfer in a 3D  spectro­
scopic imaging sequence to acquire 31P MR spectra, with signals for phosphomono- and 
diesters only, at high spatial and spectral resolution in the human brain. Since in this experi­
ment recovery of the Boltzmann equilibrium is dictated by T, relaxation of the protons we  
could use a relatively short repetition time of 1.5 seconds, which contributed to a high SNR, 
next to the use of a dedicated RF probe and 3T field strength. In this w ay  spectra could be 
acquired of 17cc voxels from the parietal and occipital lobe of the brain within clinically 
acceptable measurement times (< 1 7  minutes). O nly two 3,P MRS studies have reported on 
PME and PDE resonances in MR spectra from voxels of comparable size to the ones obtained 
in the present study: both were performed at 4T 20 21. Jensen et al measured MRSI voxels of 
15cc with a volume coil throughout the whole brain, using an acquisition time of 4 5  minutes 
20. In our study a half-volume coil was used for signal detection, which limits the choice of a 
region of interest but significantly reduces the acquisition time because of the higher sensitiv­
ity of this coil. The other study also reported on pulse-acquire 31P MRSI with a volume coil at 
short repetition time and partial k-space sampling (resulting in an acquisition time of approxi­
mately 18 minutes). The resonances of PE, PC, GPE and GPC were analysed individually, 
but only the results for the PME and PDE peaks were reported, possibly because of low SNR 
a n d /o r spectral resolution 21.
In the analysis of the data w e evaluated metabolite signals as ratios, eliminating spatial dif­
ferences in the B, profile of the 31P half-volume coil. The analysed voxels were selected from 
a region with a homogeneous B0 and 1H B, field, which avoids possible spatial variations 
in enhancement. Due to small differences in T, and T2 relaxation between PE, PC, GPE and 
GPC, the polarisation transfer efficiency may not be equal for all metabolites. Previously, we  
compared metabolite ratios derived from 1H decoupled sRINEPT and from 1H decoupled 31P 
MR spectra of the same brain volume ,6. The ratios PE/GPE and PC /G PC  averaged over 
6 age matched persons from direct 'H  decoupled 3,P MR spectra were 1 .8 7 ± 0 .2 4  and 
0 .4 7 ± 0 .0 9 ,  respectively, whereas these ratios were 1 .7 5 ± 0 .1 7  and 0 .2 9 ± 0 .0 5 , respec­
tively as derived from the sRINEPT 31P MR spectra. Thus taking the standard deviation on the 
metabolite ratios into account, the PE/GPE ratio as obtained in this study might be compared 
to corresponding ratios derived from d irec t31P MRS measurement. The observed difference 
between the ratio PC /G PC  derived from a direct 31P and a sRINEPT measurement has to 
be taken into account in quantitative comparisons of this ratio found in the present study to 
values reported for d irect31P MRS. Absolute quantification of the tissue levels of PE, PC, GPE 
and GPC can be determined by a phantom replacement method 22, including possible differ­
ences in relaxation behaviour between the in vivo and in vitro situation.
W ith the sRINEPT 31P MRSI method the age dependency and spatial distribution of ratios of 
the tissue levels of phosphorylated mono and diesters w ere analysed. Previously, various
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values have been reported for these ratios, depending on voxel size, main magnetic field 
strength and age 8<9<2,<23<24. For exam ple a PE/GPE ratio of ~ 1 .7  was measured in v ivo  
in the brain of normal volunteers of approximately 2 2  years 8 and of ~2.1 in the normal 
brain of approximately 2 5  years 23. W hereas this ratio was lower (~ 1 .42 ) in post-mortem 
specimens of elderly brain [~ 7 0  years) 9. The values for PE/GPE w e obtained in the brain 
of young adults (approximately 2 5  years) and elderly adults (> 6 0  years) are within the 
range of those reported values 8'9'23.
W e found an inverse relation between the ratio of PE/GPE, P C /G P C , PE/GPC and the 
age of the subjects. The ratio G P E /G P C  was not related to age and seems to be rather 
constant. Since the ratios do not all have the same regression behaviour, it is likely that 
this decrease in ratios represents true metabolic a n d /o r  morphological changes, instead 
of being related to anatomical changes e.g. decreasing gray matter volume in the aging  
brain 25. Several metabolite levels in the brain depend on age, however, the most dra­
matic changes occur during early brain development in foetus and neonates 26 and up to 
an age of about 16 years 9*23'27'28. Furthermore, a positive relation of total choline levels 
(PC+GPC+free choline) with age was found in 1H MR spectra of adult brain 25'27-32. This 
observation is often explained by an increased release of w ater soluble choline from cell 
membranes in the aging brain 30. A  strong inverse relation of phosphomonoesters and age  
was found in children with single voxel 1H decoupled 31P MRS, and was suggested to be 
due to myelination 23'33. The results of the present study demonstrate that the PE/GPE ratio 
continues to decrease at older age (> 5 0  y). This decline seems to be dominated by a de­
creasing PE in our studies, although an increase in GPE levels at ages above 2 5  has been 
reported for a direct 3,P MRS study 23. The decrease in P C /G P C  with age that w e found 
is perhaps less pronounced because of a larger standard deviation on the PC levels: the 
decrease in P C /G P C  seems to be dominated by a diminishing PC level. This is in line with 
a report on continuously decreasing PC levels up to an age of approximately 5 0  years, 
and the GPC levels reaching a steady state at an age of about 2 5  years 23. In a recent 
study in adults a decrease of the level of PME with increasing age was found which was 
explained by a slower membrane synthesis at older age 21. N o  relation of the level of PDE 
with age was found 21. This is in excellent agreement with our results on decreasing PE and 
PC levels with respect to the corresponding PDE resonances.
Because of the high SNR in the standard measurements, it was possible to even further 
increase spatial resolution. By reducing the voxel size with 40 % , at the cost of a 5  times 
longer acquisition time, the SNR of the individual resonances was kept similar to those 
obtained in the standard measurement. The difference in metabolite levels between gray  
and white matter became more apparent in the data from small voxels (1 Occ) as it suffered 
less from partial volume effects. W ith a further increase in spatial resolution, it should be 
possible to obtain 31P MR spectra from pure gray or white matter, especially at stronger
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B0 magnetic field strengths. In the standard measurements (1 7  minutes acquisition, voxels 
of 17cc), the evaluated voxels contained mixtures of tissue types. However, even with this 
overlap in voxel content, w e could detect differences in metabolite ratios between the gray  
and white matter voxels on an individual basis. W hen grouping the tissue types among 
all volunteers, the differences between tissue types are exceeded by differences between 
subjects, reflected by the large p-value of the unpaired t-test.
Finally w e have demonstrated in a pilot study that with sRINEPT 31P MRSI it is possible 
to obtain spectra with well-resolved PME and PDE signals with high SNR of tumour and 
healthy tissue in the brain of patients. This opens a new w indow  on the evaluation of the 
presence of these metabolites in brain tumours. In previous in v ivo  31P MRS studies, per­
formed at 1 .5T it was difficult to estimate PME and PDE levels in human brain tumour tissues 
due to spectral overlap and partial volume effects. Both increases 6 and decreases 4 of PME 
have been reported. In a more recent study of paediatric brain tumours 1H decoupling 
was applied which resulted in substantially improved spectral resolution 34. They found 
increased ratios of PE/GPE and P C /G P C  in primitive neuroectodermal tumours (PNET) 
compared to these ratios in the normal brain of age matched healthy children 34. Ex vivo 
31P MRS studies on human brain tumour tissue specimens revealed an increase (compared 
to specimens of normal brain tissue) in phosphatidylcholine and a decrease in phospha- 
tidylethanolamine 35, both precursors of PC and PE respectively, from which PME as well 
as PDE can be formed dependent on the activity of enzymes such as phospholipase-C and 
-D , choline/ethanolam ine kinase and phosphodiestrase. The increase in PE/GPE and P C / 
GPC ratios that w ere measured in G B M  and the grade 2  oligodendroglioma in the present 
study likely represents increased metabolism of membrane phospholipids and cell prolif­
eration in glial tumours 36,37. W e  found that the metabolite levels across the tumour and 
oedematous regions are heterogeneous. Spatial information about functional parameters 
such as metabolite ratios could be important in studies that investigate the effects of tumour 
treatment. Obviously, detailed studies of brain tumour subtypes with larger patient groups 
are needed to identify the potential role of PE, PC, GPE and GPC levels in tumour diagnosis 
and to further characterise their involvement in tumour metabolism.
In conclusion, a 3D  sRINEPT MRSI method was introduced that enables exploration of spa­
tially resolved phospholipid metabolism in healthy and diseased human brain in v ivo  with 
a better sensitivity than was possible in e a r lie r31P MRS methods.
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Abstract
O b je c t iv e s :  As a unique tool to assess metabolic fluxes non-invasively, ,3C MR Spectros­
copy (MRS) could help to characterise and understand malignancy in human tumours. 
However, its low sensitivity has hampered applications in patients. The aim of this study 
was to demonstrate that with sensitivity optimised localised ,3C MRS and intravenous infu­
sion of [1-,3C]glucose under euglycaemia, it is possible to assess the dynamic conversion 
of glucose into its metabolic products in v ivo  in human glioma tissue. M a t e r ia ls  a n d  
M e th o d s :  Measurements w ere done at 3T with a broadband single RF channel, and a 
quadrature ,3C surface coil inserted in a 'H  volume coil. A  ' H / ,3C polarisation transfer se­
quence was applied, modified for localised acquisition, alternatively in two (50 ml) voxels, 
one encompassing the tumour and the other normal brain tissue. R e s u lts :  After about 
2 0  minutes of [1-,3C]glucose infusion, a [3-,3C]lactate signal appeared among several 
resonances of metabolic products of glucose in MR spectra of the tumour voxel. The reso­
nance of [3-,3C]lactate was absent in MR spectra from contralateral tissue. In addition, the 
intensity of [1-,3C]glucose signals in the tumour area w ere about 5 0 %  higher than those 
in normal tissue, likely reflecting more glucose in extra- cellular space due to a defective 
blood brain barrier. The signal intensity for metabolites produced in or via the tricarboxylic 
acid cycle, was lower in the tumour than in the contralateral area, albeit that the ratios of 
isotopomer signals w ere comparable. C o n c lu s io n :  W ith  an improved ,3C MRS approach  
the uptake of glucose and its conversion into metabolites such as lactate, can be monitored 
non-invasively in v ivo  in human brain tumours. This opens the w ay  to assess metabolic activ­
ity in human tumour tissue.
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In vivo 13C MRS of a human brain tumour w ith (1-13C) glucose infusion
Introduction
Tumour cells avidly take up glucose, and prefer to produce adenosine triphosphate (ATP) 
by glycolysis rather than by oxidative phosphorylation even in the presence of oxygen , 2. 
This is w hy lactate, an end-product of glycolysis, often is elevated in tumour cells 3'8. Lactate 
levels have been proposed as biomarker for malignancy to be used in the characterisation 
of tumours 9.
In human brain tumours, lactate is commonly detected by in v ivo  1H M agnetic Resonance 
Spectroscopy (MRS) For exam ple, in regions with abnormal perfusion lactate levels 
have been used to discriminate between grade 3 and grade 4  gliomas ,2. However, the 
amount of lactate as measured by 1H MRS is not only a function of specific cellular produc­
tion and tumour hypoxia, but also of lactate accumulation in cystic lesions and draining of 
tumour tissue. Therefore, the sheer presence of lactate is of limited value as a biomarker 
for malignancy grading in individual tumours 4'13. The kinetics of lactate production may be 
better suited for this purpose as it more likely reflects the cellular glycolytic capacity. Its as­
sessment may help to unravel the role of glucose metabolism in human tumour growth and 
therapy response. Currently, the only method for the direct assessment of lactate produc­
tion in v ivo  is ,3C MRS. It has been used to monitor the conversion of infused ,3C-labelled  
glucose in studies of human brain energy metabolism 14 and of in v ivo  lactate production 
in animal tumours 3'15.
To our knowledge, ,3C MRS has not been performed to assess active metabolism in v ivo  
in human brain tumours. The relatively low sensitivity of ,3C MRS has limited its applica­
tion in humans thus far, but sensitivity can be improved by using an optimised 1H to ,3C 
polarisation transfer pulse sequence 16, an optimised quadrature ,3C-radiofrequency coil 
and a high magnetic field strength of 3 Tesla (T) and above. Altogether, this facilitates the 
study of metabolic fluxes obtained from the dynamic acquisition of ,3C-MR spectra of brain 
tissue covering ,3C resonances of a broad range of components, including lactate and 
glucose ,7. The principle aim of this study was to demonstrate that with sensitivity optimised 
localised ,3C MRS and intravenous infusion of [1-,3C]glucose under euglycaemic condi­
tions, it is possible to assess the dynamic conversion of glucose into its metabolic products 
in v ivo  in human glioma tissue. For comparison purposes the procedure was extended with 
the measurement of 2  brain regions, performed in the same examination.
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Methods
The improved ,3C MRS method was tested on a 29-year old man with a histopathologically 
validated recurrence of a high malignant glioma (presumably ex-anaplastic ependymoma) 
in the cerebellum and on a 60-year old man with a histopathologically validated glioblas­
toma multiforme in the occipital cortex. All measurements w ere carried out in compliance 
with the local institutional medical ethics committee and written informed consent was 
obtained before the experiment.
Hyperinsulinaemic Euglycaemic clamp procedure
Patients w ere admitted to the research unit at 8 .3 0  A M  in fasting condition, having 
abstained from caffeine and alcohol for 2 4  hours. An intravenous catheter was inserted 
in the antecubital vein of the right arm for infusion of 10 0%  [1-,3C]-enriched glucose 
2 0 % (w /w ) and insulin, and another catheter was inserted retrogradely in a hand vein of 
the left arm for blood sampling. A  heated patch and towel w rappings w ere used to warm  
the left hand. This facilitates blood sampling and reduces local glucose uptake by open­
ing arteriovenous shunts so that the glucose level in venous blood resembles that of arte­
rial blood, a condition referred to as arterialisation of venous blood. After cannulations, 
the patient was positioned in the scanner. After 3 measurements of natural abundance  
,3C MRS in each voxel (see next section), a hyperinsulinaemic euglycaemic glucose 
clamp 18 was initiated by infusion of insulin at a constant rate of 6 0  mU-m^-min'1 and of 
glucose 2 0 %  w /w  as required to maintain plasma glucose levels at 5 .5  m m ol/l, guided  
by plasma glucose measurements in duplicate at 5-minute intervals (Beckmann Glucose 
Analyser II, Beckman, Fullerton, CA ). In order to quickly obtain and retain plasma ,3C 
enrichment of the highest possible magnitude, 3 0  ml of 10 0%  1-,3C-enriched glucose 
2 0 %  w /w  was infused over 10  minutes at the initiation of the clamp and 1 0 0 %  1-,3C 
enriched glucose 2 0 %  w /w  was used throughout the experiment, as an adaptation to a 
recently published protocol ,9. A t the start of the clamp, 3 0  ml of 1 0 0 %  [1 -,3C]-enriched  
glucose 2 0 % (w /w ) was infused in 10  min, followed by a variab le infusion of glucose. 
The plasma glucose concentration was clamped at these high-euglycaemic levels based 
on arteria lized venous plasma glucose levels, measured in duplicate at 5-min intervals by 
the glucose oxidation method (Beckmann Glucose Analyser II, Beckman, Fullerton, CA). 
Simultaneously, blood was drawn for measurement of plasma glucose and lactate isoto­
pic enrichment by high resolution 1H N M R  at 5 0 0 M H z  (Bruker Biospin, Rheinstetten) as 
described previously ,7. Prior to [1 -,3C]glucose infusion, 3 ,3C-MR spectra per voxel (see 
below) of 2 .5  minutes each w ere acquired for a baseline dataset. After having obtained  
stable clamp conditions, another 2 8  ,3C-MR spectra of 2 .5  minutes each w ere acquired  
under euglycaemic conditions.
MRI and MRS protocol
MR imaging and spectroscopy were performed on a 3T MR system (Tim TRIO, Siemens,
In vivo 13C MRS of a human brain tumour w ith (1-13C) glucose infusion
Erlangen, Germ any) with a broadband single RF transmit channel, and a quadrature ,3G  
surface coil inserted in a quadrature 'H  volume coil, optimised for ,3C MRS of the occipital 
lobe and part of temporal and parietal lobe of the human brain ,7.
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Figure 8. I : A : Schematic overview o f the semi-adiabatic SC-DEPT sequence including an Image Selected 
In vivo Spectroscopy (ISIS) localization scheme and WALTZ!6 'H  decoupling . A t the 'H  frequency, the RF 
pulse-durations o f the 90° and a  pulses are 12 5  ps, the 180° pulse is 2 5 0  ps and the 90° elements in the 
WALTZ! 6 are 7 0 0  ps. The duration o f the adiabatic RF pulse elements are I ms. The switching time between 
the end o f an RF pulse at one frequency to the start o f the RF pulse at the other frequency is 10 0  ps.
B: Position o f the two voxels for ,3C MRS in the brain o f the patient with a high grade glioma. Voxel number
I is positioned in the healthy part o f the cerebellum; voxel number 2  encompasses the tumour (white arrow) 
as well as some normal appearing brain tissue (black arrow) and flu id (hyper intense areas).
C: Isotopic enrichment o f plasma glucose (open circles) and lactate (open squares) determined by high 
resolution NMR, plasma glucose levels (solid circles) and plasma lactate levels (solid squares) based on the 
ratio o f I a-glucose and 3-lactate signals in the HR NMR spectrum and the plasma glucose concentration 
during the glucose clamp. The shaded area refers to the bolus injection o f 3 0  ml o f 100% [ l - ' 3C]-enriched 
glucose 20% (w /w).
Note the increased plasma glucose level as well as the plasma isotopic enrichment between 0  and 10  
minutes due to the bolus [ l - ' 3C]-enriched glucose that was given during this period.
D: Reference ]3C-MR spectra o f voxels that are positioned in a volunteer similarly to the positioning in the 
patient. The SNR o f the peaks o f natural abundance ]3C in myo-inositol demonstrates almost equal sensitivity 
o f the voxel position with respect to the ]3C co il elements.
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T2-weighted transverse images served as anatomical guide for the selection of MRS voxels. 
These were acquired with the following parameters: Field of view 1 65  x  2 2 0  mm, matrix size 
1 68  x  3 2 0 , resolution 1 .0  x  0 .7  x  4 .0  mm, repetition time (TR) 4 6 3 0  ms, effective echo time 
(TE) 1 0 9  ms, turbo spin echo train length: 9  echoes.
1H to ,3C polarisation transfer was performed using a single channel distortionless enhanced 
polarisation transfer (SC-DEPT) sequence (Fig. 8.1 A) ,6. Localised ,3C-MR spectra were ob­
tained by adding an Image Selected In vivo  Spectroscopy (ISIS) sequence at the 'H  frequency 
prior to the SC-DEPT sequence ,6. For ISIS localisation 5  ms hyperbolicsecant pulses with an 
inversion bandwidth of 4kH z were used that select an almost rectangular volume. Adiabatic RF 
pulses with a bandwidth of 31 0 0 H z  were used on the ,3C frequency (Fig. 8.1 A), whereas rect­
angular RF pulses were used on the 1H frequency as homogeneous B, fields can be obtained 
with this quadrature volume coil. A  flip angle of the final proton pulse of 4 5  degrees was used, 
to obtain simultaneous optimal signals for all CH , C H 2 and C H 3 groups ,6. Other MRS param­
eters were; 200ps rectangular 'H  excitation pulse, TR 2  s, 1 35  ms WALTZ16 1H decoupling 20 
with 7 0 0  ps segments and a maximum power of 3 5 0 H z , 7 2  averages per acquisition, voxel 
size 5 4  x  3 2  x  2 9  mm (for both voxels), acquisition time 2 :2 6  min. The 1H carrier frequency 
was set to 2 .9  ppm and the carrier frequency for ,3C was set to 5 7  ppm corresponding to the 
centre of the spectral region of interest (14-1 0 0  ppm). Correction factors for differences in sen­
sitivity of the DEPT sequence to changes in carrier frequency and final a flip angle were deter­
mined using phantom measurements ,6. ,3C-MR spectra were acquired alternately from a voxel 
encompassing the tumour (from now on called the tumour voxel) and from a voxel contralateral 
to the tumour in the normal appearing brain for a direct comparison of tumour versus normal 
brain tissue within one patient (Fig. 8.1 B). Prior to the ,3C MRS measurements, local shimming 
on the water signal was performed on both regions of interest (i.e. one optimised shim-setting 
for the location of the tumour voxel and another one for the contralateral voxel). The linewidth 
of the magnitude water signal was approximately 15 Hz in the tumour and contralateral voxel. 
For 9 0  minutes ,3C MRS data was collected of the separate voxels with their corresponding 
shim values automatically loaded during the ,3C MRS measurements.
Reference measurement
To determine the possible spatial sensitivity differences of the coil-setup, a reference ,3C 
MRS measurement was obtained of natural abundance ,3C in a healthy volunteer in voxels 
positioned equal to the voxel position in the patients. The MR signals of myo-inositol (ml) 
were obtained in these measurements, as these have relative high SNR in natural abundant 
,3C MRS of the human brain, and the ml level is assumed to be equal in the left and right 
hemisphere. To obtain optimal SNR of the ml resonances the ,3C-carrier frequency was set 
to 7 3  ppm. The number of averages was 1 0 2 4 , total measurement time 3 4  min and the flip 
angle of the a pulse was set to 9 0  degrees (optimal for CH groups). Other measurement 
parameters w ere identical to the measurement in the patient as described above.
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Data analysis
The ,3C M R spectra w ere analysed using jMRUI 3 .0  software 21. A fter frequency and  
phase correction the spectra w ere averaged over 10  minutes acquisition time using a 
moving average w indow . The peaks of [1 a(J-,3C]glucose, [4-,3C]g lutam ate and [3 -,3C] 
lactate w ere  fitted with AM ARES 22 using lorentzian line shapes and soft constraints for 
the peak position and linewidth. The linewidth of the real signal of [4 -,3C ]glutam ate  
and [1 a-,3C]glucose in each averaged MR spectrum w ere fixed to equal the linewidth  
of [1 p-,3C]glucose in the same spectrum (approxim ately 4 H z ). The frequency of [1 a-,3C] 
glucose w as fixed with respect to the frequency of [1 p-,3C]glucose. Time curves of the 
peak integrals w ere obtained. The M R spectra of the baseline and the last hour of the 
measurement of the tumour voxel and the contralateral voxel w ere  also averaged and  
fitted with jM RUI. In these spectra the higher SNR allow ed fitting of also [2 -,3C] and  
[4 -,3C]glutam ine and [2-,3C]g lutam ate metabolite peaks (Fig. 8 .4 ). Here all linewidths 
of the MR signals of metabolites labelled with ,3C w ere fixed to the linewidth of the 
real signal of [4-,3C]g lutam ate (1 3 H z ). The resonances of the lipids w ere fitted using 
lorentzian lines with fixed frequency positions but soft constrains on the linewidth.
The signal to noise ratio (SNR) of the ml signal in the reference measurement in the 
brain of a healthy volunteer was determined as peak am plitude of the ml peak divided  
by the standard deviation of the noise. The SNR of the two highest ml peaks w ere aver­
aged  in the left and in the right voxel.
Results
Here w e give a detailed description of the exam ination of the 29 -y e a r old patient, in 
particular to illustrate the steps that w ere developed to analyse the data. The results 
for the other patient w ere com parab le except for a low er lactate labelling. During the 
w hole clamp procedure plasma glucose levels rem ained stable at 5 .3  ± 0 .5  mm ol/L. 
Plasma isotopic enrichment of glucose increased from 3 6 %  ± 1 .2 %  during the first 3 0  
minutes of the experim ent to 8 4 %  ± 1 .8%  during the last 3 0  minutes of the experi­
ment. Plasma isotopic enrichment of lactate slowly increased to 1 8%  at the end of the 
measurement. The estimated plasma lactate concentration increased slightly during 
the experim ent and had an average value of 1 .3 ± 0 .5  m m ol/L throughout the entire 
clamp (Fig. 8.1 C).
The voxel encompassing the tumour was segmented into 3 components, by m anually  
draw n ROIs on the T2-weighted MR im age; 1. tumour-like tissue (high signal intensity), 
2 . cerebral spinal fluid (highest signal intensity) and 3 . normal appearing  brain tissue. 
The volumes for these components w ere estimated as 4 7 % , 8% , and 4 5 %  of the total 
voxel volume, respectively (Fig. 8.1 B). C erebral spinal fluid (CSF) w as present in the 
tumour volume in a cavity, possibly due to previous resection of the prim ary tumour.
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Post-Gadolinium T1-weighted MR images from an earlier routine clinical exam ination  
showed heterogeneous contrast enhancement of parts of the tumour (Fig. 8 .3D .).
The similar SNR of the myo-inositol peaks in the reference measurement in the volunteer 
confirmed a symmetric B^profile of the ,3C coils. The difference in SNR between the left 
and the right voxel position was only 8%  (Fig. 8.1 D). The MR spectra w ere corrected for 
this difference prior to further analysis of the SNR.
MR spectra of the tumour region obtained during glucose infusion revealed a resonance at 
2 1 .2  ppm for [3-,3C]lactate with increasing intensity (Fig. 8 .2 ). The time curves of the sig­
nal integrals (in 1 0  minutes of acquisition averaged MR spectra) showed that this increase 
started 2 0  minutes after the [1-,3C]glucose bolus infusion and reached a plateau after ap­
proximately 4 5  minutes in the tumour voxel (Fig. 8.3B). In contrast, no lactate resonance 
was observed in the contralateral voxel in normal appearing brain tissue (Fig. 8 .3A ).
To rule out the possibility of merely measuring blood-born lactate leakage into the extra 
cellular and extravascular space in the tumour voxel, w e compared the measured plasma 
concentrations of glucose and lactate to the ,3C-glucose signal in the tumour voxel, as­
suming a worst case scenario that the entire tumour voxel consisted of blood vessels and 
extracellular extravascular space. For exam ple, at t= 7 0  minutes the fractional enrichment 
(FE) of plasma glucose was 84 %  and that of plasma lactate was 12%  whereas the plasma
Figure 8.2: ]3C-MR spectra o f tumour region o f the 2 9  year 
old patient with high grade glioma, averaged over 12 minu­
tes (for the time curves in figure 3 an average o f 10 minutes 
was used) o f acquisition with a [3 -'3C]lactate signal a t 2 1 .2  
ppm indicated by the arrow, at time points 27, 37, 47, 62  
and 7 7  minutes from the bolus (t=0j from left to right respec­
tively. The spectra are not normalised.frequency [ppm]
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concentrations of glucose and lactate at the corresponding time point w ere 5 .3  mmol/L 
and 1 .6  mmol/L, respectively. W ith these data and the observed total [1 a(J-,3C]glucose 
MR signal in the tumour voxel (S l=56 arbitrary units (a .u .)), w e calculated the maximum 
[3-,3C]lactate MR signal, after correction of sensitivity of the DEPT sequence for signals of 
CH and C H 3-groups, caused by the plasma lactate to be approximately 3 .6  a.u. As w e ob­
served a [3-,3C]lactate MR signal of 2 0  a.u. at t= 7 0  min, another source than from blood 
alone must have contributed to the [3-,3C]lactate signal in the tumour voxel. M oreover, the 
assumption of the tumour voxel filled with blood only, neglects the real tissue composition 
and thus heavily overestimates the contributions of blood-born lactate.
contra-lateral voxel
voxel encompassing tumor
}
normal tissue
10 20 30 40 50 60 70 
time [min]
tumour tissue
Lac3
Glu4
10 20 30 40 50 60 70 80 
time [min]
Figure 8.3: A  and B: Time curves o f peak areas o f [3- ,3C]lactate, [ I af- ,3C]glucose and [4- ,3C]glutamate 
in the tumour and contralateral voxel respectively. The peaks were fitted in MR spectra that were averaged 
using a moving w indow o f 10  minutes (w indow moves with one acquisition; 2 .5  minutes). For [3- l3C]lactate 
in the contralateral voxel a peak at the position o f 2 1.2 ppm was evaluated. C: Estimated contribution to 
signals o f [ I  - l3C]glucose and [4- l3C]glutamate from the normal tissue and tumour tissue in the voxel en­
compassing the tumour (also showing a [3- l3C]lactate curve for the tumour tissue) with a single exponential 
fit to the data points in grey. The CSF part o f the tumour encompassing voxel (8%) was considered as tumour 
tissue. The error bars on the last data point indicate the absolute fit error on the metabolite provided by  
JMRUI. D: Post Gadolinium T l weighted MR image o f the brain. A ll data in this figure was obtained from 
the 2 9  year o ld  patient with high malignant glioma.
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In addition to the [3-,3C]lactate resonance which had SNR of 2.3, some other peaks 
emerged in the ,3C-MR spectra of both voxels during the glucose infusion. In particular 
those of the isotopomers of glutamate, glutamine and aspartate (Fig. 8.4). The SNR of 
these resonances in the MR spectrum of the contralateral voxel was higher than in the 
tumour voxel, e.g. for [4-,3C]glutamate this was about 20 and 1 1, respectively. However, 
the ratio of the peak intensities of the overlapping resonances of glutamate and glutamine 
(Glx) labelled at the [2-,3C] position to the peak intensity of [4-,3C]glutamate in the tumour 
voxel was comparable to that in the contralateral voxel.
The resonances of [1 o(J-,3C]glucose became visible in spectra of both voxels at the onset 
of the infusion of labelled glucose (Fig. 8.3 and 8.4). The total glucose signal at the end 
of the measurement in the tumour voxel was about 30% larger than in the contralateral 
voxel. Since 45%  of the volume of the voxel encompassing the tumour consisted of normal
3000'
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Figure 8.4: Summed ,3C-MR spectra of 
the tumour and contralateral voxel in 
the 2 9  year old patient with high malig­
nant glioma. The spectra were normali­
sed to equal noise levels and corrected 
for the difference in sensitivity to the r e ­
coil elements with respect to the voxel 
position. The upper spectrum shows the 
average of the last hour of the measu­
rement. The lower spectrum shows the 
average of the base line measurements 
and the first 10 minutes of labelled glu­
cose infusion. Assignments;
Lac3: [3-,3C]lactate, lipids: ,3CH2- 
group of lipids, G lc la : [1 a-]3C]glucose, 
G leiß: [1 p-^CJglucose, ml: natural 
abundance ['3C]Myo-inositol, Glu2: 
[2-’3C]glutamate, Gln2: [2-’3C]gluta- 
mine, Asp2: [2-,3C]aspartate, Asp3: 
[3-’3C]aspartate, Glu4: [4-,3C]gluta- 
mate, Gln4: [4-’3C]glutamine, Glu3: 
[3-’3C]glutamate.
------------1------------1------------r
90 65 40 15
frequency [ppm]
contra-lateral
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appearing tissue, the contribution of the normal tissue to the intensity of the signals from 
[1 ap-,3C]glucose and [4-,3C]glutamate was estimated, assuming that the normal appear­
ing tissue in the tumour voxel metabolizes glucose in the same way as in the contralateral 
voxel. The tumour tissue would then be responsible for the remainder of the signals in the 
tumour voxel. Figure 8.3C shows the estimated contribution of the normal and the tumour 
tissue to the total signal intensities from [1-,3C]glucose and [4-,3C]glutamate of the tumour 
encompassing voxel. Per volume unit there was about 50%  more [1-,3C]glucose in the 
tumour tissue than in the normal tissue in the tumour encompassing voxel.
Discussion
This study demonstrates that metabolic conversion of glucose can be measured in vivo  in 
human brain tumour tissue. This was assessed non-invasively by measuring two voxels (tu­
mour and normal tissue) with ,3C MRS during infusion of [1 -,3C]glucose under euglycaemic 
conditions. After the start of [1-,3C]glucose infusion, several resonances became visible in 
the ,3C MR spectra of the tumour region, among which a [3-,3C]lactate signal. MR spectra 
of the contralateral region in normal brain tissue lacked this signal. According to the low 
lactate levels in the plasma and its low FE, it is unlikely that the high lactate signal in the 
brain tumour voxel was merely a consequence of a defect in the blood-brain barrier. Even 
when assuming maximal disruption of the blood-brain barrier, with the entire tumour voxel 
containing blood, we calculated that the maximal [3-,3C]lactate signal would be at least 
five-fold lower than the actually observed lactate signal in the tumour. These observations 
are in agreement with animal and cell studies for which it has been shown that tumours 
produce lactate because of high glycolytic activity and lowered oxidative capacity 3'7'15'23.
In the current study, the amount of viable cells in the tumour voxel could not be ascertained, 
but histopathology of a tumour biopsy revealed areas of necrosis. Therefore, it is plausible 
that the glycolytic activity in the tumour voxel as assessed by ,3C MRS was still an under­
estimation. Since the tumour voxel contained 45%  normal tissue and the [4-,3C]glutamate 
signal intensity in the tumour voxel was approximately half of the signal intensity of the 
[4-,3C]glutamate in the contralateral voxel, it is likely that the [,3C]-labelled metabolites 
that are formed in the TCA cycle in the tumour voxel originated mainly from the normal 
appearing brain tissue. The tumour cells may also have contributed to the [4-,3C]glutamate 
signal, however despite their intact TCA cycle 3'7'24 this contribution is likely to be low 7'23'24. 
Furthermore, the ratio of [2-,3C ]G lx peaks to the [4-,3C]glutamate peak in the tumour voxel 
was comparable to this ratio in the contralateral voxel. This indicates that metabolism of 
glucose beyond glycolysis proceeds in the same way in normal tissue in the tumour contain­
ing voxel as in the contralateral voxel.
In voxels encompassing the tumour, the [1-,3C]glucose signals per unit volume in cancer 
tissue were higher than in the normal contralateral tissue. In normal brain tissue the amount
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of glucose is determined by the balance between transport rate over the blood brain barrier 
and the cerebral metabolic rate of glucose, CRMg|c, 25; thus a higher glucose level can be the 
result of an increased transport rate, a decreased CMRg|cor both. In tumour tissue this relation 
is likely not valid due to defects in the blood brain barrier, necrosis or increased interstitial 
space. Post-Gadolinium T1-weighted MR images showed signal enhancement of the tumour 
tissue, consistent with a defective blood brain barrier. Therefore, the increased glucose sig­
nal in the tumour tissue is probably due to glucose leakage into interstitial and other extra 
cellular spaces. A  higher tumoural glucose level was also seen in a 'H MRS study of glioma 
growing in mouse brain, assessed under hyperglycaemic conditions, but without increased 
lactate production 26.
Another way to evaluate glucose uptake in tumours is by using FDG-PET27. However, as 
FDG is not further metabolised after its tissue uptake, this provides information about the 
rate of glucose transport over the cell membrane, rather than about its metabolism further 
downstream. Moreover, in case of a defective blood brain barrier, FDG will also leak into 
extracellular spaces, obscuring a clean measure of cellular uptake. As ,3C MRS with labelled 
glucose monitors fluxes along pathways in glucose metabolism, it could provide more insight 
in this aspect of tumour metabolism. Recently, a significant boost in signal to noise of ,3C 
MRS of tumours was explored by the use of hyperpolarisation of ,3C spins 28'29, but as yet this 
approach is only applicable to a limited number of rapid metabolic conversions.
The coil setup and pulse sequence used in this study were dedicated to reach optimal signal 
to noise of ,3C-MRS in the human brain. Previously, we demonstrated this for one large voxel 
(~125mL) in the brain ,7'19. But in the current study we realised measurements of two different 
voxels localised within the brain of the patient. To compensate for the reduction of SNR due 
to the smaller volumes, we used a higher percentage of labelled glucose during the clamp. 
However, after 80 minutes of infusion of labelled glucose the SNR of e.g. [4-,3C]glutamate 
was approximately 2 times higher in the recently published study 19, than in the present study 
(SNR corrected for volume, fractional enrichment and measurement time). However even 
with these smaller voxel sizes (~50mL) and suboptimal positioning of the voxels with respect 
to the ,3C-coil elements, ,3C-MR spectra with sufficient SNR to monitor glucose metabolism 
could be obtained. The reference measurement in the healthy volunteer revealed that the MR 
spectra of the patient were obtained from locations that exhibited almost equal sensitivity to 
the ,3C-coil elements and therefore, only required a slight signal intensity correction.
In order to estimate the fluxes of label entering the TCA cycle (Vtca) and label exchange of 
TCA cycle intermediates ([4-,3C]a-ketoglutamate and [2-,3C]Oxaloacetate) with the amino 
acids [4-,3C]glutamate and [2-,3C]aspartate (Vx) in the contra lateral voxel we used a previ­
ously described model 30. The input functions for FE of glucose and lactate and the level of 
[4-,3C]glutamate were derived from experimental data and we additionally assumed that the
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level of [3-,3C]glutamate was 0.5 times the level of [4-,3C]glutamate. This resulted in a Vtca 
of 0.67 and a Vx of 0.50 for the contra lateral voxel. Although the assumptions that the label 
exchange rate between glutamate and glutamine is equal to the Vtca and that the glutamine 
concentration in the brain is 2.5mM heavily influence the resulting values for Vtca and Vx, 
they were in the range of reported values for these metabolic fluxes 31,32.
The results in this study are the first showing active metabolism in a human brain tumour 
by ,3C MRS. We did not calculate metabolic fluxes of glucose metabolism in the tumour 
because the models available for these calculations may not be applicable to tissue in 
which the blood brain barrier is not intact. Calculated numbers for metabolic fluxes of the 
normal brain tissue could be improved by measuring MR spectra with increased SNR. If the 
current experimental design were altered to measuring only one of the two or both voxels 
simultaneously, by for example HADAMARD encoding 33, the SNR at the same temporal 
resolution would be increased by the square root of two. Furthermore, accurate fitting 
of [3-,3C]glutamate may become feasible with more SNR and by removing overlapping 
resonances by subtracting lipid signals, obtained from an accurate fit of baseline measure­
ments, from the MR spectra obtained during [1-,3C]glucose infusion. When the input func­
tion of [3-,3C]glutamate is derived from experimental data, modelling of metabolic fluxes 
becomes more accurate.
Since the voxel volumes assessed in this study are still relatively large compared to the size 
of the tumour and its heterogeneity it is not an option to increase voxel size to increase SNR. 
Lowering the temporal resolution could accommodate more averaging for every measure­
ment. Other instrumental possibilities to further increase SNR could involve using still better RF 
coils, higher magnetic fields, glucose labelling at both the C l  and C 6  position, and measur­
ing the ,3C label indirectly using its effect on resonances in 1H MR spectra u .
In conclusion, this preliminary study demonstrates that ,3C MRS with infusion of [ l- ,3C]glu- 
cose can be applied to study the dynamic conversion of glucose into metabolites such as lac­
tate in a human brain tumour in vivo. Better understanding of glucose metabolism in human 
tumour tissue can have important consequences for development of novel, more targeted, 
cancer therapy and may provide biomarkers for tumour characterisation and evaluation of 
treatment response.
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Glial brain tumours are a rather rare disease but have a high mortality and the prognosis 
of patients with glial brain tumours is very poor. Therefore, many research groups across 
the world study these brain tumours intensively. Therapies have been improving slowly 
over the last decades and are getting more specific per tumour type, but currently there 
is no cure for patients with glial brain tumours. Thus, there is a need for a non-invasive 
tool to diagnose brain tumours more accurately and to study brain tumours directly in the 
patient. The overall goal of this thesis was to develop and evaluate new Magnetic Reso­
nance Spectroscopy (MRS) methods that can be used in clinical research and diagnosis 
of human brain tumours, in particular gliomas. MRS is a technique that uses the physical 
properties of nuclei in a magnetic field to extract information about the metabolic composi­
tion of tissues. How this information was obtained in MRS experiments is briefly described in 
Chapter 2 of this thesis. Chapter 3 reviews studies that already used MRS to investigate 
brain tumours in ex vivo as well as in vivo animal models and in patients. The most common 
form of MRS currently used in clinical practice is 1H MRS. However, 31P and ,3C MRS have 
also been used for studying metabolic processes in brain tumours, but more frequently at the 
preclinical level.
One of the issues in establishing 1H MRS in daily patient care is the need for standardised 
acquisition techniques with high sensitivity. In response to this we developed a sensitive 1H 
MRSI method to be used at high magnetic field strength (> 3 Tesla). Chapter 4 describes 
the evaluation of the robustness and reproducibility of this new technique in two institutions 
where 20 volunteers were examined twice. Higher magnetic field strengths increase the 
sensitivity of 1H MRSI at the expense of problems with chemical shift displacement errors 
and radiofrequency power deposition in the human body. The solution presented here is 
the semi-LASER method, which is a short echo time MRSI technique with small chemical shift 
displacement artefacts and acceptable power deposition in the brain. With this sequence 
volume selection and localisation is performed by a double spin-echo sequence with adia­
batic refocusing pulses. Mean metabolite levels, within and between subject variance, and 
the coefficient of variation were calculated. These mean metabolite levels and coefficients 
of variation (obtained in similar regions in the brain) did not differ significantly between the 
two contributing institutions. The major source of differences between repeated measure­
ments was identified to be the between subject variation in the volunteers. All together we 
concluded that the semi-LASER 1H-MRSI method at 3 T is an adequate technique to obtain 
quantitative and reproducible measures of metabolite levels over large parts of the brain, 
applicable across multiple centres.
After establishing the performance of the semi-LASER 1H MRSI method, we applied this 
technique to patients with a brain tumour. The study described in Chapter 5 aims to dis­
criminate between glioblastoma multiforme (GBM) and metastases by short echo time 1H
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MRSI from oedematous and peripheral regions of the tumour. Furthermore, tumour infiltra­
tion was investigated by comparing MR spectra from GBM in these regions to MR spectra 
of non-infiltrating tumours (meningiomas) in similar regions. The oedematous and peritu- 
moural region were selected based on T2-weighted and contrast enhanced T1-weighted 
MRI and after quality control of the MR spectra, ratios of metabolites were calculated for 
every voxel of the region of interest (ROI). Statistical testing between patient groups was 
performed on all values inside the ROI and on the highest value of the ROI. Differences 
between tumour types were most significant when the highest values of metabolite ratios 
inside ROIs were analysed. Using the metabolite ratios with strong significant differences 
in the oedematous regions to build a classifier resulted in discrimination of GBM from MET 
with a sensitivity of 0.95 and a specificity of 0.78. The ratios of tCho and ml+Gly to tNAA 
or tCr were significantly different in the oedematous ROIs of GBM versus meningiomas 
probably due to presence of infiltrating tumour tissue in these ROIs of GBM. We conclude 
that using the highest values of inhomogeneous distributed metabolite levels throughout the 
ROI (e.g. as caused by infiltrative growth of glioma cells in the peripheral and or oedema­
tous region) picks up local differences around the bulk of the tumour and may be used as 
a marker for infiltrative tumour presence.
The detection of phosphorylated compounds in the brain such as phosphocholine (PC), 
glycerophosphocholine (GPC), phosphoethanolamine (PE) and glycerophosphoethanol- 
amine (GPE) has shown clinical potential at 1.5 T for several human diseases. However, 
phosphorous MRS at MR systems of 1.5 Tesla suffers from low sensitivity and contamina­
tion by underlying broad resonances of other phosphorylated compounds. Chapter 6 
presents a method to improve the sensitivity for these phosphorylated compounds. Transfer 
of magnetisation from 1H spins to 31P spins can improve the sensitivity with a potential 
enhancement of 2.4  (y]H/y3]p). However, when using the conventional RINEPT (refocused 
insensitive nuclei enhanced by polarisation transfer) method for this purpose, the 31P sig­
nals of PE, PC, GPE and GPC are strongly attenuated (50% or more). This is due to the 
J-couplings between 31P and 1H that have similar magnitudes for homonuclear J-coupling 
constants in PE, PC, GPE and GPC. A  method to cancel the homonuclear J-coupling effects 
in polarisation transfer experiments is to apply frequency selective refocusing pulses, which 
becomes feasible at 3 T (as compared to 1.5 T) due to the increased chemical shift disper­
sion. With selective-RINEPT 31P MRS we realised full 1H to 31P polarisation transfer using 
chemical-shift-selective refocusing pulses at 3 T and a more than twofold SNR improvement 
when compared to a direct31P MRS method.
The sRINEPT (selective refocused insensitive nuclei enhanced polarisation transfer) method 
for the detection of PE, GPE, PC and GPC was extended to a 3D MR 31P Spectroscopic 
Imaging (MRSI) sequence on a clinical 3 T MR system. Compared to earlier31P MRS meth­
ods sRINEPT MRSI improves spatial evaluation of phosphorylated compounds in the brain.
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In Chapter 7  we present spatially resolved relative levels of PC, PE, GPC and GPE in the 
human brain as a function of age. These metabolite levels can be used as a reference data 
set for clinical applications. Good signal to noise ratios were obtained from voxels of 17 
cc of the parietal and occipital lobes of the brain within a clinically acceptable measure­
ment time of 17 minutes. A  total of 1 8 healthy subjects of different ages (1 6-70 years) were 
examined with this method. A  strong inverse relation of the PE/GPE and PC/G PC ratio 
with age was found. Spatial resolution was sufficient to detect differences in metabolite 
ratios between white and gray matter. Moreover, we showed the feasibility of this method 
for clinical use in a pilot study of patients with a brain tumour. In conclusion, sRINEPT MRSI 
enables exploration of phospholipid metabolism in brain diseases with a better sensitivity 
than was possible with earlier31P MRS methods.
Experimental whole body 7  T MR systems are now available to MR researchers. Because 
of the high magnetisation at thermal equilibrium that is available at this field strength, there 
is potential for MRSI of nuclei with low gyromagnetic ratio (and thus lower sensitivity) to 
reach high spatial resolution within short measurement times. We demonstrated the use of 
a surface 31P quadrature coil in combination with a 'H CP head coil fo r31P Magnetic Reso­
nance Spectroscopic Imaging (MRSI) of the brain at 7  T with high sensitivity and spatial 
resolution. 31P MRS was run with a pulse acquire MRSI sequence with adiabatic excitation. 
With this method phosphorylated signals from the energy metabolism in the brain as well 
as resonances from phosphomono and diester compounds and inorganic phosphate were 
detected in the human brain within relatively short acquisition times of 1 6 or 25 minutes 
with a resolution of 6.3 cc and 1.7 cc respectively, (addendum to Chapter 7)
Another nucleus possessing spin that is abundant in the human body is carbon-1 3. Despite 
the fact that the natural abundance of ,3C is only 1.1 %, as a main cause for the much lower 
SNR of ,3C MRS compared to 1H MRS, ,3C MRS has frequently been used to study glucose 
metabolism in the brain. The sensitivity of ,3C MRS can be enhanced by administration of 
a ,3C-enriched compound such as [1-,3C]glucose which has the additional benefit that -  if 
glucose is metabolised - the metabolic turnover products of glucose can also be detected. 
This makes ,3C MRS a unique tool to assess metabolic fluxes non-invasively. Therefore, ,3C 
MRS could help to characterise and understand glucose metabolism and malignancy in 
human tumours. Despite the availability of methods to increase the sensitivity of ,3C MRS 
its application in patients with brain tumours has not yet been reported in the literature. In 
Chapter 8 we present the first results of localised ,3C MRS measurements in the tumour 
of a patient during intravenous infusion of [1-,3C]glucose under euglycaemic condition. 
Polarisation transfer of 'H to ,3C spins was used to obtain ,3C MR spectra from localised 
voxels in an alternating way, one voxel encompassing the tumour and another in normal 
brain tissue. After about 20 minutes of [1-,3C]glucose infusion, [3-,3C]lactate appeared 
among several resonances of metabolic products of glucose in MR spectra of the tumour
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voxel. The resonance of [3-,3C]lactate was absent in MR spectra from contralateral tissue. 
In addition, the intensity of [1-,3C]glucose signals in the tumour area were about 50% 
higher than those in normal tissue, likely reflecting more glucose in extra- cellular space 
due to a larger interstitial volume. The signal intensity for metabolites produced in or via 
the tricarboxylic acid cycle, was lower in the tumour than in the contralateral area. These 
results show that the uptake of glucose and its conversion into metabolites such as lactate 
(which is regarded as a marker for malignant tissue), can be monitored non-invasively in 
vivo  in human brain tumours.
Concluding rem arks
In this thesis we have shown that MRSI can improve brain tumour diagnosis and that MRSI 
could be used as a tool to evaluate metabolism of brain tumours. Pulse sequences for 1H 
and 31P MRSI were improved. The semi-LASER method resulted in better localisation of 
1H MR spectra and the sRINEPT method resulted in higher sensitivity of the detection of 
phosphomonoesters and phosphodiesters in the brain. The evaluation of the performance 
of new MRS sequences in multi centre studies and the improvement of the sensitivity of 
MRS -particularly fo r31P and ,3C MRS- are both necessary for the establishment of MRSI 
as a clinical diagnostic tool.
We explored possibilities of using multi-nuclear MRS(I) to characterise brain tumours and 
to investigate tumour metabolism in vivo. As shown in this thesis, the most commonly used 
form of MR spectroscopy, 1H MRSI, has potential to discriminate between tumour types and 
between normal brain tissue and tumour infiltrated brain. Better characterisation of brain 
tumours is of importance to the patients and the medical specialist determining the treat­
ment of those patients. With more information about the tumour, the treatment of the patient 
can be adapted to the individual case. A  better visualisation of the tumour will improve the 
non-invasive monitoring of treatment effects in patients.
MRS techniques that are used in experimental or in pre-clinical setting such as ,3C MRS 
with infusion of ,3C-enriched substrates are important tools in research that aims to unravel 
mechanisms of tumour growth and malignancy. The translation of these techniques into 
clinical practice has been explored in this thesis. To investigate the clinical relevance of 
new MRS techniques, the exploration started in this thesis should be extended to larger 
patient groups and should be applied across multiple research centres.
This thesis focuses on improving MRS(I) data acquisition. However, it is also important to 
make parameters obtained from MRS(I) available for diagnostic evaluation by clinicians. 
To realise this, a big effort is needed from manufactures of MR systems and scientist to 
develop methods for analysing MRS(I) data in an adequate, though simple and fast way, 
without compromising the variety of information in MR spectra.
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Gliale hersentumoren zijn een vrij zeldzame aandoening, echter de overlevingskansen 
van patiënten met een gliale tumor zijn heel erg klein. Helaas bestaat er op dit moment 
geen behandeling die tot genezing leidt van de patiënten met deze ziekte. Mede daar­
om wordt er veel onderzoek gedaan naar de herkomst en groei van hersentumoren en 
de mogelijke therapieën voor deze ziekte. Tevens is er behoefte aan een niet-invasieve 
methode om de diagnose van hersentumoren te verbeteren en om hersentumoren te kun­
nen bestuderen in het lichaam van de patiënt. De hoofddoelstelling van het onderzoek 
dat beschreven is in dit proefschrift is het ontwikkelen en evalueren van nieuwe M ag­
netische Resonantie Spectroscopie (MRS) methoden, die gebruikt kunnen worden in het 
onderzoek naar gliale hersentumoren en in de medische diagnostiek van hersentumo­
ren. MRS is een meetmethode waarmee de metabole samenstelling van lichaamsweefsels in 
kaart kan worden gebracht. Hoe deze techniek werkt, wordt beschreven in hoofdstuk 2 
van dit proefschrift. Vervolgens wordt in hoofdstuk 3 een kort overzicht gegeven van 
de bevindingen van onderzoekers die MRS gebruikten om hersentumoren in cel- en 
diermodellen en in patiënten te bestuderen. De meest gebruikte vorm van MRS in de 
medische diagnostiek is proton ('H) MRS. Fosfor (3,P) en koolstof (,3C) MRS zijn ook 
al eerder toegepast in onderzoek naar hersentumoren, echter meestal in preklinisch 
onderzoek.
Op dit moment is 1H MRS geen routinematig gebruikte techniek in de medische diag­
nostiek terwijl het wel aanvullende informatie over ziektebeelden kan geven. Een van de 
redenen hiervoor is dat de gevoeligheid van MRS en daarmee de spatiele resolutie, veel 
lager is dan die van MRI (imaging). Om de gevoeligheid van MRS te verbeteren hebben 
we een 1H MRS Imaging methode ontwikkeld voor gebruik op een MR scanner met een 
hogere gevoeligheid, bijvoorbeeld een MR scanner met een magnetische veldsterkte van 
3 Tesla (T). In hoofdstuk 4 wordt deze methode getest in twee instituten op gezonde 
vrijwilligers. MRS bij een hoger magnetisch veld leidt tot een hogere gevoeligheid van 
de detectie van metabolieten in lichaamsweefsel, maar leidt ook tot de niet gewenste 
grotere onnauwkeurigheden in frequentie verschuivingen (CSDE, chemical shift displace­
ment error) en grotere afzetting van warmte in het weefsel. De oplossing die we hiervoor 
aandragen is de semi-LASER (semi- localised adiabatic selective refocusing) methode, 
een MRSI techniek met een korte echo tijd en nauwkeurige lokalisatie zonder dat daarbij 
de voorgeschreven limieten voor de opwarming van de hersenen worden overschreden. 
De semi-LASER methode maakt gebruik van een dubbele spin echo sequentie met adia- 
batische refocuserings pulsen voor de lokalisering en selectie van het te meten volume. 
Met deze meetmethode zijn van in totaal 20 vrijwilligers in 2 instituten twee 1H MRSI 
metingen gedaan. Uit deze data zijn per instituut de gemiddelde waardes over 10 
personen van metaboliet niveaus in het brein, de intra- en inter-persoons variatie en de 
coëfficiënt van variatie bepaald. Deze parameters blijken statistisch niet significant te
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verschillen tussen de twee instituten. De voornaamste oorzaak van verschillen tussen de 
herhaalde metingen blijkt de variatie tussen personen te zijn. Uit deze resultaten kunnen 
we concluderen dat de semi-LASER 1H MRSI methode bij een veldsterkte van 3 T een 
adequate techniek is om een kwantitatieve en reproduceerbare maat voor de metaboliet 
niveaus in het brein te bepalen, onafhankelijk van het instituut waar de metingen worden 
uitgevoerd.
Nadat de kwaliteit van de semi-LASER 1H MRSI techniek in kaart was gebracht, hebben 
we deze meetmethode toegepast op patiënten met een hersentumor. In hoofdstuk 5 
beschrijven we een studie die als doelstelling heeft om op basis van 1H MRSI een onder­
scheid te maken tussen verschillende hersentumoren, namelijk glioblastoma multiforme 
(GBM) en metastases. In diezelfde studie zijn ook MR spectra afkomstig uit oedeem van 
de infiltrerende tumoren (GBM) vergeleken met MR spectra uit vergelijkbare gebieden 
van niet infiltrerende tumoren, namelijk meningiomen. Daartoe worden eerst MR spectra 
uit oedeem en de perifere zones van de tumor geselecteerd op basis van T2-gewogen 
en Tl-gewogen (met contrast middel) MRI beelden. Vervolgens worden MR spectra van 
slechte kwaliteit geëxcludeerd voor verdere analyse. Van elke patiënt is van elk gebied 
van interesse (ROI) de gemiddelde waarde binnen het ROI en de hoogste waarde in 
dat ROI van verschillende verhoudingen tussen metabolieten bepaald. Daarna zijn de 
gemiddelde ROI waarden van de patiënten met verschillende tumoren vergeleken. Een 
klassificatie algoritme gebaseerd op de 3 metabolietratios die het sterkst verschilden tus­
sen de type tumoren, resulteert in een sensitiviteit van 0.95 om GBM's van metastases te 
onderscheiden meteen specificiteit van 0.78. De statistisch significante verschillen tussen 
de verhouding van choline, en myo-inositol plus glycine ten opzichte van n-acetylaspar- 
tate of creatine van MR spectra van ROl's in oedeem gebieden van GBM's vergeleken 
met meningiomas, kunnen duiden op de mogelijke aanwezigheid van infiltrerende tumor 
cellen in deze ROl's van patiënten met GBM. Wanneer we de gemiddelde waardes 
binnen ROl's vergelijken, zijn de verschillen tussen de typen tumoren niet zo sterk als 
wanneer we de hoogste waardes in de ROl's vergelijken. Dit leidt tot de conclusie dat de 
inhomogene verdeling van metabolieten, zoals die gezien wordt in de ROl's van GBM, 
veroorzaakt zou kunnen worden door de heterogene infiltratieve groei van GBM's.
Zoals is gebleken uit studies met31P MRS op 1.5 T kunnen gefosforyleerde metabolieten 
in het brein zoals fosfocholine (PC), glycerofosfocholine (GPC), fosfoethanolamine (PE) 
en glycerofosfoethanolamine (GPE), informatie geven over verschillende hersenziekten. 
Echter de detectie van deze metabolieten bij een magnetisch veld van 1.5 T is moe­
ilijk vanwege de intrinsieke lagere magnetische gevoeligheid van fosforkernen t.o.v. 
protonkernen en vanwege de aanwezigheid van (overlappende) signalen van macro­
moleculen in het 31P spectrum. In hoofdstuk 6 introduceren we een nieuwe 31P MRS 
methode die de gevoeligheid van de detectie van PE, PC, GPE en GPC in het brein
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verbetert. Deze methode maakt gebruik van de overdracht van magnetisatie van 1H 
kernen naar 3,P kernen waarbij een intensiteitswinst van maximaal 2 .4  (y]H/y31p) te be­
halen valt. Echter wanneer dit wordt gedaan door middel van de traditionele RINEPT 
(refocused insensitive nuclei enhanced polarisation transfer) methode, dan worden 
de 31P signalen van PE, PC, GPE en G PC sterk verzwakt (50% of meer) doordat er 
zogenaamde J-koppeling plaats vindt tussen 'H kernen (homonucleaire koppeling). 
Hierdoor kan er minder magnetisatie overgedragen worden tussen 'H en 3,P kernen. 
De homonucleaire koppeling kan opgeheven worden door het gebruik van frequentie 
specifieke refocuserings pulsen. Vanwege de grote chemical shift bij een veldsterkte 
van 3 T ten opzichte van 1.5 T is het mogelijk om op 3 T de refocuserings pulsen exact 
selectief te maken zodat alleen de homonucleaire koppeling teniet gedaan wordt. Op 
deze manier laten we zien dat we met selective-RINEPT op 3 T een meer dan 2 keer 
betere signaal-ruis-verhouding van PE, PC, GPE en GPC kunnen verkrijgen dan met31P 
MRS zonder magnetisatie overdracht.
Om de spatiele verdeling van de gefosforyleerde metabolieten PE, PC, GPE en GPC in 
het brein weer te kunnen geven zijn er gradiënten voor fasecodering toegevoegd aan de 
sRINEPT-sequentie zodat het een MRS Imaging (MRSI) sequentie wordt. Hoofdstuk 7  
laat de eerste resultaten van sRINEPT 3,P MRSI in gezonde vrijwilligers van verschil­
lende leeftijden zien. De MR spectra met goede signaal-ruis-verhouding van voxels van 
17 cc in de parietaal en occipitaal kwab van de hersenen zijn verkregen met een ac- 
quisitietijd van ongeveer 17 minuten. De verhoudingen van PE t.o.v. GPE en PC t.o.v. 
G PC zijn invers gerelateerd aan de leeftijd van de vrijwilliger. De hoge resolutie van 
de MRSI maakt het mogelijk om verschillen in metaboliet niveaus tussen witte en grijze 
stof te detecteren. Bovendien hebben we de toepasbaarheid van deze methode in de 
medische diagnostiek laten zien door hem uit te voeren bij 3 patiënten met een hersen­
tumor. Hieruit concluderen wij dat de sRINEPT 3,P MRSI methode de mogelijkheid biedt 
om het metabolisme van fosfolipiden in het brein te bestuderen met een hogere gevoe­
ligheid en spatiele resolutie dan tot nu toe mogelijk was met andere 31P MRS methodes.
MR systemen voor het hele lichaam met een magnetische veldsterkte van 7  T komen 
nu ter beschikking voor experimenteel MR onderzoek. Vanwege de zeer hoge initiële 
magnetisatie bij deze veldsterkte, wordt het ook mogelijk om MRSI metingen met hoge 
spatiele resolutie te doen van kernen met een lagere gevoeligheid (zoals 31P) in een 
relatief korte meettijd. In een bijlage behorend bij hoofdstuk 7  laten we resultaten van 
31P MRSI van het brein zien bij een veldsterkte van 7 T. Voor deze metingen wordt 
gebruik gemaakt van een oppervlakte spoel, die resonant is op de frequentie van 31P, 
gecombineerd met een volume spoel die resonant is op de frequentie van 'H. Met een 
eenvoudige pulse-acquire MRSI sequentie en adiabatische excitatie worden signalen 
van het energie metabolisme, fosfomonoesters en fosfodiesters en anorganisch fosfaat
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(waaruit de pH waarde is af te leiden) in het brein in relatief korte tijd (16 tot 25 
minuten) met hoge resolutie (van respectievelijk 6.3 cc en 1.7 cc) in beeld gebracht.
Een andere kern die magnetische resonantie vertoont, is ,3C. Ondanks dat maar 1.1% 
van de koolstofatomen in menselijk weefsel ,3C is, waardoor ,3C MRS dus een heel lage 
intensiteit heeft, zijn er toch tal van experimenten gedaan met ,3C MRS om het glucose 
metabolisme in het brein te bestuderen. De gevoeligheid van ,3C MRS kan worden ver­
groot door het toedienen van een met ,3C verrijkte stof, zoals [1-,3C]glucose. Door dit 
te doen is het ook mogelijk om de opname en omzetting van glucose in het lichaam te 
volgen. Dit maakt ,3C MRS tot een unieke methode om de stofwisseling in het lichaam 
op niet-invasieve wijze te bestuderen. Informatie over de stofwisseling zou kunnen bij­
dragen aan de karakterisatie van tumoren en het in kaart brengen van hun kwaadaar­
digheid. Ondanks de mogelijkheden om de gevoeligheid van ,3C MRS te vergroten is 
deze methode nog niet eerder toegepast om het glucose metabolisme in tumoren van 
patiënten te onderzoeken. In hoofdstuk 8 presenteren we de eerste resultaten van ,3C 
MRS metingen tijdens infusie van [1-,3C]glucose in het bloed bij een patiënt met een 
hersentumor. Bovendien wordt ook hier gebruikt gemaakt van magnetisatie overdracht, 
ditmaal van 1H naar ,3C. Gedurende 1.5 uur worden MR spectra gemeten uit twee 
voxels, afwisselend in de tumor en in het normale hersenweefsel in de andere hemisfeer 
van het brein. Ongeveer 20  minuten na de start van de infusie van [1-,3C]glucose is er 
in het voxel in de tumor een signaal van [3-,3C]melkzuur zichtbaar tussen enkele andere 
resonanties van stofwisselingsproducten van [1-,3C]glucose. Het [3-,3C]melkzuur signaal 
is niet zichtbaar in het voxel in het normale hersenweefsel. Bovendien is de intensiteit van 
de signalen van [1-,3C]glucose in MR spectra uit het voxel in de tumor hoger dan in MR 
spectra uit het normale weefsel. Dit wijst op een grotere hoeveelheid glucose dat in de 
grotere extra cellulaire ruimte zit, mede veroorzaakt door een defecte bloed-hersenen- 
barrière in de tumor, waardoor glucose uit de bloedvaten lekt. De intensiteit van signalen 
van metabolieten die in of via de citroenzuurcyclus worden gevormd uit [1-13C]glucose, 
is lager in de tumor dan in het normale weefsel. Deze resultaten laten zien dat de op­
name van glucose en de omzetting naar metabole producten zoals melkzuur (dat wordt 
beschouwd als een marker voor de kwaadaardigheid van weefsel) op non-invasieve 
wijze gevolgd kan worden in de hersentumor van een patiënt.
9
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In dit proefschrift hebben we laten zien dat MRSI de medische diagnose van hersentumo­
ren kan verbeteren en dat MRSI gebruikt kan worden om de stofwisseling van hersentu­
moren te bestuderen. De verbetering en vernieuwing van meetmethodes heeft geleid tot 
een betere lokalisatie van 1H MR spectra in het brein (met semi-LASER 1H MRSI) en tot een 
hogere gevoeligheid van de detectie van fosfomonoesters en fosfodiesters in het brein (met 
sRINEPT 31P MRSI). Om MRSI als klinische geaccepteerde techniek te verwezenlijken is 
het nodig dat de betrouwbaarheid en reproduceerbaarheid van nieuwe MRS sequenties 
wordt bepaald en dat de gevoeligheid van MRS, met name van 31P en ,3C MRS verbeterd 
wordt.
De mogelijkheid om MRS(I) ('H, 31P en ,3C) te gebruiken om hersentumoren te karak­
teriseren en hun stofwisseling te bestuderen, is onderzocht in dit proefschrift. Zoals is 
gebleken uit onze studies heeft1H MRSI de potentie om hersentumoren van elkaar te onder­
scheiden en om hersenweefsel dat geïnfiltreerde tumor cellen bevat te onderscheiden van 
gezond hersenweefsel. Een betere karakterisatie van hersentumoren is van belang voor 
de patiënt en voor de behandelend arts. Wanneer meer informatie over de tumor beschik­
baar is kan therapie beter afgestemd worden per individu. Een betere visualisatie van het 
tumorweefsel zal bijdrage aan het niet-invasief monitoren van de effecten van therapie.
MRS technieken die vooral gebruikt worden in pre-klinisch onderzoek zoals ,3C MRS met 
de infusie van met ,3C verrijkte substraten zijn belangrijke handvaten in onderzoek dat 
gewijd is aan het ontrafelen van de stofwisseling, de groei en de kwaadaardigheid van 
hersentumoren. Enkele mogelijkheden voor de vertaling van deze technieken naar meth­
odes die bruikbaar zijn in de medische diagnostiek, zijn onderzocht in dit proefschrift. Om 
de klinische relevantie van nieuwe MRS technieken te bepalen, moeten zij getest worden 
op grotere patiënten aantallen en in meerdere onderzoekscentra.
De studies in dit proefschrift hebben zich gericht op de optimalisatie van MRS(I) data 
acquisitie. Echter, het is van belang om de parameters, die uit MRSI data voortkomen, een­
voudig beschikbaar te maken voor artsen. Om dit te bewerkstelligen zullen producenten 
van MRS apparatuur en onderzoekers hun krachten moeten bundelen om ervoor te zorgen 
dat MRSI data op een adequate doch snelle manier geanalyseerd kan worden, met be­
houd van de veelzijdigheid van de informatie die in MR spectra opgeslagen zit.
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Spectroscopic Im aging of 
the human brain at 7T
Adapted from: Conference proceedings, annual meeting 2010 of International Society for
Magnetic Resonance in Medicine 
High resolution 3 1P Magnetic Resonance Spectroscopic Imaging o f the human brain at 7T
J.P. W ijnen, A. Heerschap, T.W.J. Scheenen
Synopsis
In this addendum we demonstrate the use of a surface 31P quadrature coil in combination 
with a 'H CP head coil fo r31P Magnetic Resonance Spectroscopic Imaging (MRSI) of the 
brain at 7T with high sensitivity and spatial resolution. 31P MRS was run with a pulse ac­
quire MRSI sequence with adiabatic excitation. With this method signals from compounds 
involved in energy metabolism in the brain such as phosphocreatine, ATP, and inorganic 
phosphate, as well as resonances from phosphomono and diester compounds, involved in 
membrane metabolism, are detected in the human brain within relatively short acquisition 
times of 1 6 or 25 minutes.
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Introduction
Tissue levels of different phosphorylated compounds in human brain can be inves­
tigated in vivo  with 31P Magnetic Resonance Spectroscopy (MRS) ''6. However, this 
technique suffers from low signal to noise ratio (SNR) due to the intrinsic low sensitivity 
of phosphorous nuclei. Despite the use of higher magnetic field strengths (3-4 T) and 
long acquisition times to increase SNR the spatial resolution o f 31P Magnetic Resonance 
Spectroscopic Imaging (MRSI) remains rather low 7,B. With the introduction of whole 
body 7 T MR systems the sensitivity of 3,P MRS is substantially increased and 3,P MRSI 
can now be performed with clinically relevant spatial and temporal resolution.
In this work we present the use of a quadrature 3,P surface coil, which can be inserted 
into a 1H birdcage coil at 7  T to evaluate local spatial differences in MR-visible phos­
phorous compounds in the human brain. The aim of the study is to maximise the spatial 
resolution of 3,P MRSI in the human brain at 7  Tesla. The spatial resolution attainable 
at 7  T with 3,P MRSI within acceptable acquisition times for clinical use becomes close 
to what is commonly used for 1H MRSI at 1.5 T.
M aterials and Methods
H a rd w a re  a n d  subjects
Measurements were performed at a whole body 7 T MR system (Siemens, Erlangen, 
Germany). A  circularly polarised birdcage 'H head coil was combined with an in- 
house developed double loop quadrature 3,P surface coil that was inserted in the head 
coil. With this setup we were able to obtain 31P MR spectra covering the parietal and 
occipital lobe of the brain. Before every measurement, the 31P surface coil was manu­
ally tuned and matched to 50Q  at the phosphorous Larmor frequency and connected to 
the MR system within 5 minutes. Routine system-automated frequency alignment and RF 
power adjustments for the 1H nucleus was done before starting the first scout imaging 
measurements. For other imaging measurements the 1H RF power was calculated for 
a region of interest from a B, field map image. Before MRSI measurements, a large 
region of interest in the parietal and occipital lobe of the brain was shimmed using a 
supervised automated 3D mapshim algorithm. The carrier frequency of the 3,P transmit 
signal was automatically calculated from the aligned 1H water resonance, and the 31P 
RF power was set to a fixed value based on phantom measurements to assure that the 
threshold of the minimal B, field for the adiabatic RF pulse was met for the region of 
interest.
All measurements were carried out in compliance with the local institutional medical 
ethics committee and written informed consent was obtained before the measurement. 
Examinations were performed on 3 healthy volunteers, age 29 ± 4 years.
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Before MR spectroscopic measurements a 3D T1 -weighted (magnetisation preparation by 
inversion) image was acquired as an anatomical reference image set, with 1.3 mm isotro­
pic voxels, IT=1 100 ms, TR=2000 ms, TE=1.1 ms, acquisition time 4.48 minutes. Subse­
quently, 3,P MRSI was run with a pulse acquire spectroscopic imaging sequence with an 8 
ms (bandwidth 1 800Hz) adiabatic excitation RF pulse (BIR-4). The flip angle of the pulse 
was 45 degrees, which allowed using a short repetition time of 1 500ms.
Two 3,P MRSI measurements were performed. A  high resolution 3,P MRSI of only phospho- 
creatine (PCr) and y-adenosinetriphosphate (y-ATP) was obtained within 24 minutes with 
a real voxel size of 1.7 cc. The carrier frequency of the adiabatic excitation pulse was 
positioned at the frequency of PCr. Additionally a 3,P MRSI of the phosphomono and phos- 
phodiester (PME and PDE) resonances in the brain was obtained with lower resolution (real 
voxel size of 6.3 cc) within an acquisition time of 16 minutes. In these measurements the 
carrier frequency was positioned at the frequency of inorganic phosphate (Pi). The field of 
view, number of acquisition-weighted averages and the matrix size were adapted to obtain 
the desired resolution within the targeted acquisition time (24 minutes for PCr and y-ATP, 
16 minutes for PME and PDE). MR spectra were fitted with lorentzian line shapes using 
Siemens Syngo software. Metabolite maps were overlaid on a T1-weighted background 
image.
Results
In the MR spectra, the resonances of phosphoethanolamine (PE), phosphocholine (PC), 
inorganic phosphate (Pi), glycerophosphoethanolamine (GPE) and glycerophosphocholine 
(GPC) were well separated and had high SNR in the measurements with voxel sizes of 6.3 
cc (Fig. A 7 .1). In these spectra also clear signals from PCr and y-ATP could be observed. 
The a-ATP signal was attenuated by sub-optimal excitation at the limit of the bandwidth of 
the excitation pulse and the P-ATP signal was not visible at all. In some voxels of the brain 
a double Pi resonance could be observed, indicating the presence of two separate water 
fractions with different pH value. In the high-resolution measurement of PCr and y-ATP 
(voxel sizes of 1.7 cc) the signals of PME and PDE as well as a-ATP and P-ATP were not 
visible (with few exceptions in the most sensitive spot of the 3,P coil) due to too low SNR in 
these small volumes.
The metabolite map of PCr reveals the local distribution of PCr signals and the B, reception 
profile of the 31P surface coil (Fig. A7.2). Signals with sufficient SNR can be obtained from 
a large part of the parietal and occipital lobe of the brain. Outside the brain the signal 
intensity is zero as well as in the ventricles. From the corpus callosum the signal intensity 
decreases rapidly when looking at voxels at more frontal locations. Furthermore, the PCr 
distribution is symmetric in the left and right side of the brain.
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Since ratios of metabolites are independent of the B, coil profile, a colour map of these 
ratios can reveal differences in metabolite level between tissue types. Maps of PE/GPE and 
PE/GPE+GPC show differences between white and gray matter of the brain (Fig. A7.3).
Figure A 7 .1: 31P MR spectrum of white matter and a spectral map in saggita! direction overlaid on a T1 weigh­
ted image. Both MR spectra were obtained from a measurement of 16 minutes with a resolution of 6.3 cc. Sig­
nals from phosphomono and diesters as well as the energy metabolism are clearly visible and well separated.
Figure A 7.2: Metabolite maps of PCr in the transverse and saggital plane in the measurements with high 
resolution ¡1.7 cc). The B, coil profile of the 3]P surface coil is well recognisable.
Figure A 7 .3: Metabolite maps of PE/GPE (A), PE/GPE+GPC (B) and PCr (C) in the 3,P MRSI measurements 
with resolution of 6.3 cc. Differences in phosphoesters between white and gray matter become best visible 
in the PE/GPE+GPC map. PCr was also present in a large part of the brain in the measurements with a 
resolution of 6.3 cc.
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Discussion
Phosphorous MRS of the human brain at high magnetic field has been reported by other 
researchers before 9'10, however in these studies the main focus was to reveal metabolites 
from the energy metabolism and to determine relaxation times of PCr and ATPs. Besides 
assessing the resonances from the energy metabolism that have high SNR in the 31P MR 
spectrum because they are present at rather high concentrations, we were also able to 
obtain signals from PME and PDE with sufficient SNR and high spatial resolution. The 
detection of these signals on lower magnetic field strengths is hampered by low SNR and 
lower chemical shift dispersion, but might become clinically feasible with acceptable SNR 
and spatial resolution at 7  T.
A  relative simple adjustment to improve the method presented in this study is increasing the 
bandwidth of the excitation pulse such that all phosphorous resonances in the brain are 
excited. Signal loss due to T2 relaxation becomes negligible when using a pulse-acquire 
acquisition. This is advantageous for the detection of metabolites with short T2 relaxation 
times such as ATP at 7  T 9. Furthermore, the quantification of metabolites in MR spectra 
obtained with a pulse-acquire acquisition does not need a correction for T2 relaxation.
The only correction needed for quantification of the levels of phosphorous compounds in 
the MR spectra obtained in this study is a correction for T1 relaxation. Due to differences in 
T1 relaxation times between metabolites 9, each metabolite experiences a different satura­
tion, which needs to be compensated for. This can be done afterwards by calculating a 
correction factor that takes into account what repetition time and flip angle of the excitation 
pulse was used. The adiabatic pulse is insensitive for inhomogeneities in B, field, therefore, 
no extra correction for imperfect flip angle is needed since in adiabatic condition the flip 
angle can be regarded as uniform across the field of view of the coil. The influence of 
spatial variation of the sensitivity of the receive coil on metabolite quantification can be mi­
nimised by using a homogeneous volume receive coil or by calculating a correction factor 
(for the entire field of view of the coil) according to these differences in receive sensitivity.
Conclusion
We demonstrated a 31P MRSI technique to detect phosphorylated signals in the human 
brain at 7  T with high sensitivity and spatial resolution within relatively short acquisition 
times (16 or 25 minutes). The spatial distribution of phosphomono and diesters as well as 
PCr and y-ATP can be studied with high sensitivity. This enables to study the phosphorylated 
energy metabolism and the composition of phosphomono and diesters in human brain 
diseases in a clinical setting.
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Eindelijk is het dan zo ver, het manuscript is af en goedgekeurd! Tijd om even terug te 
blikken op de totstandkoming van dit proefschrift. Een dankwoord is hierbij zeker op zijn 
plaats omdat ik in mijn eentje nooit zo ver was gekomen.
Om te beginnen wil ik de mensen bedanken die ervoor gezorgd hebben dat ik dit 
promotieonderzoek kon gaan doen: mijn promotor Arend en co-promotor en Tom.
Arend, al vanaf de eerste sollicitatiegesprekken moet jij het vertrouwen hebben gehad dat 
het allemaal wel goed zou komen. Dat ik kampte met hevige RSI en daardoor eigenlijk 
helemaal geen computerwerkzaamheden kon doen, was voor jou geen belemmering 
om mij aan te nemen. En hoewel ik het eerste half jaar regelmatig heb gedacht dat het 
vanwege die RSI helemaal niets zou worden met mij als onderzoeker, heb jij daar nooit 
enige zorgen over geuit. Gelukkig vond ik professionele hulp en kreeg ik van jou de 
tijd en ruimte om te herstellen gedurende het eerste jaar van mijn aanstelling. Toen ik 
eenmaal echt op gang kwam, heb je me alle vrijheid gegeven om mijn onderzoek in te 
richten zoals ik dat wilde. Bedankt daarvoor! Je bent een echte wetenschapper, dol op 
nieuwe experimenten en altijd ontzettend nieuwsgierig naar het resultaat en dat werkte 
stimulerend! De keerzijde van je grote creativiteit en voorliefde voor brainstormen was 
dat ik meestal met meer vragen bij je weg ging dan dat ik mee gekomen was. Gelukkig 
bood Tom dan meestal snel de eerste hulp. Tom, ik was de eerste A IO  die officieel 
onder jouw verantwoording viel omdat ik deels op jouw VENI project aangesteld was. 
Ik kon te pas (en soms te onpas?) bij je binnenlopen om te vragen hoe en wat nou de 
bedoeling was van dit hele onderzoek. Ik heb veel van je geleerd en waardeer je super- 
pragmatische instelling. Met jou kon ik altijd spijkers met koppen slaan. Ook de dagen in 
Essen, waar we met de 7  Tesla scanner aan de slag mochten, waren ontzettend leerzaam 
en gezellig en deze zullen me nog lang bijblijven. Toen we met de groep verhuisden naar 
de "oudbouw", belandden we in dezelfde kamer pal naast de koffiekamer. Het klimaat 
in die ruimte liet nogal te wensen over, maar het was wel het gezelligste "kantoor" van 
de afdeling. Samen met onze andere 'roomie', Bob, discussieerden we heel wat af over 
onze onderzoeken en de gang van zaken op de afdeling en in het ziekenhuis. Bedankt 
voor alles wat je me hebt geleerd, en voor je hulp en gezelligheid!
Over 'roomies' gesproken, dan denk ik ook meteen aan Bob, alias, bobSTER. De 
verhuizing naar de oudbouw was een goede zet, eindelijk zag  ik Bob ook eens buiten de 
lunchpauzes om. Na ruim anderhalf jaar opgesloten gezeten te hebben in het dierenlab, 
bloeide je (in mijn ogen) bij ons op de kamer helemaal op. Wat heb ik mét en óm je 
gelachen! Het was enorm praktisch een IT- en Matlab-goeroe als jij dicht in de buurt te 
hebben. Bovendien was je altijd bereid om mee te denken over de interpretatie van de 
resultaten. Bedankt voor al die momenten en heel veel succes met het afronden van je 
eigen onderzoek!
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En dan niet te vergeten natuurlijk, Christine, altijd aanwezig op de afdeling van 's ochtends 
vroeg tot 's avonds laat. Lang geleden tijdens onze studie in Eindhoven, hadden we het 
allemaal al uitgedokterd: we zouden samen in een grote oude boerderij gaan wonen. Dat 
leek ons wel wat, lekker in de buitenlucht, liefst wat heuveltjes in de buurt zodat we lekker 
konden wielrennen, maar niet al ver van de stad want er moest ook gestapt kunnen worden.
De omgeving van Nijmegen leende zich hier wel voor..... Tja, die boerderij is er niet
helemaal van gekomen maar in het flatje vlakbij het ziekenhuis was het ook goed vertoeven. 
Als vriendin, huisgenoot en collega heb je altijd een bijzondere rol voor mij vervuld. Bedankt 
voor alles, voor vakinhoudelijke discussies, een luisterend oor, voor goede adviezen, voor 
het klankbord van onze (gedeelde) frustraties en voor alle gezelligheid en lol!
Sjaak, toen ik startte met mijn onderzoek had Arend jou de taak toebedeeld om mij te 
helpen met scannen en het analyseren van data zolang ik zelf de muis nog niet vast kon 
houden. Hij had geen beter persoon kunnen bedenken om mij in juist die periode te 
helpen. Jij bent de rust zelve en praatte me moed en zelfvertrouwen in. Bedankt daarvoor! 
Je hebt engelengeduld, niet alleen met mij maar ook met computers en dat is wel handig 
voor iemand die de neiging heeft om de micro-pauzes te negeren! Ik heb genoten van je 
taalgrapjes en de verhalen over HRMAS, klussen en de kids. Je was ook een goede reis- 
buddy, ik zal nooit vergeten hoe we in Grenoble tijdens een eTumour meeting met zijn 
allen op één hotelkamer moesten overnachten terwijl de knuffels de wacht hielden.
Dit brengt mij bij de andere eTumour partners. Ik wil alle eTumour-ers van Radiologie, 
Pathologie, Neurologie en Analytische Chemie bedanken voor de prettige samenwerking 
en een aantal van hen in het bijzonder.
Ivonne, je was vanaf de eerste dag dat ik op de afdeling kwam de helpende hand bij alle 
patiënten die ook MRS-onderzoek kregen. Zeker in het begin leek het wel of we hemel en 
aarde moesten bewegen om patiënten te kunnen opnemen in het onderzoek, maar jij liet je 
daardoor niet weerhouden en klom alweer in de telefoon voordat ik hem kon pakken! Het 
was leuk om van jou te leren hoe het er nu werkelijk in de praktijk aan toe gaat! Bedankt 
voor al je enthousiaste hulp en gezellige koffie- en lunchpauzes.
Ook van Bas heb ik veel kunnen leren over de klinische praktijk. Vanaf het moment dat 
jij ook op het eTumour project ging werken, kwam de patiëntenstroom pas echt op gang. 
Je was ontzettend begaan met de patiënten en was van ieders toestand feilloos op de 
hoogte. Bedankt voor de prettige samenwerking en heel veel succes bij het afronden van 
je eigen onderzoek en opleiding tot neurochirurg!
Alan, it was kind of funny that you arrived in Nijmegen just before I left the group. We 
already had a good collaboration during the eTumour project and even now I still enjoy 
your dry English humour during work related email conversations. Thank you for all the 
language corrections in my manuscript and the help with my final Nijmegen-paper.
Als laatste in dit rijtje wil ik ook Pieter (neuropathologie) bedanken voor zijn altijd
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constructieve bijdrage aan overleggen en discussies, alsook de hulp bij het schrijven van 
CMO-aanvragen en artikelen. Je enthousiasme voor onderzoek, zelfs als je er niet direct bij 
betrokken bent, werkt aanstekelijk!
En dan zijn er gelukkig altijd nog de mensen met twee rechterhanden! Andor, al mijn 
fantomen zouden meteen in de prullenbak zijn beland als jij je er niet even mee bemoeid 
had. Een echte klusheld! Bedankt voor al je hulp en vrolijkheid!
Mark, tjonge jonge, wat is het toch jammer dat die stomme spikes maar bleven komen en 
ervoor zorgden dat ik maar geen patiënten kon gaan opnemen in mijn nieuwe studie. Eén 
ding staat voor mij in ieder geval vast, aan jouw inzet en doorzettingsvermogen heeft het 
niet gelegen! Achteraf gezien heb ik juist van al dat solderen en prutsen met interfaces veel 
geleerd en het was nog gezellig ook! Dus bedankt daarvoor!
Nog zo een collega, Dennis, de eeuwige optimist en positieveling. Een nieuwe sequentie? 
Dat kost slechts 8 uur programmeren: stelt toch niets voor? Bedankt dat je me hebt 
aangestoken met het multi-nuclei virus. 31P en ,3C MRS maakte mijn promotieonderzoek een 
heel stuk uitdagender en interessanter! Ook bedankt dat je me volledig ondersteunde bij het 
aanvragen van de Marina van Damme beurs en dat je er ook nog eens als vanzelfsprekend 
vanuit ging dat ik hem zou krijgen. Gelukkig bleek dat terecht en je bent dus voorlopig nog 
niet van me af!
Wanneer je gaat werken in een onderzoeksgroep weet je van te voren dat het een komen en 
gaan van nieuwe collega's zal zijn. Het leuke van de groep van Arend was dat, ondanks die 
relatief kortstondige "werk-relaties", het toch altijd een gezellig en hecht clubje enthousiastelingen 
was. Daarom wil ik graag iedereen bedanken die daar met mij deel van uitmaakte.
Hermien, ondanks dat we "slechts" 2.5 jaar samen hebben gewerkt, lijkt het toch of we elkaar 
al veel langer kennen. Samen in de trein Utrecht-Nijmegen, samen op congres en nu weer 
samen aan de 7T-knoppen. Ik waardeer je kritische noot en bereidheid om steeds weer mee 
te zoeken naar oplossingen. Bedankt voor alles!
Marinette, bedankt voor al je hulp bij het schrijven van artikelen en analyseren van de 
ingewikkelde 13C-data, beide met een precisie die niet te evenaren valt! Van jouw NMR- en 
algemene feitenkennis kunnen we allemaal nog wat leren!
Kim, eindelijk kwam er een nieuwe AIO  en was ik niet meer de jongste van de groep. Je beet 
je helemaal vast in het ,3C-modeleren zodat je ons meteen alles kon uitleggen, bedankt! en 
succes met je volgende ,3C MRS metingen!
Alle andere AIO's en postdocs, Edwin, Fernando, Thiele, Isabell, Hetty, Patricia. Jammer dat 
jullie pas zoveel later bij de groep kwamen, ik had graag langer met jullie samengewerkt. 
Heel veel succes bij jullie onderzoek!
De stagestudenten, Miriam en Marnix. Bedankt voor jullie werk en enthousiasme. Het was 
leuk om jullie te begeleiden, en ik hoop dat het artikel naar aanleiding van jullie stageproject 
nu echt snel volgt!
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Ook de MRI-laboranten en het wetenschappenlijk personeel van de afdeling Radiologie 
wil ik hier nog bedanken. Met name Cindy, Denise, Richard, Miranda en Mark. Bedankt 
dat jullie altijd bereid waren om te schuiven met de dagindeling om weer een extra patiënt 
te kunnen opnemen in de studie! Dat geldt ook voor Marijke en Manita, die sommige 
onderzoeken wel 6 keer heen en weer hebben moeten plannen. Bedankt voor jullie hulp 
in het doolhof dat Qdoc heet!
Tot slot wil ik van deze gelegenheid gebruik maken om al die lieve mensen te bedanken 
die het leven bijzonder de moeite waard maken en dan bedoel ik met name mijn familie 
en vrienden. Want hoewel ik me altijd erg goed vermaak op mijn werk valt er daarnaast 
ook nog genoeg leuks te beleven! Bijvoorbeeld, een mooi tochtje wielrennen of een 
avondje lekker muziek maken. Het waren goede uitlaatkleppen na mislukte metingen of 
uitzichtloze analyses. Ook in de weekeinden zorgden de -meestal sportieve - uitstapjes 
met familie en vrienden voor de nodige ontspanning. Bedankt voor jullie oprechte interesse 
in mijn onderzoek en steun. Maar nog meer bedankt voor alle gezellige en mooie borrels, 
dineetjes, feestjes en vakanties!
Beste lezer, met het risico dat ik vergeten ben om jou persoonlijk te bedanken voor je 
morele en/of praktisch bijdrage aan dit proefschrift, wil ik nu toch echt de laatste woorden 
van dank richten tot de mensen die het dichts bij mij staan.
Frans, van je grote broer kun je alles leren! Of het nu banden plakken, wiskunde of 
programmeren betreft, zelfs het promoveren heb ik van je af kunnen kijken. Bedankt voor 
praktische hulp en tips bij het afronden van dit proefschrift en bedankt dat je altijd en 
overal voor me klaar hebt gestaan!
Dat geldt ook voor mijn ouders; Thei en Marianne, jullie hebben mij allebei op geheel 
eigen wijze altijd gesteund tijdens mijn promotieonderzoek (en daarvoor). Ik ben jullie 
ontzettend dankbaar voor het onvoorwaardelijk vertrouwen in mij en de eindeloze hulp in 
alle tijden. En niet te vergeten, bedankt voor het kritisch lezen van alle punten en komma's 
in dit boekje!
David, ik weet niet precies waarvóór en hoe ik je moet bedanken (hoe typisch!) maar 
ik weet wel dat jij mij de afgelopen jaren er doorheen hebt gesleept als ik het echt niet 
meer zag zitten. Ik ben blij dat ik alles met jou mocht delen, zowel de successen als de 
tegenslagen. En hoewel je vakinhoudelijk misschien niet alle details kon begrijpen, liet je 
toch altijd al je analytische vaardigheden op kritische maar integere wijze op mij en mijn 
onderzoek los! Bedankt dat je in me gelooft, ik verheug me op ons volgende avontuur!
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